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Abbreviations 
AA Adjuvant Arthritis 
ACPA Anti Cyclic Citrullinated Protein Antibody 
APCs antigen Presenting Cells 
BCIP 5-Bromo-4-chloro-3'-indolyphosphate p-toluidine 
CBBR-250 Coomassie Brilliant Blue R-250 
CD Complementarity Determinant 
Cl Chapter 1 
CDNB 1 Chloro 2, 4- Di Nitro Benzene 
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DCs Dendritic Cells 
dH=O Double distilled water 
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mm millimetre 
NASA[Ds Non-Steroidal Anti-inflammatory Drugs 
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NFAT Nuclear Factor of Activate T cell 
NFkBp65 Nuclear Factor kappa B p65 
NOD-SOD Non-obese diabetic—severe combined immuno-deficiency. 
NK cells I Natural Killer cells 
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PAGE Poly-Acrylamide Gel Electrophoresis 
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PMSF Phenylmethanesulfonyl fluoride 
PRRS Pathogen recognition receptors 
PBS Phosphate Buffered Saline 
PTPN-22 Protein tyrosine pbosphatase, non-receptor type- 22. 
PVDF Pulyuirwlidenc fluoride 
RA Rheumatoid Arthritis 
RANKL-L Receptor Activator of NF-kappaB Ligand 
RBCs Red Blood Cells 
ROS Reactive Oxygen Species 
RT Room Temperature 
SCID Sever Combined Immunodeficient 
SCF Stem Cell Factor 
SDF Stromal Cel I derived factor 
SOS Sodium Dodecyl Sulphate 
SEA Schistosoma Egg Antigen 
SEM Scanning Electron Microscopy 
SF Synovial Fluid 
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STAT Signal Transducer and Activator of Transcription 
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Reagents 
& Formulations 
NFkB p65 extraction solution: 
1. Buffer A 
10rnN1 HEPES. p11-7.9. 	1.5mM MgCl2, 
I OmNI KCI, 	 1mM DTT, 
lmM PMSF. 	 0.1%DTT 
2. Buffer B 
25% v/v glycerol. 	 20mM HEPES. pH-7.9, 
42mM NaCl. 	 1.5mM MgCl2, 
2mM EDTA, 	 1 mM DTT, 
1 mM PMSF 
Dot Blot, Western Blot and ELISA reagents: 
1. PBS-T 
50mM PBS, pI-I-7.4 	 1 L 
0.5% Tween-20 	 5 nil 
2. BSA- 5% 
13SA 	 5 gm. 
PBS-"I' 	 100 ml. 
BSA was dissolved in PBS-T buffer by gentle mixing. BSA (5% w/v) was used to 
block non specific binding sites on PVDF membrane. The dilution of primary 
antibody for detection of protein of interest and secondary antibody (conjugate) is 
mentioned in the respective protocols provided in materials and methods. 
3. Detection reagent 
i. One tris buffer tablet (Sigma) dissolved in 20 ml of PBS-T 
ii. One BCIP/NBT (Sigma) tablet dissolved in 10 ml of tris 
buffer The vial containing BCIP/NBT tablet in tris- I-IC1 buffer was wrapped with 
aluminium foil to avoid direct sunlight. 
SDS-PAGE buffers and solutions: 
1. Acry lamide/Bis (30%►T, 2.67%C) 
.Acr} lamide 	 29.2 g/100ml 
N'N his methylene-acrylamide 	0.8 g/100ml 
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&agents et Tonnu&Cians 
The reagents were dissolved in 50m1 of distilled water (dH20) separately, mixed and 
adjusted uptol DOmi with dH2O. 
2. 10% SOS 
SDS 	 10 g/ l00nil 
The SDS was dissolved by gentle stirring in 90 not of dH2O and brought to 100 not with 
dH2O. 
3. 1.5 M Tris-HCI buffer, pH- 8.8 
Tris base 18.15 g/ 100 ml 
dH2O 80 ml 
Tris was dissolved in 80 ml of dH2O and the pH - 8.8 was adjusted with 6N HCI. The 
volume was brought to 150 ml with dH20 and stored at -4°C. 
4. 0.5 M Tris-HCI buffer, pH- 6.8  
Tris base 6.0 g 
dH2O 60.0 not 
Tris was dissolved in 60 ml of dH10 and then pH- 6,8 was adjusted with 6N HCI. The 
volume was brought to ISO nil with dlh0 and stored at -CC. 
5., Sample buffer 
dl[20 3.55 ml 
0.5M Tris-HCI. pH-6.8 1.25 not 
Glycerol 2.5 ml 
10% (w/v) SDS 2.0 ml 
0.5 % (w/v) Bromophenol Blue 0.2 ml 
Total Volume 9.5 ml 
The solution was stored at -4°C. 5Oµ1 (3-ntercaptoethanol was mixed to 950µ1 of sample 
buffer prior to use. 
6.  10% Ammonium persulphate (APS) 
Ammonium peraulphate 100 mg 
APS was dissolved in I out of d112 0. Solution was always prepared fresh. 
7.  loX Running buffer 
Tris base 30.3 g 
Glycine 144.4 g 
SDS to g 
All the reagents were prepared in dH2O and brought to a final volume of I L. 
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Gel formulation for SDS-PAGE: 
1. Separating Gel (11%) 
dHzO 	 3.7 ml. 
Acrylamide./Bis 	 3.7 ml. 
Separating gel buffer (pH-8.8) 	2.5 ml. 
SDS (10%) 	 0.1 ml. 
All the above solutions were mixed and 501d fresh APS (10%) and 5µl TEMED were 
added just prior to pouring the solution. 
2. Stacking Ccl (5%) 
dH2O 	 5.7 ml. 
Acrylamide%Ris 	 1.7 ml. 
Stacking gel buffer (pH-8.8) 	2.5 ml. 
SDS (10%) 	 0.1 ml. 
The above solutions/buffer were mixed and 50µl APS (10%) and lOµ1 TEMED was 
added just prior to pouring the solution. 
Gel formulation for gelatine substrate zymography: 
The composition of gel was similar to the conventional reducing SDS-PAGE gel 
except additional gelatine was used. 
1. Gelatin 
Gelatin solution was dissolved in separating gel to achieve the final concentration: 
lmg/ml. In zymography, sample buffer was devoid of 13- mercaptoethenol. 
2. Washing buffer 
Tris-base. pH-7.6 	 6.0578 
NaCI 	 11.688 
1 riton-X 	 2.5% 
The tris-HCI buffer, pH-7.6 was prepared in 500m1 of d1120 and other reagents were 
added. After that volume was brought to IL with dH2O. This buffer was used to 
remove SDS from the gel after electrophoresis. 
3. Digestion butler, pH-7.6 
Tris-base 	 6.057 g 
NaCI 	 11.688 g 
CaC12 	 0.368 g 
Brij-35 	 0.02% 
vii. 
Rgngents eZTonna(ations 
The tris base was dissolved in 200m1 and pH 7.6 was adjusted. After that other 
reagents were added and brought to 1L with dHZO. 
4. (Fixation solution 
Methenol 	 50% (v/v) 
Acetic acid glacial 	 10%(v /v) 
dHZO 	 40% (v/v) 
5. Gel staining solution 
CBBR-250 	2.5g 
Coommassie Brilliant Blue R-250 (CBBR-250) was added in 100 ml of fixation 
solution, mixed properly and stored at room temperature. 
6. Destaining solution 
Contained similar composition as fixation solution. 
1x Sodium phosphate buffer saline, pH-7.4 (1 litre): 
(JIM Na2HPO4 14.2 g 
0.IM NaH2PO4 15.6 g 
0.15M NaCI 8.82 g 
Solution was adjusted to pH-7.4 by mixing NaH,PO4 into Na2HPO4 and required 
quantity of 0.15M NaCl was added in to the solution. the butler was stored at room 
temperature. 
Hanks Balanced Salt Solution (HBSS) (1 litre): 
NaCl 8.000 g 
KCI 0.400 g 
Na.HPO4.7H2O 0.050 g 
KH,PO, 0.060 g 
MgSO4.7H20 0.200 g 
NaHCO3 0.220 g 
CaC12 0.1858 
All the reagents were dissolved in dH2O one by one and brought to 1L with dH2O. 
The buffer was stored at room temperature. 
0.05 NITris-HCI buffer, pH-7.6: 
Tris (hydoxymethyle amino methane) 6.057g 
Tris base was dissolved in 200m1 of distilled water, adjusted to pH-7.6 with HCl and 
brought up to IL with distilled water and stored at room temperature. 
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Super oxide dismutase assay solutions; 
Tris-Cacodylate buffer 50mM 
DTPA 1 mM 
EDTA 1mM 
Pyrogallol 2.6mM 
Glutathiune-S-transferase assay solution: 
Sodium Phosphate Buffer O.IM 
CDNB 1.0mM 
Reduced glutathione 1.0mM 
Catalase assay solutions: 
H202 30mM 
Sodium phosphate buffer 50mM 
Nitric Oxide (NO) assay solutions (1 litre) 
1. Nitrite standard solution 
NaNO2 6.89 g 
Dissolved in IL of distilled water. 
2. Griess Reagent solution 
Griess reagent 40.0 g 
Griess reagent was prepared just before NO assay. The reagent was dissolved in 0.IM 
PBS pH-7.4 and stored in dark. 
Lipid peroxidation assay solutions (l litre): 
Thiobarbituric acid 6.70 gi lL 
3% TCA 30.00 g! I L 
All the reagents were prepared separately. 
Protein Carbonylation solutions (1 litre): 
40% TCA 400.00 g/ lL 
DNPH(0.02M) 3.96g1IL 
Guanidine HC1(6M) 573.18 g/ l L 
All the reagents were prepared separately. 
Tissue Fixatives for Scanning Electron Microscopy: 
Paraformaldehyde 4g1100 nil dH2O 
Sodium phosphate buffer 0.2M 
Glutaraldehyde 25% stock 
ix 
Ncagen1s aZ Formulation 
100 nil ofparaformaldehyde in double distilled water was prepared in a conical flask 
at 60°C. The mouth of the flask was covered. The solution was cooled and filtered and 
equal volume of 0.2M Sodium phosphate buffer, pH-7.4 was added to make 2% 
paraformaldehyde stock solution, then 10 ml of glutaraldehyde (from stock) was 
added in 90m1 of 2% paraformaldchydc solution to make the final concentration of 
the fixative in the ratio- 2% paraformaldehyde : 2.5% glutaraldehyde. 
Tissue Fixative for Histology (10% neutral buffered formaline): 
Formaldehyde (41% stock) 	24.39 nil 
Sodium phosphate buffer (O.1M) 75.61 ml 
The formaldehyde solution was mixed in sodium phosphate buffer, pH-7.4 and stored 
at RT. 
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GENERAL INTRODUCTION 
(Introduction to Model parasites) 
Taxonomic Classification of Fasciola gigantica and Gigantocotyle explanatttm 
Taxon Fasciola gigantica Gigantocotyle explanation 
Kingdom Platyhelminthes Platyhelminthes 
Class Trematoda Trematoda 
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Order Echinostomida Echinostomida 
Sub Order Echinostomata Paramphistomata 
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Ilelminthes are wide ranging parasitic worm like organisms, mainly belonging 
to the phylum platyhelminthes, which includes flat worms; and the nemathelminthes, 
which includes round .corms or nematodes (Robert, 1996). It is estimated that 
helminthes infect around 3 billion people worldwide (flotez et al., 2008). Helminth 
infection causes millions of death worldwide, mainly in developing countries (Loc. 
Cit.; Pullan and Brooker. 2008). Among the platyhelminthes the class trematoda 
includes a wide variety of flukes which infect both animals and humans. causing 
enormous morbidity and mortality. Fasciola gigantica are large, leaf shaped, 
trematode parasites of mammals particularly ruminants and humans, causing the 
disease, Fasciolosis (Dalton, 1999), which is an economically important helminth 
disease, impeding the productivity of domestic animals worldwide. Another 
trematode parasite species commonly infecting the buffalo liver is the Gigantocotyle 
explanatum, which causes amphistomosis. Both Fasciola gigantica and Gigantocotyle 
erplanaluin are the digenetic trematodes of domestic livestock of the tropical and sub 
tropical areas of the world. Both the parasites are commonly inhabited in hepato-
biliary system of the herbivores and ruminants like cattle, camel, buffalo, sheep etc. 
F. gigantica is closely related to the Fasciola hepatica which is the inhabitant of 
Gencraf Introduction 
mainly temperate climate but it has been reported from all the continents of the world 
(except Antarctica) as a result of the immigration of the European settlers (Mark, 
2008). 
In buffaloes the prominent clinical manifestation of tropical fasciolosis by 
Fusciolu giganhicu include retarded weight gain despite unaltered digestibility of 
nutrients in the infected host, partial appetite or complete inappetence, constipation 
and for diarrhea, sub-mandibular edema and progressive anemia etc. (Mehra et al.. 
1999; Yadav et al., 1999). Fasciolosis caused by infection with tropical liver fluke. 
Fasciola gigantica, is regarded as one of the most important single helminth infection 
of ruminants in Asia and Africa (Boray, 1985; Harrison et al., 1996; Malone, 1997). 
Estimated prevalence of F. gigantica in ruminants ranges upto 80-100 % in some 
countries (Spithill. 1999). Together with major nematode infections, fasciolosis is a 
big threat throughout Asia, south-east Asia and Africa and is thus significantly 
hampering the global food production (Murrell, 1994). It has been estimated that 
world population growth will demand a threefold increase in food production by the 
year 2050 and consumption of livestock products may rise several fold. This high 
demand subsequently exert a pressure to increase the productivity of life stock with a 
40-50% increase in meat production projected for developing countries (Loc.cit.). 
Since tropical fasciolosis is one of the significant factor which limit the livestock 
productivity, therefore, the development of sustainable strategies for controlling 
F. gigantica infection is a priority. Strategic use of anthelmintics, introduction of 
genetically engineered animals with high genetic resistance to the parasites or by the 
use of vaccines, biological control and better herd management that all can play an 
excellent role in sustainable control of fasciolosis (Loc. Cit.; Roberts and Suhardono, 
1996). 
Gigantocolyle c tpplanataunt is another neglected tropical parasite of water 
buffalo. Prevalence of infection is very high in Indian subcontinent. Personal survey 
revealed that one out of three sacrificed buffaloes at the local slaughter house suffered 
from this infection. Economic loss due to G. expalanatuin cannot be well said because 
of the non-availability of data. The infected livers show hemorrhages and connective 
tissue proliferation at the site of attachment, vascular degeneration in the liver and 
hyperplasia in the bile duct, thereby seriously affecting the health and productivity of 
infected animals (Swarup et al., 1987). 
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Life ('%rlc of Fasciolu /;igrutticu 
Definitive host discharge immature eggs in hi liars duct and stool. l:<....s become 
embr'onated in \\ater. Egg releases meracidia \\hick invade suitable snail 
intermediate host (/.rnrnuea currirtrlur•ia). In snarl, the parasite under goes several 
de\ elopmental changes (sporoc\ st. redia. ceracariae) (Fig. 1). 
the cerrariae are released from the snail and enc\st as metacercariae on aquatic 
'egetation or other surface. Dark condition induce cerearial emergence. Mammals 
acquire infection b\ eating \egetation containing metacercariae. human can become 
infected h\ ingesting fresh \\ater plants. especially %atercress containing 
metacercariae. Atier ingestion metacercariae e\c\st in duodenum and migrate through 
intestinal \'all, the peritoneal cavit\ and liner parenchyma in to the hiliar\ duct \\here 
the\ cfe\ elop in to the adult. In humans maturation of adult flukes takes approxinlatel\ 
-4 months. The adult flukes reside in the large hiliar\ duct of mammalian host. 
Fisciola can intent a number of ruminant animals and also lahclrator animals like rat. 
rabbit etc. 
Life Cycle of Gi/;cntoeott/e e.vplanalum 
ite c' etc is more or less very similar to /-'. ,t'is;cnlica in its Ii e stages except the 
intermediate host species: 1_i'ntnura t,•uttculuru. Dit't'erencc lie,, onl\ in its intermediate 
host. \liracicliae stage infects \\ide range of snail species (Fit.2). 
Contribution of the Ii~er flukes in the present thesis 
I Ielnlinth parasite,, induce the Fh2 t\ pe of anti-inflaniniatcr\ immune response 
in contrast to bacterial. \iral infection and au1clrnVlurle disease condition where 
immune response is pro-inflammatory Th I t\ pe. 'tile research \\ork of the present 
thesis has been dig ided in to to parts: In Part 1- the immunological role different 
doses of Fa.cciolcr gigawica and Gigot» ocntt'le e.vhuncdtcm and the combined somatic 
antigens of- both the flukes as established in \\'istar rats h\ using serum c tokine as a 
prime parameter that ser\ ed as a marker for the t\ pe of immune response ('I'h 1 or 
1112) against these antigens. Additionally. certain oxictati e stress markers like nitric 
oxide (NO) that also act as an important signaling molecule for determination of t\pe 
of immune response. nlalondialdeh\de INIDA) and protein rarhon lation (PC) \Here 
also investigated in serum and different tissues. In fart 2- I he establishment of 
immune response further -,aye insight to use these antigens for the treatment of 
Th l Th 17 mediated iutlamrllator\ aluo{nlrlllnle arthritis Using collagen induced 
arthritis (CIA) in \Vistar rats as an animal model .l. After successful establishment of 
C'enerariiurodfUCt ion 
CIA model. different doses of F. gigunlicu and G. explunalunz and combined antigens 
were used to treat the diseased rats and therapeutic potency was ascertained by serum 
pro inflammatory cvtokincs (I FN-'1 and TNF-a) and anti-inilaWlmatc)t•\ cvtokines (II.-
4 and II.-10). level of' difierent matrix metalloprotcinases. transcription factor NFkI3 
p65. antioxidant enzymes (super oxide dismutase. glutathione-S-translerase and 
catalase). oxidative damage markers (NO. MDA and PC) in joints, scanning electron 
microscopy of patellae and synovvial histology. 
Life Cycle of Fasciolrr zi. antiea 
Definitive host; cattle or sheep 
Eggs pass into faeces 
Infection by; 
food/pasture 
ingestion 
1 	i 	~ Zoonosis 
	
__	 .4.,. 
Embryonate 
in water 
F.xcyst in 
Eneyst oil duodenum  
lo
xlation and Juveniles  
Infectbn in Iher penetrate 	 Adult fluke 
gut and liver 
Metacercaria 	 Tropical liver fluke life cycle Miracidium 
Cercaria 
release and 	 infect the snail 
locate substrate 
foroncystment 
NEJ 
Sporocyst 
Intramolluscan 
d~ 	stages 
Figure.l. Life cycle of F. gliga►uirc►. The eggs laid b\ the adult worm passes in faeces. In 
appropriate environmental conditions miracidium development starts \\ ithin the eggs. 
Upon hatching of eggs the miracidium is released and rinds its way into the snail host. 
where it undergoes different developmental stages namely sporocvst. redia. ceracaria. 
C'ercariae emerge from snails and inunediatel\ transform into metacercariac. \0hich are 
the infective stage for ruminants and humans. 
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Figure.2. Life cycle of G. explanatum. The eggs laid by the adult worms pass in 
faeces. Under the suitable conditions the eggs hatch out to release miracidium, 
which undergo different developmental changes within the infected snail host: 
sporocyst, radia, ceracaria which finally emerges out from the snail and encyst 
to become meetacercaria on the vegetation. Metacercaria is the infective stage 
for ruminants and human. 
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"TIhe evaluation of therapeutic potentia[andpathologica(consequences of 
'Fascio&a gigantica and 9lgantocoty&e explanatum derived somatic 
products. " 
cP1C1: Introluction 
CHAPTER 1 
1.1-INTRODUCTION 
Helminth parasites consist of diverse group of metazoans. These parasites 
have huge burden on human and ruminants in most of the world and cause serious 
pathological conditions in infected individuals (Allen and 'viaizels, 1997). The 
consequence of helminth infection is more severe due to the large number of infected 
individual than the severity of infection (Allen and MacDonald, 1998). Helminth 
infection causes high morbidity and less mortality. The severity of disease is the 
outcome of high parasitic burden as well as weak and inappropriate immune response 
of the host. The tropical liver fluke, Fasciola gigantica, is a digenetic trernatode 
similar to the temperate species, F. hepalica. which commonly infect the ruminant 
animals and inhabit their bile ducts. The distribution of both the parasites is wide 
spread all over the world. These parasites are the causative agent of fasciolosis. In 
contrast to F. hepatica, F. gigantica have very few cases of zoonosis. 
Fasciolosis is one of the most common problems in cattle, buffaloes, sheep and 
goat etc. The impact of this disease on countries economy is very unfortunate. Poor 
meat quality, low milk production and poor wool quality are the major problems of 
fasciolosis (Salcha. 1991). The F giganticu and F. hepatica infection alone incur 
about 3000 million USDs economic losses worldwide (Morphew et al., 201 I). In 
contrast to the F. gigantica, Gigantocotyle explanatum is mainly restricted to tropical 
and sub-tropical countries, including India. This amphistome parasite is also found 
inside the bile ducts of cattles and buffaloes. A recent report from the Planning 
Commission (2011-12) (Anon, 2011-2012) revealed that a number of outbreaks of 
fasciolosis and amphistomosis have been reported from various part of the country. 
However, no data is available regarding the economic losses incurred, particularly due 
to amphistomosis. But it has been observed that this parasite also causes pathological 
conditions like hemorrhages and connective tissue proliferation at the site of 
attachment, liver vascular degeneration and bile duct hyperpla.sia, thereby seriously 
affecting the health and productivity of the infected animals (Swamp et al., 1987). 
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Both the parasite (F. glgatuica and G. explanatarn) are widely spread in Indian live 
stock as well as human infections have also been documented (Yadev et al., 2009; 
Chaudhary et al., 2014). 
Faseiolosis is not only restricted to ruminants but also about 17 million people 
are considered to be suffering from fasciolosis (Hopkin, 1992) and aboct 180 million 
people are at the risk of infection. Consumption of contaminated water, raw 
vegetables, and unhygienic conditions arc the major source of zuonosis. Human 
fasciolosis is supposed to vary from one region to other region. Areas like South 
America, Iran, Egypt, Portugal and France are hypoendemic for parasitic infections 
(Esteban et al., 1997) while Bolivia and Peru, the infection is considered to be 
hyperendemic and it is a serious health problem. High prevalence up to 72% and 
100% has been observed in Bolivian and Altiplano (high plane) respectively (Mas-
Comma et al., 1999). European countries like France and Spain are also not devoid of 
the human fasciolosis. 
The life paltem of the Fasciola sp. inside the definitive host mainly contributes 
to the pathological and immunological conditions. Newly excysted juveniles penetrate 
the intestinal wall, enter into the peritoneal cavity, migrate to the liver and burrow the 
liver parenchyma to reach its final destination. During the parenchymal stage parasite 
causes severe pathology. The extent of the damage increases as the fluke grows to 
maturity. It is observed that migration tracts og flukes have many cellular debris, 
blood cells and infiltration of many immune cells including macrophaghes, 
eosinophils, plasma cells and CD3' lymphocytes along with the proliferation of 
fibrous connective tissues (Martinez-Moreno et al., 1999). The level of eosinophils is 
very high during parenchyma stage and persists at elevated level even after the 
parasites enter inside the bile duct in case of hF hepatica (Ross et al.. 1996). It has 
been experimentally proved that in sheep, F. hepatica induces grzanulomatous tissue 
formation in hepatic parenchyma (Chauvin and Boulard, 1996). Recruitment of 
immune cells due to F. hepatica infection occupy a large proportion of liver 
parenchyma which ultimately cause severe damage (Loc. Cit.). 
The disease severity reflects the level of infection. The acute Fasciola infection 
may cause sudden death especially in sheep. Sever symptoms are not easily apparent 
at the early stage of infection but the presence of abdominal pain reflect the presence 
of disease. During chronic infection the animal suffer from ventral edema, pallor of 
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mucus membrane. wool break. weight loss while chronic infection in sheep leads to 
death with plenty of eggs in faeces. 
Changes in blood constituents have also been found during F. hepcurcu 
infection. Anemic conditions are observed in experimentally infected mice at the 
parenchymal stage of infection (Dawes, 1963). Level of albumin and 
immunoglobulins also change after the infection. Hyperglobulinaemia and 
h' poalhuRUnemia is also observed during Fusciulu infection. Furthermore the 
migratory flukes secrete endoproteinases which help the parasites during migration 
(Dalton and Heffernan. 1999). 1-hcsc protcinascs including cathcpsin L1, secreted by 
F. hel)aheu, are involved in degradation of extracellular matrix and membrane 
component and help in parasitic migration (Berasain et al., 1997). The parenchymal 
damage affects the plasma albumin (Anderson et al., 1977). The elevated level of 
imniunoglobulins like IgM, IgGI and IgE several weeks after infection is very 
obvious (Holmes et al., 1968). Besides these biochemical changes it is found that 
ROS (Reactive Oxygen Species) increases after the parasitic infections (Smith and 
Bryant. 1989: Boczon et al., 1996) resulting in an imbalance of the oxidant-
antioxidant mechanism. If the antioxidant mechanism became ineffective the level of 
antioxidant enzymes decreases and peroxidation of lipids lead to severe damage of 
cell membranes and formation of carbonylated proteins. Kolodziejczyk et al. (200 5) 
reported decreased level of super oxide dismutase. glutathione peroxides and high 
level of lipid peroxidation during the migratory phase of F. hepatica. 
Nitric oxide (NO) play an important role in many physiological processes like 
vasodilation, nerve transmission etc., but on the other hand endogenous and 
exogenous NO plays a significant role in killing of parasites including Fu.seiolu. NO 
generated by monocytes and macrophages trigger the cytotoxic effect on Fuscio(u 
hepuuicu (Piedrafita et al.. 2001). NO also inhibits the parasite cysteine proteinases 
and thus affecting the parasite viability (Salvati et al., 2001). Cysteine proteinases are 
the major component of F gigantic and F. heperlica excretory/secretory products and 
are involved in parasite establishment. The inhibition of the enzyme activity reflects a 
protective behavior of NO against parasitic infections. Furthermore. it has also been 
found that the NO production by macrophages which have been classically activated 
by IFN-y, 'l'NF-u. has been mainly established in Sehislusorrru sp. and Fcrsciolu sp. 
(Cervi et al., 1998; Gazzinelli et al.. 1992; Sibille et al.. 2004) infection. 
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Against the host's protective mechanisms which may include killing of the 
parasites, the Fasciola sp. have developed several methods of escape from such 
strategies of the host. For example; (a) superoxide free radicals produced by host cells 
in response to the infection are neutralized by the superoxide dismutase antioxidant 
mechanism as evident in case of 1•1 gigmnlica juveniles (Ganga et al.. 2007; Piedrafita 
et al.. 2007). (h) F. hepulica cathepsin I. propteinases involved in the cleavage of 
immunoglohulins IgE and IgG which are responsible for the antibody dependent 
cellular toxicity (Smith. 1993). Beside this, Fasciola sp. derived products have strong 
tendency to suppress the inflammatory immune response created by the host. Studies 
suggested that the E; S of F. hepatica suppress lymphocyte stimulation in case of 
sheep and rat (Cervi et al., 1999; Moreau et al., 2002). Immune response during 
Fasciola is characterized by Th2 type of response. The detailed overview of Th2 type 
of immune response has been given in the section of review of literature. Briefly, Th2 
immune response is mainly dominated by anti inflammatory cytokines like 11.4. 
IL-10. IL-13. and IL-6. 'l hese cytokines act antagonistically towards the Thl type 
cytokines, v0hich are pro-inflammatory in nature and characterized by IL-12, IFN-y, 
TNF-u etc. During I iscio/a infection J helper cell clones promote the synthesis of 
IgG 1 via IL-4 (Th2 type of cytokinc) expression (Brown et al., 1999). The level of 
IgG2 is decreased in case of F: hepatica infection. This IgG2 isotype is enhanced by 
Thl cytokinc IFN-y (1-:rtes et al.. 1994) but due to the immunodominant Th2 response 
the production of IgG2 is blocked. The change in immunoglobulin isotype secretion is 
due to the polarized immune response towards Th2 type and it is consistent even in 
chronic infection (Clcry ct al., 1996). 
Besides the natural or experimental infection, the parasite derived antigens also 
produce Th2 type of response. Several studies suggest the antigenicity of Fasclula 
EIS products (Jefferies et al., 1997; Milbourne and Howell, 1997, O'Neill et al., 
2001). 0' Neill (200)) demonstrated that the Fasciola EIS products mount immuno 
suppressive response by inducing the production of type2 cytokine repertoires. EIS 
products also found to enhance the eosinophils (Loc Cit.). Milbourne and Howell 
(1997) demonstrated that E!S of Fasciola contain IL-5 like substance, probably 
responsible for local and systemic eosinophilia. 
YLL. I Ant roductton 
In case of G. expl natum nothing is known about the immunology as well as 
biochemical parameter involved during the establishment within the definitive trust. 
Therefore, the present study becomes all the more important. 
Aims and Objectives 
The purpose of this study is to evaluate the cytokine milieu in the serum of 
Wistar mts in response to the F. gigandca and O, explanatum derived somatic 
antigens together with certain ethoingicul as well as signaling rnolecnii,ca. The scrum 
cytokine repertoire can be used to ascertain the line of T helper cell immune response 
against those vurtigecs. Level of Nitric oxide (NO), malondialdehyde (MDA) and 
protein carbony lation (PC)  can be used as a pathological marker during the amigenic 
inoculation. NO can also be used as a signaling molecule for immune response against 
these anti ens. Thcsc immunological and biochemical parameter used as a homologue 
of the independent as well as concurrent infection with EE gigantica and 
G. explanaAum ht Wistar Rat>. 
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CHAPTER 2 
1.2- REVIEW OF LITERATURE 
pidemiological studies suggest that the T helper cells play an important role 
in development of strong adaptive immunity in the form of Th2 type of response 
(Maizels and Yazdanhaksh, 2003). Innate immune mechanism has lesser role as most 
of the helminthes are too large to be phagocytosed. Hence, anti worm mechanism is 
mainly mediated by the activation of strong Th2 response. 
Before reviewing the Th2 response in details, it is important to know that how 
naive cells undergo differentiation in to different "1 cell subsets like ThI, Th2, Th17 
and inducible regulatory T cells inside the host after a stimuli (Zhu et a)., 2010) (Fig. I 
& 2). 
Differentiation of naive T helper cells in to different subsets: 
The differentiation of naive I' helper cells is achieved by a stimulus in the form 
of processed peptide antigen, presented by major histocompatibility complex I l (MI IC 
11) on antigen presenting cells (ADCs). The presentation of antigen is mediated by the 
T cell receptors (TCR), present on the surface of T helper cells. The antigenic contact 
with these cells promotes differentiation which gives rise to an effector T cell clones, 
specific for the same antigen MHC II complex. These effector cells are CD4+ and can 
be divided in to three main types with distinct cytokine secretion which give a unique 
functional characteristic to each type of cell. Depending upon the cytokine nature 
these subsets of naive CD4+ cells are referred as Th l , Th2, Th17 and T-regulatory. 
This cytokine based phenotype differentiation of CD4- cells is triggered by various 
kinds of infectious agents as well as self antigens (Fig. 1). 
Thl cell secrete the inflammatory cytokines including IFN-y and TNF43 and 
"ITNF-cu which are protective against the intracellular infection by virus, bacteria and 
other microorganisms which grow inside the cells like macrophages (Kidd, 2003; 
Roitt and Delves, 2001). Th2 cell signature cytokines are Interleukin-4 (I1,-41, 11.-5, 
IL-9, 1L-13, and IL-25 (also known as lI,-17E). These cells are responsible for the 
activation of antibody production, activation of mast cell, cosinophils, and basophils 
through different cytokine milieu. Th17 cells are characterized by the secretion of 
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11:17, 11.-17F, 11.-6, TNF-u. H.-22, and other cvtokines These cells are involved in 
tissue inflammation, activation and recruitment of neutrophils to defy extracellular 
bacteria and autoimmune disorders like rheumatoid arthritis. Inhibition of dendritic 
cell maturation and secretion of T cell inhibitory molecules lead to the development 
of other non effector cells called as T regulatory cells which secret TGF-13 and IL I 0 
which modulate 1' cell activity and suppress some of their function and induce 
tolerance to antigen. In a broader sense the Thi cells mediate cellular immune 
response, while Th2 cells are involved in humoral immune response. The Thl, Th2, 
ThI7 subsets and their released cytokine are antagonistic to each other and one or 
other cytokine is dominant in response to a particular pathogen at one time. This 
specific immune response to particular pathogen involves differential pathways 
associated with different molecular determinants (Kai.ko et al., 2007). 
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figure.I. Antigen presenting cells (AP('s) induced activation of naive T helper cell (ThO) and 
differentiation towards different cell lineage. (Image Source: Peterson, 2012). 
Overview of immune response during Ilelminth Infection: 
llelminth infection is mainly characterized by the Th2 type response %here 'fh2 
cell subset is involved in the production of immunoglobulin E (lgL) by B cell class 
switching mediated by 11.4. IgF immune complex activate innate immune cells 
I_basophils and mast cells, resulting in their degranulation) by cross linking high-
affinity Fe receptor of IgE (FceRl) on the surface of these cells. The activated 
tia 
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basophils and eosinophils secrete various mediators that include eytokine, chemokine, 
heparin, histamine, serotonin and proteases which trigger smooth muscle contraction, 
vascular permeability and infiltration of inflammatory cell. The IgE cross-linking 
further enhance the expression of FccRl by these cells which provide a powerful 
amplification mechanism of IgE mediated immune response. Th2 cells also migrated 
to the lungs and interstitial tissues where they leads to the IL-5 mediated recruitment 
of eosinophils and mast cells through IL-9 causing to tissue eosinophilia and mast cell 
hyperplasia. Th2 cells induce mucus production, goblet cell metaplasia and airway 
hyper-responsiveness by directly acting on the epithelial cells (through Ih4, [1-9 and 
IL-13) and smooth muscle cells (through 11.4 and IL13). Hence the Th2 response 
amplifies along with innate immune cells therefore a cross talk between innate and 
adaptive immune system is very important for parasite expulsion (Paul and Zhu, 
2010). 
Physical barrier and parasite recognition 
In spite of Th2 response as a major drive in helminth infection the innate 
immune response also plays a crucial role to protect the host from the parasitic 
infections. It is as important as the adaptive immune response because it acts as a. first 
line of defense which includes physical barrier (Male et al., 2006) and the innate cells 
etc. Physical barriers including skin and the mucosal lining do not allow the pathogen 
to enter inside the host. The second innate immune barrier is the recognition of the 
pathogen by the receptors present on innate cell like APCs called as pathogen 
recognition receptors (FRRs), These PRRs recognize the PAMPs (pathogen 
associated molecular patterns) which are not naturally found on host cells (Medzhitov 
and Jeneva, 2000). The Toll like receptors (TLRs) are the best characterized familyof 
PRRs (Mcdzhitov, 2001; Takeda and Akira. 2005; West, 2006). There are 10 known 
Toll like receptors (TLRs) in humans and 13 in mice (Kumagai et al., 2008). TLRs are 
expressed mostly by APCs including macrophages and B lymphocytes, but most 
importantly by Dendritic Cells (DCs) (McGettrick and O'Neill, 2007). Along with 
TLRs, other PRRs like C-type lectin receptors (CLRs) also play important roles in 
innate PAMPs recognition. C-type lectin receptors (CLRs) are transmembrane lectins 
(sugar-binding proteins) which recognize carbohydrate glycan structures present on 
the pathogens (Geiltenbeek et al., 2004). 
Hehninth derived molecules are recognized by the host in an effort to generate 
an immune response to eliminate the parasite. But the current knowledge how 
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helminthes are recognized by the innate immune cells is limited by a limited number 
of PRR ligands of parasite origin (McGuinness at al., 2003; Zaccone at al., 2006). In a 
number of cases recognition of helminth derived molecules has been demonstrated to 
be dependent upon various TLRs, including TLR2, TLR3 and most prominently 
TLR4. The best described helminth-derived product is Acanthacheilonema vireae 
ES-62 which is recognized by DCs in a TLR4 dependent manner ((toodridge et al., 
2001 and 2005). Similarly. LNFPIII is also recognized in a TLR4 dependent fashion 
(Pemna-Wright etal.. 2006). 
Innate cols in Helminth Infections 	 - 
InnaI,e cells are very important for initiation as well as effector phase of Th2 
type of responses. Secretion of cylokines by CD4~ Th2 effector cells instruct and 
amplify the innate effector cells and the activated innate cells in turn help to sustain 
and promote expansion of the Th2 effector cell population. The effector immune 
response is the outcome of such cross talk (Anthony at al., 2007). 
Macrophage and Neutrophils 
The macrophages promote Thl type response to infectious bacteria and viruses. 
The classically activated macrophages are thought to destroy the microorganisms by 
inducible nitric oxide dependent pathway (Mantovani at al., 2005). However, many 
studies suggest the alternative activation of macrophages at the site of helminth 
infection (Anthony at al„ 2006; Loc. cit., 2005; Rodriguez-Sosa at al., 2002; Ilerbert 
at al., 2004; Gupta at al., 2004; Reece el al., 2006). The alternative activation of 
macrophages is triggered by cytokines like IL4, 1L13, ITAO and IL21 (Loc.cit. 
Anderson and Mosser, 2002; Mosser, 2003; Loc. cit.). The alternative activated 
macrophages cause healing of wounds produced by the large migrating helminth 
parasites, by clearing matrix and cell debris and also by releasing cytokines. growth 
factors and angiogenic factors that promote libroplasias and angiogenesis (Martin and 
Leibovich, 2005). 
The neutrophils are also activated and recruited at the site of infection during 
tissue invasion by hclminths (Loc. cit.; Morimoto et al., 2004). The nentrophils work 
in coordination with other cell population including eosinophils and macrophages, 
and potentiate direct damage to tissue dwelling heiminthes. In vivo studies suggest 
that neutrophils inhibit the Heligmocomoides poZygyru.r and were also damaging in 
vitro (Loq. cif.). 
14 
;PIC2: Rcweu of Lit 
Eosinophils 
During helminth infection, high level of' blood eosinophilia is reported (Ganley-
Leal et al., 2006) and these eosinophils rapidly migrate to the site of infection where 
they degranulate, releasing eosinophil secondary granule proteins (ESGPs). A major 
effector function of eosinophils and their ESGP might be more or less similar to the 
macrophages. in tissue remodeling and debris clearance following tissue injury and 
wound healing response following tissue invasion by parasites (l.oc. cit.). 
Basophils and mast cells 
The numbers of basophils increase in the blood and tissues following helminth 
infection. In .\'ipppwtrongvlus hrasiliensis infection. IL-4 producing basophils are 
easily detectable in the liver, lung. and spleen but absent in lymph nodes and Peyer's 
patches (\lin et al., 2004: Shinkai et al., 2002). IL-4 is the major secreted cytokine by 
the basophils and eosinophils at early stage of the Th2 cell response. suggesting that 
they promote the development of' Th2 cells or their recruitment to the site of 
inflammation (1.oc. cit.). 
The mast cells have many similarities with basophils. in the cell surface 
expression of the high affinity Fe receptor for IgE (FceRI) and TLRs: TLR2 and 
TLR4. The mast cells release IL-4 and other mediators upon activation and it has been 
recently found that they are derived from a common progenitor (Arinobu et al., 2005). 
Ho%kever, mast cells reside in peripheral tissues unlike the basophils which circulate 
in the blood. Therefore. mast cells are first to encounter with the invading pathogen. 
CD4 I cell derived cytokine enhance the recruitment of mucosal mast cells in 
affected tissues during helminth infection, for example. IL-4 dependent mucosal 
mastocytosis is associated with a resistant phenotype to II. polygyrus (Behnke et al., 
2003). But under certain cases increased mastocytosis is not observed in granuloma 
where larva develops (Morimoto et al., 2004). The mast cells have restricted role 
during Schislo.vonut infection but it is assumed that these cells may have certain role 
during cercarial penetration through the skin (Gerken et al., 1990). 
Other Cell Population 
Recently scveral non leukocyte populations have hcen described having role in 
helminth infections. In vitro studies suggest that intestinal epithelial cells inhibit th. 
ability of DCs to promote Thl type response by thymic stromal lymphopoeti 
("ISLI'), that block the production of IL-12 by DC's (Rimoldi et al., 2005). 
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The natural killer cells have been shown to be activated by helminth infection 
(Hsieh et al., 2004; Tliba et al.. 2002). During Trichuris muris infection gut resident 
NK cells produce IL-13 in SCID (Sever Combined lmmunodeficient) mice 
(McDermott et al., 2005). The protective roles of these cells are unclear. Recent 
studies have implicated IL-25 in promotion of host protective Th2 type immune 
response during intestinal nematode infection, and also in recruitment of newly 
identified non B cells. and non T cells population that express elevated level of Th2 
type cytokine mRNA to draining mesenteric lymph nodes (Anthony et al.. 2007). 
These cells either have different I ineage or perhaps a precursor population of mast cell 
or basophils and express cKIT but no FecRl that contribute to the development of the 
Th2 type response (Fallon and Mangan. 2006). 
T and B cells as adaptive Immune cells 
The development of effector Th2 cells following infection with helminthes is 
the major achievement of these parasites. The Th2 dominated cytokine response has 
broad effect, promoting anthelmintic effect or function in a variety of ways. 
CD4+ T helper as a heterogeneous effector cells 
The helminth infection induced effector Th2 cells are characterized by high 
level of their signature cytokines IL-4, IL-5, IL-9, IL-13 and recently identified IL-21; 
and inhibition of IFN-y and IL-17 production (Anthony, 2007). During immune 
response to S. man.coni, Th2 cells can also produce 11.-10 (cause et al., 2003). 
Following infection with different species of bacteria and viruses, the naive T cells 
differentiate toward "I h 1 lineage, which is determined by microbial pathogen 
associated molecular patterns (PAMPs) that hind to "I'LRs and other innate receptor 
pattern expressed on antigen presenting cells with high level of !FN-y and low level of 
!L-4. The recent studies show that hchninthcs can also provide an adjuvant function, 
driving Th2 cell differentiation in rho to non parasite antigens (Liu et al.. 2005: 
Holland et al.. 2000). In this context IL-2 mediates initial Th2 cell differentiation 
whereas IL-4 is required fir expansion of antigen specific Th2 cells. The source of 
II,-4 may be the non T cells, bystander T cells and antigen specific Th2 cells that 
produce IL-4 and promoting proliferation through an autocrine feedback loop. In fact, 
autocrine IL-4 produced by antigen specific CD4+ T cells is sufficient to support Th2 
cell differentiation and expansion during N. brasiliensis infection (Loc. cit.). The 
associated structures on hehninthes that drive Th2 cell response are not yet clearly 
defined. However, available data suggest that lipoproteins, lipids, and glycans 
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expressed by certain helminthes might function as PAMPs to drive Th2 cell 
differentiation (Okano et al., 1999; Hokke and Yazdanbakhsh, 2005; Akdis et al., 
2003; van der Kleij et al., 2002). Recently, chitin was identified as a potential Th2 cell 
stimulating PAMP in helminthes (Phillips et al., 2003). The role of DCs in 
preferentially promoting Th2 cell differentiation during helminth infection is unclear, 
however several studies indicate that DCs are activated following exposure to 
Schiosrosoma egg antigen (SEA) and preferentially induce Th2 cell differentiation 
(Jankovic et al., 2004; Cervi et al., 2004). 
During helminth infection. Th2 cells orchestrate the activation and expansion of 
leucocytes primarily through the production of cytokines, an essential function that 
serve to amplify and sustain the Th2 type response. In addition, TL-4 and IL-13 can 
directly affect cell populations that express IL-4R but that arc not derived from bone 
marrow, but from tissues such as small-intestine, smooth muscle cells, epithelial cells 
and mesenteric neurons (Finkelman et al., 2004). IL4R signaling is largely dependent 
on the signal transducer and activator of transcription factor 6 (STATE). H. poly'nus 
infection induces STATE dependent changes in epithelial cell function, increased 
smooth muscle contractility, increased mucus production, and enhanced fluid in the 
gut lumen (Madden et al., 2004; Slica-Donohue et al., 200; Madden et al., 2002). 
These studies suggest that Th2 cell derived li, 4 and IL-13 contribute in a STAT6 
dependent manner to the weep and sweep response that is characteristic of many 
intestinal helminthes, in which increased ]urinal fluid (weep) and muscle 
contractility (sweep) arc speculated to make the intestinal lumen an inhospitable 
environment for the helminth parasites (Anthony et As 2007). So multiple host 
protective mechanism might contribute to an effective H polygyrus response with 
macrophages targeting developing parasite during the tissue dwelling phase and 
eytokine induced change in gut physiology affecting adult worms in intestinal lumen. 
The immune response is generally inhibited during H. polygyrus infection (Loc. Cit.). 
In case of scltistosomes infection an early Thl type response is elicited which 
typically changes to a Th2 type response following parasite egg deposition (Pearce 
and MacDonald, 2002; Stadeeker et al., 2004). 
The host specific CD4 T cell response to schistosomes infection stimulate 
parasite growth and development and results in an inflammatory environment which 
compel the translocation of parasite eggs from the intravascular compartment into the 
intestinal lumen (Davies et al., 2001, Docnhoff, 1998). The controlled hepato- 
17 
PIC2: `Retina ofLiterature 
intestinal granulomatous inflammation around the egg in the Thz type polarized 
milieu might represent a compromise between the parasite and the vertebrate host, 
allowing the parasite to complete life cycle, while at the same time protecting the host 
from severe lethal disease. In certain experimental mouse strains the host- parasite 
interaction is not achieved to the balance and this results in a severe pathological 
inflammatory response mediated by CD44 ThI and Th17 cells (Stadecker et al., 2004: 
Pearce and MacDonald, 2002; Rutitzky et al., 2005). 
CD4f T cells also have a recently discovered subpopulatiou i.e. Th17, defined 
by their production of IL-17 that can mediate chronic inflammation in autoimmune 
disease such as arthritis (Cua et al., 2003). Th17 cells are stimulated by IL-23 
(Aggarwal et al., 2003). In sehistosomosis, immunization with soluble egg antigen 
(SEA) along with complete Freund's adjuvant in wild type or IL-12 p35 deficient 
C57BL/6 mice mimic the egg induced pathology that is associated with elevated 
IL-17 level and fail to occur in mice lacking [L12p40 (Rutitzky et al., 2001 and 2005). 
Thus 1L-1i- IL-23 is critical for development of severe schistosomosis, although a 
role for the IL-12-IPA`-y pathway cannot be completely disregarded. Consistent with 
this interpretation, administration of IL-17 specific antibody can reduce naturally 
developed extensive pathology in CBA trice (Joe. cit.), More recent studies have 
shown that cytokines like IL-21, TGF-p and IL-6 are the key inducer of Th17 cell 
expansion, and the IL-23 act as survival and expansion factor for this subset of T 
helper cells (Veldhoen et al., 2006; Bettelli et al., 2006). 
Regulatory T cells 
The available studies suggest that the T regulatory cells (Tregs) have an 
important role in suppression of immune response during filarial parasite infection. It 
is found that the population of Tregs expand after the nematode infection (Loc.cit.; 
Summer ct al., 2003; Anthony et al., 2007). The following (Fig. 2) can give a brief 
idea about the differentiation of Th subpopulations (Loc.cit.). 
in vivo depletion of T regs leads to increase killing of Liwmosoides sigmudontis 
(Taylor et al., 2005), suggesting that T regs are essential for the immunosuppression 
of host responses during the parasitic infection. T reg cell populations are essential for 
the down regulation of Thl inflammatory response against SEA, however initially it 
was thought that this role is mainly mediated by the ILI O cytokine (Loc. cit.). 
But findings of McKee and Pearce (2004) and Baumgart at al. (2006) indicate 
that T reg cells function through yet unidentified IL-10 independent mechanism as 
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well, T ree cells are also important in Th2 type of response in chronic S. munsoni 
infection (Loc.cit. and l avlor et al., 2006). Future studies need to explore the role of 
Th2 cells, T reg cells, alternative activated macrophages and perhaps other innate cell 
population in the control of Thl and Th17 cell mediated inflammation and 
upregulation of Th2 type of responses. 
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Figure.2. Differentiation of name' cell 
Naive ('LM 1 T helper cell differentiate into different type of effector and regulatory 
cell during helminth infection. Specific transcription factors and cytokines contribute to 
the differentiation of these T cell subpopulations and such a differential activation play 
a key role in determining whether an immune response will contribute to host 
protection or not Antigen presenting cells (AP(s) produce IL-12 which in turn induces 
I bet (a transcription factor) expression. driving 'I [hi cell dif ercntiation. These cells 
produce If\-Y. and arc unable to clear helminth parasites. [he circumstances leading to 
the Th2 cell differentiation are not very clear. The IL-2. IL-25 and thyrnic stromal 
lymphopoietin (TSLP) and associated transcription factors are supposed to be involved 
in T cell differentiation. ('ytokines produced by fh2 cells contribute to the anthelmintic 
immunity by instructing innate bone narrow and nonbone marrow derived strong fh2 
type responses which control I'h I and "I'h 17 cell mediated exacerbated inflammation, in 
case of schistosomosis or it develops a great resistance in 11. po/vgvru.s infection. 
I Iowever. prolonged and chronic potent 'l h2-cell responses can also lead to harmful 
Th2-type inflammatory responses including fibrosis. The transcription factor Fork head 
box l'3 (FUXP=) together with the cytokines I'G1--(i and 11,-2, stimulate regulatory 
-1' cells (T reg cells) differentiation. I reg can inhibit the immune response through 
IL-10. which is no longer considered to he exclusi%ely a Th2-type cytokinc, and it can 
be produced by Tb 1. 'Ch2, and T reg cells and down regulates both Th I and Th2 type 
responses. 
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Anti body response during helminth infection 
During helminth infection the Th cell clone responsible for the Th2 type of 
response upregulates the 1L4 mediated B cell class switching to IgE which is a 
primary mediator of acute allergic and asthmatic reactions that binds FceR 1 on mast 
cells and basophils which cause the mast cell degranulation and release of soluble 
mediators (Boyce, 2003.) The Th2 type cytokine IL-4 and IL13 increased the 
sensitivity of target cells to basophils and mast cells derived mediators, through IL-4R 
mediated signaling pathway. Thus Th2 response enhance the IgF. effect in presence of 
Th2 type of cytokine which result in increased vascular permeability, smooth muscle 
contractile, and also the recruitment of Th2 type of effector cells, including 
eosinophils and Th2 cells (Finkelman et al., 2004) (Fig 3). 
Other antibody classes like 19M and IgG also have roles during helminth 
infection. For example secreted IgM which recognizes larval parasite and act in T cell 
independent manner, is essential for timely expulsion of filarial parasites (Rajan et al., 
2005). The ability of host for the production of IgG2 in response to IFN-y (Estes and 
Brown, 2002) is inhibited as a result of polarized Th2 response. This Th2 response is 
found to be consistent in chronically infected animals (Clarke and Little, 1996) with 
major immunoglobulin isotype IgG I was dominant during F. hepatica infection. 
Cytokines: a key player during helminth infection 
The cytokines play a key role in worm expulsion. This cvtokine dependent 
anti-worm mechanism elicits various immune and non immune cells to get rid of the 
parasitic infection. This immune response is referred as the tvpe2 (Th2) immune 
response where innate and adaptive immune cells work together for parasite removal 
(Anthony, 2006). Th2 type of immunity is characterized by high level of IL-4, IL-5. 
IL-13 and IL-21 secretion, antibody class switching towards IgE, activation and 
expansion of Th2 cell mast cells, basophils and eosinophils. IL-25 also act as a Th2 
cytokine and is involved in nematode parasite expulsion (Owyang et al., 2006: Fallon 
and Mangan, 2006). According to the Fallon and Mangan (2006) the exact role of IL-
25 is unclear. The IFN-y is the Thl type of' cytokine and involved in killing of 
intracellular bacteria and viruses which increase the number of Thl cells, cvtotoxic 
CD8+ T cells, neutrophils and macrophages (Loc. cit.). The role of IL-10 is 
controversial. IL-10 was initially characterized as Th2 type cytokine, more recently it 
is found that this cytokine is also produced by Thl and T regulatory cells that down 
regulate both Thl and Th2 response (Loc. cit.). Th2 cytokines viz. JL-4, IL-13, IL-21 
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and IL-25 can also downregulate the Thl and Th-17 type of immune response (Loc. 
cit.) (Fig•3). 
 • 
d~ 	~ 	• 	• •~ ~ . 1 8' 	. uK1t C! ~ IIKreAt'U 
era J We 
• • • r. 	.h ; 
[tu... 	N and )nsep. 
r!`SQOItSt 
•5 ' 
Natwe Revie" mmunoiogv 
Figure.3. Schematic diagram showing the role of 'Fh2 cytokines in parasite expulsion through 
various Th2 cytokine dependent mechanisms (Image Source: Anthony, 2007). Cytokines play an 
important role in development of immune response during helminthic infections Th2 cells 
produce cytokines primarily in lymph nodes and periphery. IL-5 together with IL-4. IL-9 and IL-
13 tugger eosinophilia and cross linking of FceRI (High Affinity Rc receptor RI) can result in 
enhanced mast cells and basophil cells degranulation and release of mediators For expulsion of 
intestinal worms IL-4 and IL -I ± stimulate smooth muscle contraction, increase intestinal 
permeability and elevated goblet mucus secretion and also enhance the responsiveness to mast cell 
derived mediators. IL-4 along with other signals lead to antibody class switching toward IgE 1L4, 
IL-13 and IL-21 stimulate the development of alternative activated macrophages (AAM) leading 
to upregulation of arginase-I expression and in some cases these might lead to fibrosis as in case 
of chronic Schistosomosis, cKIT FceRl population migrate toward lymph nodes upon stimulus 
received by IL-25 and upregulate Th2 type of mRNA. RELM, resistin like molecule. CIIAFFs, 
chitaniase and FIZZ family member 
Nitric Oxide (NO): 
NO is an important molecule which is being utilized throughout the animal 
kingdom, involved in cell to cell communication as a signaling or toxic agent. It is 
produced by many cell types, and in mammals it acts as a vascular relaxing agent, an 
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inhibitor of platelet aggregation and relaxing agent (Moncada et al., 1991; Lincolon et 
al., 1997; Coleman, 2001). Besides its physiological role the NO is also generated 
during immunity and inflammation while its role in these cases is very complex and 
less defined (Loc. cit.). NO is involved in innate defense mechanism against parasitic 
protozoan infections, allergic disease such as asthma and hence its level becomes 
higher during inflammation. Equally under certain circumstances it also acts as an 
immune suppressor via its inhibitory or apoptotic effect on cells (Loc. cit.). The high 
level of NO is perhaps due to the upregulation of inducible NO synthase in response 
to pro-inflammatory cytokines during infections or exposures to specific parasitic 
antigens. Pro-inflammatory cvtokines like IFN-y, TNF-a and IL-113 and pathogen 
derived antigens such as glycosylphosphatidylinositols are supposed to be involved in 
stimulation of iNOS (inducible Nitric Oxide synthase) in infected cells (Almeida 
et al., 2000; Lycon, 1995; Tachado at al., 1997). 
Generation of Nitric Oxide 
NO is produced universally from L ariginine and molecular oxygen via an 
enzymatic process which utilizes electron donated by NADH. NO synthase change 
L- arginine to NO via generation of intermediate species, N hydroxyl-L-Ar-L-
citrulline. One molecule of L-arginine converts into one molecule of NO and nitrogen 
atom of latter comes from a terminal guanidine group of the arginine side chain 
(Coleman, 2001). 
Nitric oxide during Ilelminthic Infection 
It is well known that the bacteria, viruses and parasitic protozoan induce Th 1 
type of response, characterized by high level of pro-inflammatory cytokines such as 
IFN-y, 	TNF-a, IL-1(3, while in case of helminthes the immune response is 
characterized by anti inflammatory cytokines. In such cases it can be assumed that the 
role of NO against helminth might be limited, but it is not true. More recently it has 
been investigated that NO play an important role in defense during helminth infection 
such as .Schistosoma mansonn, Trichinosis, Gastrointestinal nematodes, lymphatic 
filiriasis (Rosa-Brunet, et al., 1999). 
NO during Schistosomosis: 
Trematode parasite of genus Sc/z stosvmu, are the causative agent of 
schistosomosis. Free swimming larvae penetrate the skin and develop in to the 
schistosomula inside the host. Schistosomula migrate to the hepatic portal system 
(S. mansoni and S. japonicuin) or to the venule of urinogenital system (S. 
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hematohium), intravascularly where parasite mature. Eggs laid by adult female worm 
excreted by gaining access to the intestinal lumen or urinary canal. All the eggs are 
not excreted out successfully while some are swept to the liver or bladder, where they 
develop the pathological lesions/wounds. Severity of disease is caused by the host 
immune reaction with the trapped eggs which induce granuloma formation by the 
excessive recruitment of macrophages, eosinophils, lymphocytes and fibroblast. In 
fact formation of granuloma is an effective protective mechanism of the host to 
preventing the hepatocytes to come in direct contact with the egg released hepato-
toxic antigens, but high level of infection causes fibrotic lesions leading to organ 
malfunction. The importance of exploring the role of NO has got a lot of attention, 
particularly in the light of finding that the Th2 response which was regarded as a 
detrimental is intact host protective during Schistosoma infection (Pearce et al., 1998, 
Rosa-Brunet, 2001). Recently it has been found that the laboratory infection of S. 
mansoni in IL-4 -I- mice (unable to mount Th2 response), develop severe disease with 
high level of pro-inflammatory cytokines and significant increase in NO level both in 
vitro as well as in vivo (Rosa-Brunet ct al, 1999, HotTman et al., 2000; Loc. cit). In 
vitro studies on peripheral blood mononuclear cells showed the production of NO 
following the Schistosoma antigen exposure (Oliveira ct al., 1998). It is also 
speculated that the NO may regulate the granuloma formation (Oliveira et al., 1999). 
It is observed that at the onset of egg deposition, immune response is toward Thl type 
with elevated level of Till cytokines and NO. It is being proposed that at this early 
stage of disease, NO may protect the early hepatic damage by shielding the 
hepatocytes from '1NF-a induced apoptosis and free radical (Loc. cit). 
Lipid peroxidation and Protein carbonylation during helminthic Infection: 
The Production of reactive oxygen species (ROS) is very important for normal 
cellular metabolism (Mecord, 1993). Excessive ROS generation produces lethal and 
adverse effect on cell functioning (Gregorevic et al., 2001; Fattman et al., 2003). The 
hepatic surgery, hemorrhagic shock, and parasitic infections lead to the production of 
ROS and lipid peroxidation (Bilzcr and Gcrbes, 2000; Jacsclilce, 2000). ROS can 
cause damage to all type of biomolecules including DNA, lipid and protein and the 
target for such oxidative stress depends upon the cell type, nature of stress imposed, 
site of generation and its proximity and severity of stress (Dalle-Donne et al., 2003). 
Excessive ROS generation causes the cellular damage in the form of lipid 
peroxidation during which malondialdehyde (MDA), one of the final products of 
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LPO, is excessively formed. Thus, the MDA level is considered a surrogate marker of 
oxidative stress (Nielsen et al., 1997; Draper and Hadley. 1990). To overcome the 
adverse effects of ROS, cell has inbuilt machinery in the form of antioxidant system. 
Superoxide dismutase (SOD) is an important antioxidant enzyme; it specifically 
converts superoxide radicals to hydrogen peroxide (Andersen et al., 1997) and -
ultimately catalase and glutathione peroxidase (GPx) detoxify hydrogen peroxide to 
water (Inoue. 1994). Inflammatory reactions lead to a decrease in erythrocyte 
antioxidant enzyme activities of patients with fasciolosis and other parasitic 
infections, while MDA levels in serum or plasma increases in the presence of 
inflammation (Kaya et al., 2007). Leucocytes of Rats, infected with Fasciola, show an 
increased production of ROS (Smith and Bryant, 1992). Oxidative stress during 
fasciolosis is the causative agent of lipid peroxidution (MaVei-Facino et al., 1989). 
Although many researches have shown that the ROS serve to combat the infection 
(Sadeghi-Hashjin and Naem, 2001), but the newly excysted juvenile of F hepatica 
was found resistant to ROS (Piedrafita et al., 2000). Protein modifications also occur 
by high level of ROS or by the secondary by-products of oxidative stress (Berlelt and 
Stadtman, 1997) about which almost nothing is known in liver fluke infection. 
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CHAPTER 3 
1.3-MATERIALS & METHODS 
1.3.1. Preparation of Fasciola gigantica and Gigantocotyle explanatum cell free 
somatic extract for immunization 
The adult live worms were obtained from infected Indian water buffaloes, 
slaughtered at the local abattoir. Both the flukes were separately washed five times in 
Hanks Balanced Salt Solution (HBSS). Worms were also washed once more with 
I00mM phosphate buffered saline (PBS). pH 7.4, containing 05% 
antibiotic/antimycotic solution (Himedia) to remove other microbes. After that worms 
were incubated in water bath at 37C for 1 hour to allow the regurgitation of gut 
contents. These worms were then homogenized in 100mM PBS, pH 7.4. The 
homogenate was centrifuged at 10000xg for 30 minutes at 4'C in a refrigerated 
centrifuge (Eppendorf, Germany). The supernatant was aliquoted and stored at -80°C. 
The cell free supernatants were denoted as Fg-Ag for F. gigantica and Ge-Ag for 
G. explanatum. Before every use of these antigens, protein concentration was 
determined by the method of Spector (1978) using bovine serum albumin as standard. 
1.3.2, Animal Model 
The animal based studies were carried out on female Wistar Rats, each 
weighing around 2008, were procured under the license of Departmental Animal 
Ethical Committee of Department of Biochemistry, AMU, Aligarh, India and 
maintained as per the guideline of CPCSEA (Committee for the Purpose of Control 
and Supervision on Experiments on Animals). The Animals were maintained under 
standard conditions at 25±2° C temperature and I I±I hours dark and light cycle, in 
the Animal House of the Department of Zoology, AMU, Aligarh, fulfilling all the 
standard conditions required for animal maintenance. The animals were fed ad libitum 
on commercial pellet diet and clean water recommended for rats. 
1.3.3. Immunization of Wistar rats with Fg-Ag and Ge-Ag and a combination 
(1:1) of both the somatic antigens (CF-Ag) 
The study was divided into two experimental setups. In Experimental Setup-I 
(ESU-I): rats were exposed to antigen only for 24 hours while in Experimental 
Setup-B (ESU-II) the exposure was prolonged up to 22 days daily. Each experimental 
setup contained 4 dillerent groups that were further subdivided into 3 subgroups 
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containing 5 Wistar rats in each. Three different doses; 50µg, 100pg. 150pg of 
Fg-Ag, Ge-Ag and the combined (denoted as GE-Ag; prepared by mixing equal 
quantity of both the flukes' somatic antigens) somatic antigens per rat were injected 
separately in each subgroup for 24 hours (in ESU-I) and daily for 22 days (in ESU-]I). 
Injections were given subcutaneously in the tail of rats. The control group, containing 
5 rats, was received O.1M PBS, pll-7.4, subcutaneously. After that the rats were 
sacrificed and sera as well as different tissues were collected. The tissues were 
washed and stored at -80'C until use. A schematic diagram of experimental design 
and schedule of immunization is as follows 
Experimental Design and Schedule of immunization 
Daily immunization with the different eoncentronons (50p9. 100pg, 
t eopg) of Eg-Ag, Ge-Ag & OF-Ag 
OD to 	 7D 	 [4n 	 21U24II 
ESU-I: Rats were 	 ESU-I1: Rats . 
sacrificed and saa sacrificed and sere 
different 	tissue were 	 drnerent 	tssueswere 
coiiected collected 
Group!(Fg-Aglnunuuized) Group II(Ge-Aglummuizned) Group(JI(GF_Aglmmunized) 
(F giganbca somatic antigens) (O. explanatum somatic antigens) (Combination of Fglgantica end 
G expI nr. somatic antigens) 
y d y 
Three Sub Groups (SGs) Three Suh Groups(SGs) ThrceSub Groups(SGs) 
SC [:5 Rats (50ue:Fg-Ag) SGl: 5 Rats(50pg: Ge-Ag) SGI: 3 Rals(50pg.GF-Ag) 
SC II: 5 Ruts(IOOpg:Fg-Ag) SC!!: 5 Rats(100pg.Ge-Ag) S611: 5 Rats(IOUpg GF-Ag) 
SGlll.: Rats(150pg:Fg-A2) 5GIII: 5 Rats(15Ogg:Ge-Ag) 5G11I: 5 Rats (150pg_GF-Ag) 
Figure.l. 	chematic details showing experimental design and schedule of immunization in  
Wistar Rats with liver fluke antigens. 
1.3.4. Collection of Serum 
The serum was collected from control and both the ESUs (ESU-I & ESU-lq in 
i 
exactly similar manner. Briefly, blood was collected by cardiac puncture with 5 ml 
syringe fitted with 22 gauge needle from 24 hours and 22 days ESUs. The blood was 
stored for 5-10 minutes at room temperature (RI) and then at 4`C for 2-3 hours, in 
3.0 ml clot activator serum collection vials. During this period of time RBCs were 
clumped and serum was oozed out from whole blood. The tubes were centrifuged at 
3200xg for 10 minutes at 4'C in a cooling centrifuge (Eppendorf, Germany) and 
serum was aliquoted and stored at - S0°C until used.  
in 
flC3: Matena& e Methodr 
1.3.5. Homogenate preparation of visceral organs 
The liver, spleen, kidney and lungs are the most susceptible organs during 
inflammation or parasitic infections. Therefore, these organs were selected for various 
biochemical studies from each experimental group. 'These organs were aseptically 
removed from each rat, washed with 100tmM PBS, pll- 7.4 and homogenized in 
50mM tris-HCI buffer, pH- 7.6. The homogenates was centrifuged at 10.000xg for 
15 minutes at 4°C in cooling centrifuge (Eppendorl). The supernatant was aliquoted 
and stored at -S0'C. The protein was estimated by the method as previously described. 
1.3.6. Serum Cytokine Assay 
The detection of serum cytokines is a very reliable and important parameter to 
know the nature of host immune response against any pathogen or in autoimmue 
disease condition. The polymorphic mononuclear cells are supposed to be the major 
source of different serum cytokines and other inflammatory mediators but the 
different immune cells at the inflammatory site also enrich the serum and plasma with 
these immune mediators and thus analysis of serum biomarkers give a strong clue 
about the cytokine milieu during a particular disease or at diseased site. In this study 
we performed flow cytometry based cytokine detection through CBD Rat Soluble 
Protein Flex Set and Soluble Protein Master Buffer kit where the soluble analytes of 
low dose were detected through the particles with discrete fluorescent intensity. This 
system is able to detect the analytes in the range of 40 to 10,000 pg/ml assays. This 
assay system works on the basic flow cytometry principle where any particle of 
known fluorescence and size can be detected. In BD CBA Rat Soluble Protein Flex 
Set System each bead is coated with a capture antibody for a soluble cytokine. The 
detection reagent used in the BD CBA Rat Soluble Protein Flex Set System provides a 
fluorescent signal in proportion to the amount of bound analytes. When the capture 
beads and detection reagents are incubated with standard samples containing known  
analytes, sandwich complex (capture bead + analyte+ detection reagents) is formed. 
These complexes can be measured using flow cytometry to identify particles with 
fluorescent characteristics of both the bead and the detector. 
The cytokines of interest were analyzed using CBA kit (BD Bioscience) and as 
per the instructions provided by the manufacturer. Briefly, to detect the analytes of 
interest i.e. cytokines, the Rat Soluble Protein Flex Set Standard was prepared by 
pooling all the standards i.e. of 1L-4 iL10, IFN-y, TNF-a, in a 15 nil polypropylene 
27 
P1C3:Materials 'Vetiiods 
tube and reconstituted with Assay Diluent provided with the kit. It was labeled as a 
'Top Standard'. From this top standard we diluted the Rat Soluble Protein Flex Set 
Standard up to 1:256 by serial dilution. The approximate dose (pg/ml) at each dilution 
was provided in kit instruction guide. After standard preparation we mixed the Rat 
Soluble Protein Flex Set capture beads of known cytokines according to the 
experimental requirement as each tube of known and unknown sample required 50 µl 
of diluted beads. These ('BA beads were ready to transfer into the assay tube. The Rat 
Soluble Protein Flex Set Detection Reagent was also prepared in the same way as the 
capture beads. For performing the assay 50 pl of standards from each standard as well 
as rat serum sample at the dilution of 1:4 was mixed gently with 50 µI of Capture 
Beads in separate tubes. The tubes were incubated for 1 hour at room temperature. 
Now 50 tl of detection reagent was added and mixed again gently and incubated at 
room temperature for 2 hours. After that 1 ml of wash buffer was added to each tube 
and centrifuged at 200xg for 5 minutes. The supernatant was aspirated very carefully 
and discarded from each tube. At last 300µl of Wash buffer was added to each tube 
and vortexed to resuspend the heads and then samples were acquired on LSR II Flow 
Cytometer at BD FACS Academy at Jamia I Iamdard Central University, New Delhi, 
India. The data was analyzed using FCAP ARRAY software version 3.0. 
Bead-based Flow Cytometric Sandwich Immunoassay 
Laser 1: Ex 635 nm 	Em: 660 nm 
	 Laser 2: Ex 488 nm 
Em: 680 nm Em: 578 nm 
Capture 
	
Detection 
Ab 
	
Ab 
Capture Bead 
	
Standard or 
Test Analyte 
Figure.2. Schematics showing the principle of bead based Flow Cytometry (Image Source: 
Erika A O'Donnell et. al.. 2013). 
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1.3.7. Measurement of Nitric oxide (NO) by Griess reaction 
Nitric oxide (NO) Ie\el was determined by the method of Sajad et al. (2009) 
using the Griess Reagent System (Sigma). NO is an important physiological 
messenger and effector molecule in immunological systems (Bredt and Snyder, 1994). 
NO assay of different visceral organs like liver, spleen. kidney, lungs and the serum 
was determined to know the level of this inflammatory mediator during antigenic 
exposure. The stock solution for nitrite standard was prepared in 0.1M PBS or water 
and 100 MM nitrite solution was prepared by diluting stock solution 1:1000 in matrix 
(buffer which was used for sample preparation) used for experimental samples. 
Standard was prepared in triplicate in 96 well ELISA plate by serial dilution with 
dilution factor of 0.5. Absorbance value was recorded at 540 nm. Standard curve was 
plotted against known dose of nitrite and change in OD was measured. 
The cell free suspension of different visceral organs and serum (at 1:1 dilution 
with PBS) was prepared for NO detection and 50pl of experimental sample was used 
in 96 well ELISA plate in triplicate. After that 100pl of Griess reagent (0.04gJml) was 
added by multichannel pipette quickly. Sample was incubated at room temperature for 
5- 10 minutes in dark. "I he reading was taken at 54Onm on iMark Elisa Plate Reader 
(BioRad). The level of NO (µi-1/mg protein for organs and µM/ml for serum) in 
unknown sample was measured by comparing with standard curve. 
1.3.8. Lipid Peroxidase Assay 
Malondialdehyde (NIDA) is an end product of lipid peroxidation process 
therefore it is used as a marker of' lipid peroxidation during parasitic infection and 
other inflammatory diseases. Its level in different organs and serum from each 
experimental group was determined by the procedure of Buege and Aust (1978). The 
reaction mixture contained 0.5 ml homogenate (sample) with equal volume of TBA 
('l'hiobarbituric acid) (0.67%) and "I'CA (Trichloroacetic acid) (3%) in centrifuge 
tubes that were incubated in a boiling water bath for 20 minutes. Thereafter, the 
reaction mixture was centrifuged at S000xg for 15 minutes. The absorbance of the 
pink supernatant was recorded at 530 nm. !'he level was expressed in nmolcs of MDA 
formed per mg of the protein by using molar extinction co-efficient of 
1.56x 10-'\M1" cm-1 for MDA-TBA colored complex. In case of tissue sample the MDA 
level was expressed per mg of tissue protein while in serum the level was expressed 
per ml of serum sample. 
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1.3.9. Protein Carbonvlation 
Protein oxidation was carried out by the estimation of total carbonyl content in 
the sample by the method of Levine et al. (1994). The 1.0 ml of sample was mixed 
with 0.4 ml of ice cold 40% TCA and centrifugation at 4 °C for 10 minutes at 
12000x g. The pellet was dissolved in 0.2 ml of PBS (100mM, p11 7.4) in which 
0.4 ml of DNPH (2.4-Dinitrophenylhydrazine) (20mM prepared in 4 N HCI) was 
added. This reaction mixture was incubated for 90 minutes at 37°C on shaking water 
bath followed by centrifugation at 12000x g and the pellet thus obtained was further 
mixed with 0.35 ml of 40% TCA and centrifuged again at 12000x g. This final pellet 
was washed thrice with 1 ml of mixture of ethanol and ethyl acetate (1:1; v/v). 
Finally, it was dissoh-ed in Inil of guanidine HO (6M) and the absorbance was 
recorded at 280nm against guanidine IICI as blank. The carbonyl content was 
expressed in nmoles per mg of protein using a formulae taking molar extinction 
co-efficient of DNPII as 1100 M-'cm* In case of tissue sample the MDA level was 
expressed per mg of the protein while in serum the level was expressed per ml of 
serum sample. 
13.10. Protein Estimation: 
The protein content was assayed by the dye binding method of Spector (1978) 
using bovine serum albumin as the standard. 
1.3.11. Statistical Analysis; 
All the experimental results obtained from replicates used in each experiment 
were subjected to statistical analysis. The nearest values in triplicate were taken into 
consideration. The cytokinc based studies were carried out at cull in duplicate due to 
the high cost of Cytokine Bead Array kit (CBA kit). The data was subjected to 
statistical analysis on One Way ANOVA by using Tukie's Comparison Test on 
statistical software- `GraphPad Prism 5' and the level of significance was determined. 
The p value less than 0.05 was considered as statistically significant. The data was 
represented as Mean±SE. 
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CHAPTER 4 
1.4-RESULTS 
The results of the present study on the serum cytokines and the biochemical 
parameters like nitric oxide (NO), malondialdehyde (MDA) and Protein carbonylation 
(PC) in serum and different tissues of Wistar Rats exposed to Fasciola gigantica (Fg). 
Gigantocotyle explunatum (Ge) and their combined (GF) somatic antigens (Ags) for 
different time periods, are summarized in tables- 1.4.1 to 1.4.8 and figures 1.4.1.1 to 
1.4.2.5 The initial response of the experimental host was checked at 24 hours of 
antigenic exposure. while the subsequent response was analyzed after 22 days of daily 
antigenic exposure. the time at which all the experimental rats were sacrificed to 
harvest all the experimental material. This time period (22 days) coincides with the 
duration required for termination of the experiments on collagen induced arthritis 
(CIA) (Part- II of this thesis) in experimental Wistar rats, and hence the present results 
reflect the host response following exposure to only parasite antigens under non-
inflammatory condition i.e. without experimental CIA. 
1.4.1. Serum and Organs based studies in Wistar Rats after 24 hours of antigenic 
exposure with F. gigantica and G. ezplanatum derived somatic products alone as 
well as their combined form. 
1.4.1.1. Serum Cy tokine analysis after 24 hours of antigenic exposure. 
The serum cytokine level was detected for establishing the Thl/Th2 milieu after 
the exposure with the different doses (50µg, 100µg and 150µg) of each somatic 
antigen derived from adult flukes of Fasciola gigantica (Fg). Giguntocotyle 
explanalurn (Ge) and their combined (GF) somatic antigens (Ag). 
The serum IL-10 level of the control rats was 1011±91.12 pg/mI while it 
Increased to 1136±120.0, 3503 ±796.7 and 3702±73.54 pg/mI when rats were exposed 
to 50µg. I 00 tg and 150µg of Fg-Age respectively showing an increasing trend in dose 
dependent manner (Table.1.4.1 and Fig.1.4.1.1.a), whereas in response to Ge-Ag 
IL-10 level was 1989=100.7, 2087±188.9 and 2338±94.85 pg/mI at three different 
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doses respectively, showing an increase in dose dependent manner (Table. 1.4.1 and 
Fig.1.4.1.1.a). The combined antigens of the two worms (GF-Ag) also caused the dose 
dependent increase in IL-10 (Table.l.4.1 and Fig.1.4.1.1.a). Considering the overall 
results the serum IL-10 level increased significantly at most of the doses as compared 
to the control when exposed to the liver fluke antigens individually or in combined 
form. 
The serum IL-4 level of the control rats was 12.01+1.245 pg/ml while it 
increased to 17.72= 4.405, 52.86 f 10.33 and 117.5 ±15.15 pg/ml when rats were 
exposed to 50µg, 100µg and 150µg of Fg-Ag respectively (Table.1.4.1 and 
Fig.1.4.1.1.b) whereas in response to Ge-Ag the level was 45.49 f 4.485, 
51.93+1.310 and 59.26±1.135 pg/ml at three different doses respectively (Tabie.1.4.1 
and Fig.1,4,1.I.b). As evident before the combined antigens of the two worms 
(GE-Ag) also caused the dose dependent increase in IL-4 level (I able. 1.4.1 and 
Fig.1.4.1.1.b). Considering the overall results the serum IL-10 level increased 
significantly at certain doses as compared to the control when exposed to the liver 
fluke antigens individually or in combined form. 
The serum IFN-y level of the control rats was 40.74+3.470 pg/ml while it 
increased to 61.93±6.425, 82.55±16.15 and 79.73=6.625 pg/ml when rats were 
exposed to SOpg, I00µg and ISOlng of Fg-Ag respectively showing an increase 
initially and then insignificant difference between the higher doses (Table.1.4.1 and 
Fig.1.4,1.1.c), whereas in response to Ge-Ag the level was 50,51 ± 1.460, 
67.50± 1,605 and 66.92= 4.840 pg/ml at three different doses respectively showing 
somewhat similar trend as Fg-Ag (Table.1.4.1 and Fig.1.4.1.Lc). The combined 
antigens of the two worms (GF-Ag) produced non dose dependent changes in IFN-y 
level (Table.1.4.1 and Fig.i.4.1.1.c). Considering overall results the serum [FN-y 
level increased significantly at certain doses when exposed to the individual liver 
fluke antigens but its level declined substantially in rats exposed to the higher doses of 
the combined antigens (GF-Ag) as compared to the controls. 
The serum TNF-a level of the control rats was 139.2+9.960 pg/ml while it 
increased to 198.9+ 2.865, 466.5± 398.5 and 55.66± 16.47 625 pg/ml when rats were 
exposed to 50µg, 100µg and ISOpg of Fg-Ag respectively (Table.1.4.1 and 
Fig.1.4.1.1.d) where as in response to Ge-Ag the level was 4726+ 5.830, 
169.5± 2733 and 242.7± 5.400 pg/mi at three different doses respectively, showing 
some increasing trend in dose dependent manner but the increase in TNF-a level was 
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insignificant as compared to control (Table.1.4.land Fig.1.4.1.d). The combined 
antigens of the two worms (GF-Ag) produced dose dependent increase in TNF-a level 
but insignificant in comparison to the control (Table.l.4.1 and Fig.1.4.1.1.d). 
Considering the overall results the serum TNF-a level was insignificantly increased 
while the level was dropped at certain doses of antigenic exposure of rats as compared 
to their controls. 
1.4.1.2. Nitric Oxide (NO) level in serum and different tissues of Wistar rats after 
24 hours of antigenic exposure. 
The serum nitric oxide (NO) level of the control rats was 8.967± 1.667 µmol/ml 
while it increased to 27.43± 0.8819, 28.81± 3.158 and 25.85± 3.890 µcool/ml when 
rats were exposed to 5Opg, 100µg and 150µg of Fg-Ag respectively, showing a 
significant increase as compared to controls (Table.1.4.2 and Fig. 1.4.1.2.a). whereas 
serum NO level in response to Ge-Ag was 21.49± 2.568, 32.48± 5.826 and 
32.20 2.120 µmot/ml at three different doses respectively (Table.1.4.2 and 
Fig.1.4.1.2.a1. The combined antigens of the two worms (GF-Ag) caused dose 
dependent decrease in NO level at three different doses (Table.1.4.2 and 
Fig.1.4.1.2.a). Considering the overall results the serum NO level was significantly 
increased as compared to the control when exposed to the liver fluke antigens 
individually or in combined form. 
In liver, the NO level of control rats was 1.623±0.0623 µmol/mg protein which 
increased at all antigenic exposures but there was no dose dependent increase in NO 
level when rats were exposed to 50µg. 100µg and 150µg of Fg-Ag (Table.1.4.2 and 
Fig.1.4.1.3.a). whereas NO level in response to Ge-Ag was 22.95± 4.930, 
32.63± 3.033 and 17.13± 1.725 µmollmg protein at three different doses respectively 
(Table.1.4.2 and Fig.1.4.1.3.a). The combined antigens of the two worms (GF-Ag) 
were responsible for dose dependent decrease in NO level at three different doses 
(Table. 1.4.2 and Fig.1.4.1.3.a). Considering the overall results the liver NO level was 
significantly increased as compared to the control when exposed to the liver fluke 
antigens individually or in combined form. 
The NO level in Spleen of control rats was 0.6567± 0.077 µmol/mg protein 
\%hile it increased to 30.07± 5.382, 44.57± 4.087 and 61.66± 1.317 µmol/mg protein 
ml when rats were exposed to 50µg, 100µg and 150µg of Fg-Ag respectively showing 
dose dependent increase (Table.1.4.2 and Fig.1.4.1.3.b), while NO level in response 
to Ge-Ag was 85.87± 3.20, 33.80±1.185 and 42.57= 1.746 µmol/mg protein at three 
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different doses respectively, showing no dose dependent increase (Table. 1.4.2 and 
Fig.1.4.1.3.b). The effect of combined antigens of the two worms (OF-Ag) produced 
dose dependent increase in NO level (Table.1.4.2 and Fig.1.4.1.3.b). The overall 
results showed a significant increase in serum NO level at all the antigenic exposures 
as compared to the control when exposed to the liver fluke antigens individually or in 
combined form. 
In Lungs, the NO level in control rats was 0.5967+ 0.0731 pmolimg protein 
while it increased to 13.891 1.943, 13.53 1.038 and 3.253+ 0.6278 when rats were 
exposed to 50jig, 100µg and 150pg of Fg-Ag respectively showing a significant but 
non dose dependent increase (Table.1.4.2 and Fig,1.4.1,3.c), whereas the level of NO 
in response to Ge-Ag was 163030.6682, 10.51±1.465 and 26.87±5.117 at three 
different doses of antigen respectively, again showing a non dose dependent increase 
(Table.1.4t2 and Fig. 1.4. t.3.c). The combined antigens of the two worms (GF-Ag) 
also produced non dose dependent effect (Table.1.4.2 and Fig.1.4.1.3.c). Considering 
overall results the serum NO level was significantly increased as compared to the 
control when exposed to the liver fluke antigens individually or in combined form. 
In kidneys, the NO level in control rats was 0.3000= 0.02309 µmo]/mg protein 
while it increased to 39.30± 2.164, 88.30± 5.401 and 21.50± 2.272 µmol/mg when 
exposed rats to 50µg, 100µg and 150µg of Fg-Ag respectively (Table.1.4.2 and 
Fig.1.4.1.3.d), whereas the level of NO in response to Ge-Ag was 32.92± 2.735, 
20.27± 1 J57 and 26.83± 1.752 at three different doses of antigen respectively 
(Table.l.4.2 and Fig.1.4.1.3.d). The combined antigens of the two worms (GF-Ag) 
were responsible for non dose dependent increase of NO level (Table.1.4.2 and 
Fig.1.4.l.3.d). However, considering the overall results, the kidney NO level was 
significantly increased as compared to the control when exposed to the liver fluke 
antigens individually or in combined form in a dose independent manner. 	 - 	- 
1.4.1.3. Malondialdchyde (MDA) level in serum and different tissues after 24 
hours of antigenic exposure: 
The, serum malondialdehyde (MDA) level of the control rats was 2.473+ 0.2474 
nmo]m] while it increased to 3.223± 0.1880. 3.473± 0.1534 and 2.893± 0.1157 
mnoJnil when rats were exposed to 50µg, 100µg and 150µg of Fg-Ag respectively. 
showing a highly significant increase in the MDA level 	(fable. 1.4.3 and  
Fig.1.4.1.2.b), whereas the serum MDA level in response to Ge-Ag was 
3.300± 0.4509, 3.440± 0.1790 and 3.557± 0.2942 mnol/ml at three different doses 
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respectively, showing somewhat dose dependent increase (Table.1.4.3 and 
Fig.1.4.1.2.b). The combined antigens of the two worms (GF-Ag) also produced 
significant change in MDA level at three different doses (Table.1.4.3 and 
Fig.1.4.1.2.b). As evident, the overall results revealed that the serum MDA level was 
insignificantly altered as compared to the controls when exposed to the liver fluke 
antigens individually or in combined form. 
The liver was found to be the most affected organ in terms of lipid peroxidation 
after 24 hours exposure with different antigens. The MDA level in control rats was 
0.07533±0.00448 nmol/mg protein while it increased to 0.3810±0.0565, 
0.3067±0.0403 and 0.3537±0.0254 nmol/mg protein when exposed to 50µg, 100µb, 
and 150µi, of Fg-Ag respectively showing a several fold increase in a non dose 
dependent manner (Table.1.4.3 and Fig. 1.4.1.4.a). whereas the MDA level in response 
to Ge-Ag was 0.3240±0.0287. 0.2543±0.0175 and 0.2920±0.0104 nmol/mg proteins 
at three different doses respectively, showing a similar pattern (Table.1.4.3 and 
Fig.1.4.1.4.a). All the three doses of the combined antigens of the two worms; 
((IF-Ag) also increased MDA level significantly (Table.1.4.3 and 1.4.1.4.a). 
Considering overall results the liver MDA level was significantly increased as 
compared to the control when the rats were exposed to the liver fluke antigens 
individually or in combined form. 
In spleen. the MDA level in control rats was 0.3103± 0.02030 nrool/mg protein, 
while it change to 0.6073±0.0409, 0.3403±0.0339 and 0.3197±0.0338 nmol/mg 
protein when exposed rats to 50µg, l 00µg and 150µg of Fg-Ag respectively, showing 
a decrease in NIDA level at higher doses of antigen (Table.1.4.3 and Fig.1.4.1.4.b) 
where as the MDA level in response to Ge-Ag was 0.2017±0.0167. 0.2057±0.0189 
and 0.1270± 0.018 nmol/mg protein at three different dose respectively showing non 
dose dependent change (Table.1.4.3 and Fig.1.4.1.4.b). The combined antigens of the 
two worms (GF-Ag) produced dose dependent decrease in MDA level (Table.1.4.3 
and Fig.1.4.1.4.b). Considering overall results the serum MDA level was significantly 
increased only at lowest doses of Fg-Ag and GF-Ag as compared to the control. 
In lungs. the MDA level in control rats was 0.2433± 0.02333 nmol/mg protein 
while it increased to 0.4143± 0.01, 1.562± 0.2689 and 3.177± 0.4062 nmol/mg 
protein when exposed the rats to 50µg (Fg50), 100µg (Fg100) and 150µg (Fg150) of 
Fg-Ag respectively showing dose dependent increase ('Fable. 1.4.3 and Fig.1.4.1.4.c) 
where as the MDA level in response to Ge-Ag was 0.3273±0.0157, 0.276710.0108 
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and 0.305±0.033 at three different dose respectively showing non dose dependent 
increase (Table.1.4.3 and Fig. 1.4.1 .4.c). The effect of combined antigens of the two 
worms (GF-Ag) was a dose dependent decrease in MDA level (Table.] .4.3 and 
Fig.1.4.l.4.c). Considering the overall results the lung MDA level was significantly 
increased at higher doses of Fg-Ag exposed rats. 
In kidneys, the MDA level in control rats was 0.2863f 0.04302 nmol/mg 
protein while it increased to 0.5493' 0.06, 0541+ 0.030 and 0.693+ 0.039 nmol/mg 
protein when rats were exposed to 501g, 100µg and 150µg of Fg-Ag respectively, 
showing non dose dependent increase (Table.l.4.3 and Fig.1.4.1.4.d), whereas the 
MDA level in response to Ge-Ag was 0.899± 0,094, 0.478= 0,044 and 1.227+ 0.1930 
nmol/mg protein at three different dose respectively, again showing a non dose 
dependent increase (Table.1.4.3 and Fig. 1.4.1.4.d). The combined antigens of the two 
worms (GF-Ag) also produced significant increase in MDA level (Table 1.4.3 and 
Fig.1.4.1.4.d). Considering the overall results the MDA level was significantly 
increased at most of the antigenic doses used in this study as compared to the controls. 
1.4.1.4. Protein Carbonylation (PC) in serum and different tissues of Wistar rats 
after 24 hours of antigenic exposure: 
The serum PC level in control rats was 1.200± 0.1732 nmollml while it changed 
to 1.273± 0.018, 1.177± 0.08 and 1.417±0.0593 nmol/ml when rats were exposed to 
50µe, 100µg and 150µg of Fg-Ag respectively, showing an insignificant change in a 
non dose dependent manner (Table.1.4.4 and Fig.1.4.1.2.c), whereas in response to 
Ge-Ag the PC level was 1.0171 0.056, 1.307' 0.051 and 1.433+ 0.053 mnol/ml at 
three different dose respectively, and the change appeared to be insignificant as 
compared to the control (Table.1.4.4 and Fig.1.4.1.2.e) and similar trend in the PC 
was observed when the experimental rats were exposed to the combined antigens of 
the two worms (GFAg) (fable.1.4.4 and Fig.1.4.1.2.c). Considering the overall 
results the PC level was insignificantly increased or decreased at different doses of 
antigens as compared to the controls following exposure to the liver fluke anpgen.s 
individually or in combined form. 
In liver, the PC level in control rats was 2.667±0.2848 mnol/mg protein which 
increased to 4.500=0 2309. 4.540±0.2358 and 4403+0.2617 nmol/mg protein when 
rats were exposed to 50µg, 100µg and 150µg of Fg-Ag respectively, showing a 
significant increase in PC level without exhibiting a dose dependent effect 
(Table.1.4.4 and Fig.1.4.t.5.a), whereas the PC level in response to Ge-Ag was 
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2.55310.2598, 3.100=0.2082 and 3.600±0.2646 nmol/mg protein at three different 
doses respectively, showing some dose dependent response (Table.!.4.4 and 
Fig. 1.3.1.S.a). The combined antigens of the two worms (OF-Ag) increased PC level 
at the higher doses (Table.1.4.4 and Fig.1.3.1.5.a). Considering the overall results the 
PC level was significantly increased when the rats were exposed to Fg-Ag at all the 
doses and to GF-Ag at the higher doses only as compared to the controls. 
In spleen, very low level of PC was observed. The PC level in control rats was 
3.567±0.2186 nmol/mg protein while changed to 11.52±2.418, 2.600±0.7024 and 
5.380±0.3128 when rats were exposed to 50µg, 1001rg and 150µg of Fg-Ag 
respectively, showing non dose dependent trend in PC level (Table. 1.4.4 and 
Fig.1.4.1.5.b) where as in response to the Ge-Ag the PC level was 3.86730.08819, 
4.267=0.6360 and 7.433±1.009 nmol/mg protein at three different doses respectively, 
showing slight dose dependent increase in PC level (Table.l.4.4 and Fig.1.4.1.5.b). 
The PC level with respect to the different doses of the combined antigens of the two 
worms (GF-Ag) was somewhat similar but still higher than the control (Tahle.1.4.4 
and Fig. 1.4.l.5.b). The overall results do not show any significant change in PC level 
in spleen except at the lowest dose of the Fg-Ag, the reason for which is difficult to 
explain at this stage. 
In lungs, the PC level in control rats was 1.030±0.2706 nmol/mg protein while 
it increased to 6.587=0.8310, 15.44±2.292 and 30.89±9.104 mnol/mg protein when 
rats were exposed to 50µg (Fg50), 100µg (Fg100) and 150pg (Fg150) of Fg-Ag 
respectively, showing a definite dose dependent increase (Table.1.4.4 and 
Fig.1.4.L5.e), which was not evident when the rats were exposed to Gc-Ag in which 
the PC level was 3.800±0.1155, 3.333}0.4372 and 4.833±0.5457 nmol/mg protein, at 
three different doses respectively (Table.1.4.4 and Fig1.4.1-5-c). 'the combined 
antigens of the two worms (OF-Ag) also increased PC level in lungs (Table.1.4.4 and 
Fig.1.4.1.5.c) where higher doses of antigens appeared to be more effective. 
Considering the overall results the PC level was significantly increased by the Fg-Ag 
and GF-Ag as compared to the controls. 
In kidneys, the PC level in control rats was 1.167±0.0882, while it increased to 
5.109±0.0668, 4.754±0.129 and 5.767±0.088 nmol!mg protein when rats were 
exposed to 50µg, 100pg and 150pg of Fg-Ag respectively, showing a significant non 
dose dependent increase (Table.1.4.4 and Fig.1.4.1.5.d), whereas the PC level in 
response to Ge-Ag was 7.967±0.5696, 4.267±0.4702 and 2.500±0.2082 nmolimg 
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protein at three different doses respectively, interestingly showing dose dependent 
decrease in PC level which was still higher significantly as compared to the control 
(Table.1.4.4 and Fig.1.4.1.5.d). The combined antigens of the two worms (GF-Ag) 
were shown the dose dependent increase (Table. 1.4.4 and Fig.1.4.1.5.d). Considering 
the overall results the PC' level was significantly increased at certain doses of antigen 
as compared to the control when exposed to the liver fluke antigens individually or in 
combined form. 
1.4.2. Serum and Organ based studies in Wistar Rats after 22 days of antigenic 
exposure with F. giganlica and G. explanalum derived somatic products alone as 
well as their combined form. 
1.4.2.1. Serum Cytokine analysis in Wistar Rats after 22 days of antigenic 
exposure. 
The serum II.-l0 level in control rats was 1081±153.6 pg/mI while it increased 
almost three fold to 3030±239.4. 4049±262.7 and 3221±561.6 pg/ml when rats were 
exposed to 50µg. 100µg, and 150µg of Fg-Ag respectively, but in a non dose 
dependent manner (Table.1.4.5 and Fig.1.4.2.1.a) whereas in response to Ge-Ag the 
level was 1846±166.7, 5947±779.1 and 3276±443.7 pg/mI at three different doses 
respectively showing again a dose independent increase (Table.1.4.5 and 
Fig. 1.4.2.1.a). The combined antigens of the two wonns (GF-Ag) clearly produced a 
significant increase in IL-10 level particularly at higher doses (Table.1.4.5 and 
Fig.l.4.2.1.a). Considering the overall results the IL-10 level was significantly 
increased at most of the antigenic doses as compared to the controls. 
The serum IL-4 level in control Rats was 11.70±0.6100 pg/ml while it increased 
to 100.6±10.39, 137.1±23.38 and 165.5±14.94 pg rnI when rats were exposed to 
50µg. I 00pg. and 150µg of Fg-Ag respectively, showing a significant dose dependent 
increase (Table.1.4.5 and Fig.1.4.2.1.b) whereas in response to Ge-Ag the IL-4 level 
was 19.36±8.885, 196.9±40.76 and 178.2±42.02 pg/ml at three different doses 
respectively, showing a significant increase at the higher doses (Table.1.4.5 and 
Figl.4.2.1.b). The combined antigens of the two worms (GF-Ag) also increased IL-4 
level significantly (Table.1.4.5 and Fig.1.4.2.l.b), particularly at the higher doses of 
the combined antigens. Considering the overall results, the IL-4 level was 
significantly higher at most of the doses of antigens as compared to the controls 
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following the exposure of rats to the liver fluke antigens individually or in 
combination. 
The serum IFN-y level in control rats was 38.65±7.550 pg/nil while it first 
increased to 94.45±13.61 and then decease to 69.56±0.745 and 39.96±1.730 pg/nil 
when rats were exposed to 50µg, 100µg and 150µg of Fg-Ag respectively 
("I'able.l.4.5 and Fig.1.4.2.1.c) whereas in response to Ge-Ag the levels were 
85.30 13.0, 55.65.6.U5 and 40.73=8.185 pg/ml at three different doses (Table.1.4.5 
and Fig. 1.4.2.1.c). The combined antigens of the two worms (GF-Ag) maintained the 
IFN-y level close to the control level (Table.1.4.5 and Fig.1.4.2.1.c). Considering the 
overall results, the IFN-y level was significantly increased only at the lowest doses of 
Fg-Ag and Ge-Ag as compared to the control, whereas the highest dose of each 
treatment maintained the II:N-y level close to the control level indicating dose 
dependent anti-inflammatory role of parasite antigens. 
The serum TNF-u level in control rats was 143.8±13.25 pg/mI while it changed 
to 250.0±37.55, 177.8±34.19 and 51.06+9.370 pg/ml when rats were exposed to 
50µg, 100µg and 150µg of F -Ag respectively showing non dose dependent trend 
(Table.l.4.5 and Fig.1.4.2.l.d) whereas in response to Ge-Ag the level was 
248.2±49.70, 184.1;-5.5 and 146.0±6.15 pg/ml at three different doses respectively, 
showing dose dependent decrease in the TNF-a level (Table.1.4.5 and Fig. 1.4.2.1.d). 
The combined antigens of the two worms (GF-Ag) increased TNF-u level at the 
lowest dose, while the highest dose appeared to be somewhat inhibitory (Table.1.4.5 
and Fig.1.4 2.l.d). Considering overall results, the level of serum "1'NF-a showed a 
decreasing trend from lower to higher doses of different antigens given to the 
experimental rats. 
1.4.2.2. Nitric Oxide (NO) level in scrum and different tissues of Wistar Rats 
after 22 days of antigenic exposure. 
Nitric oxide level in serum of control rats was 8.20±0.9452 pmol/ml while it 
increased to 23.76±1.594. 27.33±2.888 and 24.80± 2.214 µtnol/ml when rats were 
exposed to 50po. 100µg and 150µg of Fg-Ag respectively (Table.1.4.6 and 
Fig.1.4.2.2.a), whereas in response to Ge-Ag the NO level was 22.60±1.258, 
30.402.581 and 22.70± 2.285 pmol/ml at three different doses (Tahle.1.4.6 and 
Fig. I .4.2.2.a) showing a significant increase over the control in a non dose dependent 
trend. The combined antigens of the two worms (GF-Ag) also produced similar trend 
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of NO level except the highest dose, which was not so effective and the NO level 
remained close to the control (Table.1.4.6 and Fig.1.4.2.2.a). Considering all the 
results, the NO level was significantly increased following exposure of rats to the 
liver fluke antigens individually or in combined form. 
In liver, the NO level in control rats was 1.667±0.2728 tmol/mg protein while it 
increased to 5.380±0.2551. 5.980±0.2859 and 5.887±0.7226 µcool/mg protein when 
rats were exposed to 50pg, I00µg and 150µg of Fg-Ag respectively, (Table. 1.4.6 and 
Fig.1.4.2.3.a) where as in response to the Ge-Ag the level of NO was 5.340±0.1447, 
5.767±0.1764 and 3.737±0.1484 tcool/mg protein at three different doses (Table.1.4.6 
and Fig.1.4 2.3.a) showing a significant but non dose dependent increase. The 
combined antigens of the two worms (GF-Ag) also increased NO level significantly 
without dose dependent trend (Table.1.4.6 and Fig.1.4.2.3.a). The NO level in 
immunized rats was significantly increased at all the doses of different antigen as 
compared to the non-immunized controls. 
In spleen, the NO level in control rats was 0.6733± 0.0736 p.mol/mg protein 
while it increased several folds to 10.82±0.8495, 11.22±1.341and 13.13±1.55 
pmol/mg protein when rats were exposed to 50µg, 100µg and 150µg of Fg-Ag 
respectively, showing dose dependent increase (Table.1.4.6 and Fig.1.4.2.3.b) 
whereas in response to the Ge-Ag the NO level was 6.533± 0.8353, 4.1±0.9074 and 
4.40± 1.002 µmot/mg protein at three different dose showing a several fold increase 
in NO level as compared to the control and the dose dependent effect was not evident 
(Table.1.4.6 and Fig.1.4.2.3.b) even with the combined antigens of the two worms 
((iF-Ag) (Table.1.4.6 and Fig.1.4.2.3.b). Considering overall results, the spleen NO 
level was significantly enhanced by the Fg-antigens as compared to the control as 
well as other antigenic treatments. 
In lungs. the NO level in control rats was 0.7967±0.1322 µmol/mg protein 
while it increased to 16.90-t0.866, 11.13±1.433 and 7.457±1.806 µcool/mg protein 
when rats were exposed to 50µg, 100µg and 150µg of Fg-Ag respectively, showing a 
several fold increase at the lowest dose and then NO level decreases at the higher 
doses but still higher than the control (Table.1.4.6 and Fig.1.4.2.3.c), whereas in 
response to the Ge-Ag the level was 3.633±0.3528, 4.633±0.2404 and 4.867±0.4702 
µcool/mg protein at three different doses respectively, showing non dose dependent 
trend (Table.1.4.6 and Fig.1.4.2.3.c). Though combined antigens of the two 'Norms 
(GF-Ag) also increased NO level but dose effect was not evident (Table.1.4.6 and 
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Fig.1.4.2.3.c). An overall increase in NO level in the lungs was observed in rats 
exposed to the liver fluke antigens individually or to their combined form. 
In kidneys the NO level in control rats was 0.370+0.0416 µmol/mg protein 
while it increased to 15.10=2.597, 8.700±1.823 and 9.40±1.137 lunol/mg protein 
when rats were exposed to 50µg, 100pg and 150µg of Fg-Ag respectively, showing 
non dose dependent change (Table.l.4.6 and Fig.1.4.2.3.d), whereas in response to 
the Ge-Ag the level was 6.933±1.364, 4.60+0.6928 and 2.767±0.5925 pmol/mg 
protein at three different doses respectively (Table.L4.6 and Fig.1.4.2.3.d). All the 
doses of the combined antigens of the two worms (GF-Ag) increased NO level 
without any significant variation with respect to different doses (Table.1.4.6 and 
Figl.4.2.3,0). Considering overall results, the NO level was significantly increased at 
all the doses of the antigens used as compared to the control following exposure of 
rats to the liver fluke antigens individually or in combined form. 
1.4.2.3. Malundialdehvde (MDA) level in serum and different tissues after 22 
days of antigenic exposure in Wistar Rats. 
The MDA level in serum of control rats was 2.487+ 0.2167 nmol/ml which 
increased to 2.347x0.2021. 2.160± 0.09644 and 1.990± 0.08660 when rats were 
exposed to 50µg, I OOpg and 150µg of Fg-Ag respectively, showing an insignificant 
change in MDA level in a non dose dependent manner (Table.l.4.7 and 
Fig.JA.2.2.b), whereas in response to Ge-Ag the level was 2.660+ 0.3717, 
2.590±0.1626 and 2.790=0.2511 nmol/nil at three different doses showing a similar 
trend as Fg-Ag (Table.1.4.7 and Fig.l.4.2.2.b), while the combined antigens of the 
two worms (GF-Ag) produced non dose dependent effect on MDA level ('I'able.1.4.7 
and Fig.1.4.2.2.b). Considering overall results, the serum MDA level was not 
influenced significantly following exposure of experimental rats to any of the antigens 
used in this study. 
In liver, the MDA level in control rats was 0.0840±0.006110 mnol/mg protein 
white it increased to 0.2300±0.02082, 0.2333+0.01453 and 0.230010.02517 nmol/mg 
protein when rats were exposed to 50µg 100µg and I50pg of Fg-Ag respectively, 
showing a non dose dependent effect (Table. 1.4.7 and Fig.1.4.2.4.a). whereas in 
response to Ge-Ag the level was 0.2633+0.01764, 0.4667=0.02404 and 
0.210010.01155 mnol/mg protein at three different doses showing again non dose 
dependent response (Table.l.4.7 and Fig.! .4.2.4.a). The combined antigens of the two 
worms (GF-Ag) also did not show any dose dependent effect on the MDA level 
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(Table.1.4.7 and Fig.l.4.2.4.a). Considering overall results a significantly increased 
liver MDA level was recorded in response to different antigens as well as to their 
different doses when compared to the control rats. 
In spleen, the MDA level in control rats was 0.3333± 0.02603 nmol/mg protein 
which increased to 3.223±0.1920, L203±0.2858 and 0.6167±0.1919 nmol/mg protein 
when rats were exposed to 50µg. 100µg and 150µg of Fg-Ag respectively 
(Table.1.4.7 and Fig.1.4.2.4.b). whereas in response to Ge-Ag the level was 
0.7867±0.03480, 1.083±0.05239 and 0.7933±0.02963 nmol/mg protein at three 
different doses respectively (Table.1.4.7 and Fig.1.4.2.4.b). In response to the 
combined antigens of the two worms (GF-Ag) the MDA level remained elevated 
insignificantly as compared to the control (Table. 1.4.7 and Fig.1.4.2.4.b). Considering 
the overall results. the NO level significantly increased at the lowest dose of Fg-Ag 
and lowest dose of Ge-Ag then it declines but the level remained still higher as 
compared to the control level. 
In lungs, the MDA level in control rats was 0.3333±0.02906 nmol/mg protein 
while it increased 0.6900±0.05508, 1.170±0.1739 and 0.5433±0.03528 nmol/mg 
protein when rats were exposed to 50Ag, 100}tg and 150µg of Fg-Ag respectively 
showing (Table.l.4.7 and Fig.1.4.2.4.c), whereas in response to the Ge-Ag the MDA 
level was 0.9367±0.03383, 1.053±0.08570 and 1.030±0.08737 nmol/mg protein at 
three different dose respectively (Table.l.4.7 and Fig.1.4.2.4.c). The combined 
antigens of the two worms (GF-Ag) show dose dependent decrease in MDA level 
(Table.1.4.7 and Fig.1.4.2.2.c). Considering the overall results, the lungs MDA level 
remained higher in all the treated rats with different doses of antigens used in the 
present study. 
In kidneys, the MDA level in control rats was 0.3833±0.02906 nmol/mg protein 
while it increased to 0.7133±0.02333. 0.3700±0.07638 and 1.367±0.2603 nmol/mg 
protein when rats were exposed to 50µg, 100µg and 150µg of Fg-Ag respectively 
showing dose independent trend (Table.1.4.7 and Fig.1.4.2.4.d), whereas in response 
to the Ge-Ag the MDA level at three different doses also increased insignificantly 
(Table.1.4.7 and Fig.l.4.2.4.d) while the combined antigens of the two worms 
(GF-Ag) were shown dose dependent increase in MDA level (Table.1.4.7 and 
Fig.1.4.2.4.d). Considering overall results, the MDA level was significantly increased 
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only at Fg 150 as compared to the control while an insignificant increase at some other 
doses was also evident. 
1.4.2.4. Protein Carbonylatiun (PC) in serum and different tissues of Wistar Rats 
after 22 days of antigenic exposure. 
The scrum PC level in control rats was 2.153+0.3968 while it was 
insignificantly altered following the exposure of Wistar rats to different doses of 
Fg-Ag, Ge-Ag and GF-Ag (Table.l.4.3 and Fig.1.4.2.2.c) 
In liver, PC level in control rats was 2.53310.2186 which increased to 
9.667±0.8212, 9.733±0.6360 and 10.13±0.4372 nmol/mg protein when rats were 
exposed to 50pg, 100pg and 150µg of Fg-Ag respectively, showing a significant 
increase without any dose dependent effect. (Table.1.4.8 and Fig.1.4.2.5.a), whereas 
in response to Ge-Ag the level was 3.633+0.2963, 13.30±04509 and 11.80±0.3786 
nmol/mg protein at three different doses respectively, showing dose independent 
increase in PC level (Table.1.4.8 and Fig.l.4.2.5.a). Increased PC level in response to 
the combined antigens of the two worms (GF-Ag) also did not show any dose effect 
(Table. 1.4.8 and Fig.1.4.2.5.a). Considering the overall results, the PC level 
significantly increased at most of the doses of antigens as compared to the controls 
when exposed to the liver fluke antigens individually or in combined form. 
In spleen, the PC level in control rats was 3.833+0.4910 nmol/mg proteins while 
it increased to 31.73±1.714, 34,40±2.358 and 32.37±2.829 tmtol/ing protein when rats 
were exposed to 50µg, 100µg and l50pg of Fg-Ag respectively, showing non dose 
dependent effect (Table. 1.4.8 and Fig.l.4.2.5.b), whereas in response to Ge-Ag the 
PC level was 32.70±0.8505, 39.80+2.641 and 51.90±3.110 at three different doses of 
antigen respectively (Table.1.4.8 and Fig.1.4.2.5.b). The combined antigens of the 
two worms (GF-Ag) showed an inhibitory trend as compared to other two treatments 
but the absolute level of PC was still higher as compared to the control (Table.1.4.8 
and Fig.l .425.b). Considering the overall results, the PC level was significantly 
higher as compared to the control. 
In lungs, the PC level in control rats was 1.867±0.3528 which increased to 
45.07±4.001, 27.73±3.670 and 33.40±2.358 when rats were exposed to 50µg, 100µg 
and 150µg of Fg-Ag respectively (Table.1.4.8 and Fig.1.4.2.5.c), where as in response 
to Ge-Ag some dose dependent trend was evident in PC level (Table.l.4.8 and 
Fig.l.4.2.5.c) while the combined antigens of the two worms (GF .Ag) brought down 
the PC level as compared to other treatments but the level was still higher than the 
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control level (Table.1.4.8 and Fig.1.4.2.5.c). Considering the overall results, the PC 
level was significantly increased at individual antigenic doses of Fg-Ag and Ge-Ag 
but not by their combined form. 
The 	level in the kidneys of control Wistar rats was 1567±0.3844, while it 
increased to 39.70-7.323, 27.37±2.025 and 44.70±1.739 nmol/mg protein when rats 
were exposed to 50µg, 100µg and 150µg of Fg-Ag respectively, showing a non dose 
dependent effect of tropical liver fluke antigens (Table.1.4.8 and Fig.1.4.2.5.d), 
whereas in response to three different doses of Ge-Ag the PC level was 28.17f4.092, 
31.77±3.213 and 48.67+1.273 nmol/mg protein, respectively, showing dose 
dependent increase (Table.l.4.8 and Fig.1.4.2.5.d), while the combined antigens of 
the two worms increased PC level without showing any dependent effect (Table.1.4.8 
and Fig.l.4.2.5.d). Considering the overall results, the PC level was significantly 
increased at most of the doses of individual antigen of the two flukes used in this 
study as compared to the control rats which were not exposed to the liver fluke 
antigens individually or in combined form, but the rats exposed to the combined 
antigens (OF-Ag) showed comparatively low level of PC though it was still higher 
than the control. 
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FIGURES 
1.4.1.1. Serum cytokine analysis in Wistar rats after 24 hours antigenic exposure. 
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Figure.1.4.1.1. Th-2 dominated serum cytokine response in Wistar rats after immunization with 
different doses (50µg, 100µg and 150µg) of f . grgculticcr (Fg) somatic antigens (Ag), 
G. explainlzim (Ge) and l~igantocotvle-Faasciola (GF) antigens (Ag) for 24 hours. After 24 
hours of exposure of rat to liver fluke antigens the overall serum cytokine level was not altered 
in a dose dependent manner. However, the level of anti-inflammatory cytokine i.e. IL-l0 was 
significantly elevated after 100µg and 150µg Fg-Ag exposure. A significant increase in IL-10 
level was observed in Ge-Ag exposed rats at all the doses. while the significant elevation was 
observed only at 100µg and 150µb of GF-Ag exposed rats (a) Similar results were obtained in 
case of serum IL-4 after different antigen exposure (b). The significant increase in IFN-y level 
at Mpg and 150µg of Fg-Ag was observed, while insignificant increase was observed in case 
of Ge-Ag exposed rats The level of IFN-y was significantly increased in rats exposed to 50µg 
of GF-Ag, however at highest doses the level was considerably low when compared with the 
control (c) The changes in the level of TNF-u in response to different doses of Fg-Ag, Ge-Ag 
and GF-Ag were not significant (d) The p< 005 () and p<0 01- p<0.0001 (**) were 
considered significant and the values represented as MeantSE. 
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1.4.1.2. Serum Nitric Oxide (NO), Malondialdehyde (MDA) and Protein 
Carbonylation (PC) analysis in Wistar rats after 24 hours of antigenic exposure. 
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Figure.1.4.1.2. Nitric Oxide (NO), Malondialdehyde (MDA) and Protein 
Carbonylation (PC) level in serum of Wistar rats after immunization with the 
different doses (50µg, 100µg and 150µg) of Fg-Ag Ge-Ag and GF-Ag for 24 
hours. The level of NO was significantly elevated in response to Fg-Ag, Ge-Ag 
and GF-Ag vs control (a). Significant increase in lipid peroxidation was not 
observed at any of the antigenic exposure (b). Serum protein carbonylation was 
insignificantly changed at all the antigenic exposures (c). The p< 0.05 (*) and 
p-=0.01- p<0.0001 (**) was considered significant and the values represented as 
Mean+SE. 
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1.4.1.3. Nitric Oxide (NO) level in different tissues of Wistar rats after 24 hours 
of antigenic exposure. 
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Figure.1.4.1.3. Nitric oxide (NO) level in different organs (liver, spleen, lung, and kidney) of 
Wistar rats after immunization with different doses (50µg, 100µg and 150118) of 
Fg-Ag. Ge-Ag and GF-Ab for 24 hours. The level of NO was significantly elevated in 
liver in response all the antigenic exposure. But the NO production in liver was 
decreased from lower (50µg) towards higher dose (150 µg) in each antigenic exposure 
clearly showing that the higher doses were somewhat inhibitory but still much higher 
than the control (a). In case of spleen the NO level increased consistently and 
significantly at all the doses of Fg-Ag whereas Ge-Ag exposed rat showed significant 
increase in NO level at all dose but level was decreased with increase in antigen dose 
but still higher than the control, while in case of GF-Ag, NO level was elevated 
significantly at all the antigenic doses (b). The lung and kidney showed no dose 
dependent change in NO level but showed elevation at certain doses except GF-Ag in 
case of kidney (c & d). The p< 0.05 (*) and p<0.01-<0.0001 (**) was considered 
significant and the values represented as Mean SE. 
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1.4.1.4. Malondialdehyde (MDA) level in different tissues of Wistar rats after 24 
hours of antigenic exposure. 
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Figure.1.4.1.4. MDA level in different organs (liver, spleen, lung, and kidney) of 
Wistar rats after immunization with different doses of (50µg, 100µg and 150µg) 
of Fg-Ag, Ge-Ag and GF-Ag for 24 hours. The level of MDA significantly 
elevated in liver in response to all the doses of each treatment in non dose 
dependent manner (a). In spleen MDA was increased significantly only at 50µg 
of Fg-Ag and 1 SO jig of Ge-Ag, while there was insignificant difference at other 
doses (b). The lungs showed limited response in MDA level at 100µg and 150 
pg of Fg-Ag (c). A significant increase was observed at doses of 50µg and 
150µg of Ge-Ag in kidney, while rest of the doses did not produce significant 
changes (d). The p< 0.05 (*) and p<0.01-<0.0001 (**) was considered 
significant and the values represented as Mean-SE. 
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1.4.1.5. Protein carbonylation (PC) level in different tissues of Wistar Rats after 
24 hours of antigenic exposure. 
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Figure.l.4.1.5. Protein Carbonylation (PC) in different organs (liver, spleen, lung, 
and kidney) of Wistar rats after immunization with different doses (50µg, 
I00pg and 150µg) of Fg-Ag, Ge-Ag and GF-Ag for 24 hours. In liver, spleen 
and lungs no significant change was observed in protein carbonylation except at 
certain doses (asterix in above figure, a, b and c). In kidneys maximum PC was 
observed. The level of PC was elevated at all the doses of each antigenic 
exposure of rats. But in case of Ge-Ag the level decreased from lower to higher 
dose (d). The p< 0.05 (*) and p<0.01-<O.0001 (**) was considered significant 
and the values represented as Mean±SE. 
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1.4.2.1. Serum Cytokine analysis in Wistar rats after 22 days of antigenic 
exposure. 
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Figure.1.4.2.1. Th-2 dominated serum cytokine response in Wistar rats after 22 days 
of immunization with the different doses (50µg, 100µg and 150µg) of Fg-Ag, 
Ge-Ag and GF-Ag, for 22 days. The level of anti-inflammatory cytokine i.e. 
IL-10, was elevated at all doses of Fg-Ag while in case of Ge-Ag and GF-Ag 
the significant elevation was observed at highest doses (100µg and 150µg) (a). 
IL-4 showed significant increase in serum at all the doses of Fg-Ag but at the 
higher doses (100µg and 150µg) of Ge-Ag and GF-Ag (b). The level of IFN-y 
was increased significantly at 50µg of Fg-Ag and then dropped close to the 
control at the highest dose. The level was significantly increased at 50µg, of 
Ge-Ag and then dropped at highest dose, while no change was observed at the 
different doses of GF-Ag where the level of IFN-y remained close to the control 
(c). The level of TNF-a was increased significantly at 50µg of Fg-Ag but rest of 
the antigenic exposures did not show significant change (d). The p< 0.05 (*) 
and p<-0.01-<0.0001 (**) was considered significant and the values represented 
as Mean±SE. 
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11.4.2.2. Serum Nitric Oxide (NO), Mlalondialdehvde (MDA) and Protein 
Carbone lation (PC) level in Wistar rats after 22 days of antigenic exposure. 
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Figure.1.4.2.2. Nitric oxide (NO), Malondialdehvde (MDA) and Protein 
Carbonvlation (PC) in serum of Wistar rats after immunization with different 
quantity (50µg, 100µg and 150µg) of Fg-Ag, Ge-Ag and GF-Ag for 22 days. 
The level of NO was significantly increased under almost all the antigenic 
exposures except at 150µg of GF-Ag where the level was found close to the 
control (a). Serum MDA and PC level was not altered in a significant manner at 
any of the antigen exposure (figure b & c). The per' 0.05 (*) and p<0.01-<0.000 l 
(**) was considered significant and the values represented as Meani.SE. 
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1.4.2.3. Nitric Oxide (NO) level in different tissues of Wistar rats after 22 days of 
antigenic exposure. 
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Figure.1.4.2.3. Nitric oxide (NO) level in different organs (liver, spleen, lungs and kidney) 
of' Wistar rats after immunization with different doses (50ftg, 100µg and 150µg) of 
Fg-Ag , Ge-Ag and GF-Ag for 22 days. The level of NO was significantly increased 
in liver at all the doses of each treatment (a). In spleen, the NO level was increased 
significantly after Fg-Ag treatments in dose dependent manner. There was no 
significant change observed in Ge-Ag and GF-Ag exposed rats (b). In lungs, the NO 
level was increased at 50µg and 100µg of Fg-Ag with decrease in level from lower to 
higher doses while at rest of the antigenic exposure insignificant changes was observed 
though the level of NO still appeared higher than the control (c). In kidneys the NO 
level was significantly increased at all the antigenic exposures of Fg-Ag. Although, the 
level was decreased from 50µg to 150µg of antigens. The increase in NO level was 
significant at 50µg of Ge-Ag while rest of the doses of Ge-Ag did not show significant 
increase, whereas all the doses of GF-Ag were shown statistically insignificant 
difference in NO level (d). The p< 0.05 (*) and p<0.01-<O.0001 (**) was considered 
significant and the values represented as Mean±SE. 
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1.4.2.4. Malondialdehyde (MDA) in different tissues of Wistar rats after 22 days of 
antigenic exposure. 
Figure.1.4.2.4. Malondialdehyde (MDA) level in different organs (liver, spleen, lungs and 
kidney) of Wistar rats after immunization with different doses (50µg, 100µg and 
150µg) of Fg-Ag. Ge-Ag and GF-Ag for 22 days. The level of MDA was significantly 
increased in liver at all the dose of each antigenic exposure (a). In spleen, the NO level 
was first increased significantly at doses 50µg and 100µg of Fg-Ag and then the level 
declined at the highest dose. remaining close to the control level. There was no 
significant change due to Ge-Ag and GF-Ag except at 100 .tg of Ge-Ag (b). In lungs, 
The MDA level was significantly increased at 100µg of Fg-Ag. while changes at other 
doses of Fg-Ag were statistically insignificant, whereas a significant increase was 
observed at all the doses of Ge-Ag and at 50µg of GF-Ag (c). In kidneys a significant 
increase in MDA level was observed at ) 50.tg of Fg-Ag, while rest of the antigens 
produced an insignificant increase in MDA level in kidneys (d). The p< 0.05 (*) and 
p<-0.01-<0.000I (**) was considered significant and the values represented as 
MeaniSE. 
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1.4.2.5. Protein Carbonylation (PC) in different tissues of Wistar rats after 22 
days of antigenic exposure. 
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Figure.1.4.2.5. Protein Carbonylation (PC) in different organs (liver, spleen, lungs, and 
kidney) of Wistar rats after immunization with different doses of (50µg, 100µg and 
150µg) Fg-Ag. Ge-Ag and GF-Ag for 22 days. The significant increase in PC occurred 
in liver at all the doses except at 50µg of Ge-Ag (a). The PC level significantly 
increased in spleen in Fg-Ag and Ge-Ag exposed rats, while no change was observed in 
PC level in GF-Ag exposed rats (b). In lungs, the PC level increased at all the doses of 
Fg-Ag but only at higher doses (100µg and 150µg) of Ge-Ag, while no statistically 
significant increase was observed in GF-Ag exposed rats (c). In kidney. a significant 
increase in PC level was observed at all the doses of Fg-Ag and Ge-Ag. while 
statistically insignificant increase was observed in case of GF-Ag exposed rats (d). The 
p< 0.05 (*) and p<0.01-<0.0001 (**) was considered significant and the values 
represented as \lean±SE. 
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Table, 1.4.1. Serum cvcokine level in Wistar rats after exposure ith different doses of! tit tla gr' inii~ ~r IFg~, i tigaruoroi►1c e plwnalurm (Ge) 
and combined 61gunlocoti'Ie•Id.wiola (GF) somatic antigens (Ag) for 24 hours. 
Immunization 
_ 	----- 
Control 	
,anti en ---_._--------- 	-- ----- - 	-- --~- _ _ ------ --- __-- - _ _ . 
- l 	F, giga►iticn 	g (Ng) G. vplarratum 	Antigen (NS) ~ Gigantocohde•Fasciola Antigens 
(µg) 
Cy ones 	...... 	50 	100 J150 	50 	100 flQt0TooHso 
L. 
1011± 	1136± 	3503± 	3702± 11989± 	2087±2338± 	7 	+ 	2665± 2 	_ 102. t 1890_ . 
1110 	91.12 	120.0 196.7 	73.54 	100.7 	188.9 	94.85 307.1 122.4 167.3 
_> 	 ; F - 11.74;r=0.9136.-Df_19 
1I4 	1101± 	17.12±4. 52.861 	117,5±45,49± 	r 	51.931 	T 59.26+- 24.98± 37.54±- 11.44± 
1.245 	j 	405 10.33 	15.15 	4.485 	1.310 	1.135 3.090 7.695 1.460 
! 	O.0001; F= 20,69; r= U 9490; Df 19 _ 
IF\•Y 	40.74± 	6193± 	28 55± 	19.73± 50.51± 	61.50± 	66.92+ 96,56± 15.96± 30.65± 
3.470 	6.425 	J 16.15 	6.625 	1,1.460 	1.605 	j 4.840 _ 1,345 6.160 1.890 
z<0 !; F- 	 9U 88; Df=19 - ~- -- -- -- --- 
TNF•a 	139.2± 	198.9± 	466.5± 	55.66± 	47.26± 	169.5± 	242.7± 127.8± 185.3± 299.9± 
9.960 	1.865 	398.5 	16.47 	! 	5.830 	27.73 	5.400 11.46 10.61 78.42 
0.65@0; F:0 991?4: r 	U 4509; Df 19 
The doses o o- tokines were calculated in pgg'ml of serum sample. All the 	alues are represented as Mean±SE with p value <O.C5 was 
considered as significant), F value, r~ value and Df value 
Table.1,4.2 Nitric Oxide (NO) level in Wistar rats after exposure with different dose of antigens of Fg-Ag, Ge-Ag and GF•Ag for 24 hours 
Immunization 	Control ' F. gigantica 	Antigen 	G. explanaiuni 	Antigen 	GigantocoNle-Fasciota 
	
(µg) 	 (µg) 	 Antigens (µg) 
(NO) 1 - 	50 	100 	150 	50 	100 	150 	50 	100 	150 
Serum 	8.967± 	27.43- 	28.81 	25.85: j 21.491 	32.481 	32.20± 	24.70: 	22.71: 	17.70- 
1.667 	0.8819 	3.158 	3.890 	2.568 	5.826 	2.1.29 	2,120 _3.1101.097 
p= 0.0010; F= 5.256; r'= 0.7028; Df= 29 
Liver 	1.6231 	30.37.E 	22.621 	24.15- 	22.951 	32.63± 	17.131 	25.79= 	24.70+ 	1990:. 
0.0623 	1.878 	0.9680 	0.6241 	4.930 	3.933 	1,725 	4.327 	1.153 	1.510 
_____ ~~ _ p- 0.0001; F= 11.40; r == 0.8369; Dfi 29 
Spleen 	0.6567± 	30,07: 	44.57: 	61.66_8S 871 	33.80= 	42.57: 	35.90 	40.13= 	49,00_ 
0.07753 	5.382 	4.087 	1.317 	3.200 	1.185 	1.746 	5.782 _4.2121.801 
_ _ 
 
0.00U 1; F= 41.24; r`= 0.9489: Df= 29. 
Lung 	3.5967± 	13.89 	13.53= 	3,2531 	16.30: 	10.513 	26.872 	4.033: 	28.63- 	7.167{ 
0.07311 	L943 	1.038 	0.6218 - 0.6682 	1.456 	5.117 	0.6936 	508I.450 
p= < 0.0001; F=12.88; r'= 0.8529: Dfi 29 
Kidney 	0.3000± 	39.30: 	88.30+ 	21.501 	32.92: 	20.271 	26.83: 	29.07± 	25.831 	19.43± 
0.02309 2.264 5.401 2.272 2.735 1.577 1.752 1.770 1.267 3.792 
p= < 0.0001; F= 72.64; r`= 0.9103; Df-29 
The doses of NO in organs was calculated in mol,:mg protein, while in serum pmoI'ml of serum. All the values are represented as Meani:SE 
Iue. r` value and Df value. 
Toble.1,4,3, Malondialdehyde I MDA I level in Wistar rats after exposure «nth different doses of antigens of Fg-Ag, Ge-Ag and OF-Ag for 24 
hours. 
Immunization 	Control 	F. gigantica 	Antigen 	G. planatum 	Antigen 	Gigantocottle-Fasciola 
	
() (µg) Antigens (gg) 
H
MDA
_ 	
50 	100 	150 	SO 	100 ---150 	50 	100 150 
Serum 	2.413± 	323±3.473± 	2.893± 	3.300± 	3.440± - 3.557± 	3.220± 	3.403± 	2.8931 
0.2474 	0.1880 	0.1534 	0.1157 	0.4509 	0.1790 	0.2942 	0.1908 	0.1997 	0.1157 
I 	 p= 0.0812: F- 2.09?; r` 0.4850; Di 29 
Liver 	0.01533±0.0 0.3810±0.0 0.3067±0 0.3537± 0.3240±0 0.2543±0.0 0.2920±0.0 0.4401±0 0.3667±0 0.3813±0 
0448- _ 56 .040 0.02 5 	.029 	l 	17 	10 , 	. .018 .012 .016 
p- < 0.0001:1 	13.S5; r' - 0.8591: Uf 29 -~ 
Spleen 0.3103± 0.6073±0.0 	0.3403±0 0.3191± 2011±0 	0.20510.0 	0.127± 0.411±0. 0.342± 0.2803± 
0.02030 41 .034 0.034 	I 	.017 	19 	0.018 121 0.027 0.0208 
p 	0.0001: F- 8.342: r'- 0,7896: Df= 29 
Lung 0.2433± 0.4143± 1.562± 3.177± 	0.3273±0 	0.2767±0.0 	0.305± 0.860±0. 0.715±0. 0.5230± 
0.02333 0.01 0.2689 0.4062 .016 	11 	0.033 0289 0377 0.0066 -----• p. < 0.0001; F 34.50; r - 0.9395; Uf= 29 _1-- ..._...---- 
0.2863+ 0.5493+ O.S60± 0.603± 0.6543±0 liidne 0.541+ 0.693± 	0.899± 	0.418± 	1,221± 
0.04302 l 0.06 	0.0301 0,039 	0.094 	0.044 	0.1930 	0.033 	0.052 	.083 
p= < 0.0001: F-- 9.906: r`- 0.8168, Df- r 29 
The doses of NIDA in organs was calculated in nmol mg protein, while in serum nmol - ml of serum. All the values are represented as Mean-SE 
with p value (<0,05 was considered as significant), F value, (value and Df value. 
Table.l.4,4, Protein Carbonvlation (PC) level in Wistar Rats after exposure with different doses of antigens of Fg-Ag, Ge-Ag and GF•Ag for 24 
hours 
Immunization 	Control 	F. gigantica 
(µg) 
Antigen G. erplana1um 
(µg) 
Antigen Gigantocotj'le-Fasciola 
Antigens (µg) 
PC 	--•--- 	SO 	100 180 50 	100 150 50 	100 	
151) 
Serum 	1.200± 	1.273± 	1.1771 1.411± 1.011± 	1.301± 1.433± 1.323± 	1.247± 	1.220± 
0.1732 	0.018 	0.08 0.0593 0.056 	0.051 0.053 0.044 	0.114 	0.113 
p= 0.1054; F= 1.933 .58 0.462: Df= 29  
Liver 	1.661± 4.500± 	4.540± 4.4031 2.553± 3.100± 3.600± 	3.1471 4.677± 4.713± 
0.2848 0.2309 	0.2358 0.2617 0.2598 0.2082 0.2646 	0.1255 0.4746 0.2791 
p=< 0.0001; F=9.962; r`=0.8176; Df 29  
Spleen 	3.567± 	f  11.52± 	2.600±T 5.380± 	3.867± 	4.267± 	7.433± 1  5.563± 	5.767± 	5.3531 
0.2186 	2.418 	0.7024 	0.3128 	0.08819 	0.6360 	1.009 	0.8331 	0,3528 	0.6394 
p= 0.0002; F= 6.860; r= 0.7553; Df= 29 
Lung 1,030± 6.587± 15.44± 30 89± 3.800± 3.333± 4.833± 6.370± 16.281 22.101 
0.2706 i  0.8310 	2.292 	9.104 	0.1155 	0.4372 	0.5457 	0.7935 	4.574 	4.290  
p= 0.0001, F= 7.345; r`= 0.7611-1 Df= 29 
Kidney 	1.167± 	5.109±4.754 	5.7671 	7,9671 	4.267±23± 	4.580± 	5.3531 	5.980± 
0.0882 ;  0.0_668 	0.129 	0.088 	0.5696 	0.4702 	0.2082 	0.1242 	0.0717 	0.0917 
p=< 0.0001; F= 53,58; r'= 0.9602; DF- 29 
The doses of PC in organs was calculated in nmol!mg protein while in serum nmol,'ml of serum. All the values are represented 
as Mean- SF with p value V0.05 was considered as siunificant). F value, r`value and Df value. 
Table. L4,5, Serum ^,u"'Dtlevel in Wisiar rats  aA". exposure wi t h differen t doses of antigens of Ft~Ao  Gp•A ; and C[ jg for ?l days. 
Immunization 	Control 	F1 gigansica 	 G. ipThi:atuni 	Gig Qn1ocor!e-Fascio!a 
(ytokines 	 ISO 	50 	100 	150 	50 	109 	150 
11-10 	1081± 	3030± 	4049± 	3221± 	1846± 	5947± 	3276± 	1314± 	2647± 	3954± 
0.6100 	10.39 	23.38 	14.94 	8.885 	40.79 	42.02 	1.075 	12.45 	13.67 
7.550 	13.61 	0.7450 	1.730 	13.30 	6.050 	8.185 	3.220 	7.940 	0.2050 
TNF•u 	143.8± 	250.3± 177.8±3 51,36± 248.2± 184.1± 	146.0± [211.6± 165,3± 	91.94± 
T-------'---'-------- -- — 	--' ---'-------- 
The doses of cy tokines calculated in m,m|"f serum sample. All the val 	are represented as Mean±SE with va l ue  //1)05 was considered 
 
F value ` value and Pfvalue 
Table.l,4.6. Nitric Oxide (NO) level in W star rats after exposure with dillerent doses of antigens of Fg•Ag, Ge•Ag and GF•Ag for 22 days. 
Immunization 	Control 	F, gigantica 	 G. erplanatum 	Fasciola•Gigantocoh'Ie 
Antigen (µg) Antigen (pig) Antigens (pg) 
NO 	..--• 	SO 	100 	150 	SO 	100 	180 	SOT 100 	
150 
	
Serum 
	
8.200± 23.67± 27.33± 24.801 22.60± 30.40± 22.701 23.67± 22.001 9.933± 
0.9452 	1.594 	2.888 	2,214L 1.258 	2,581 	2.285 	1.443 	1.415 	1.475 
p= < 0.0001; F=13.6 	= 0.8599; Df= 29 
Liver 	1667± 9.380± 5.980± 5.887± 5.340± 5.767± 3.737± 5.367± 3.6671 6.097± 
0.2728 0.2551 0.2859 0.7226 0.1447 ; 0.1764 	0.1484 	0.2333 	0.2728 ; 0.3830 
 
r < 0.0001: F=18.59, r'- 0.8932, Df 29 
Spleen 	0.6733± 10.82± 11.28± 13.13± 6.5331 j 4.100± 	4.400± 	3.767± 	3.823± 	4.067± 
0,0736 0.8495  1.341 	1.550 	0.8353 ! 0.9074 1 1.002 	0.2028 	0.5359 	0.5239 
p- <0.0001: F 20.64;r'=0.9028-,Df=29 
Lung 	0.7967± 	16.90± 	11.131 	7.457± x633± 1 4.633  ± r 	.867t 	4.600± 	3.867± 	2.633± 
0.1322 0.8660 1.433 1.806 	0.3528 	0.2404 ; 0.4702 	1.044 	0.4410 	0,3844  
-H 11II± 
  	p= < 0.0001; F= ?8.19; 	29  
Kidney 	0.370± 	15.10± 	8.7001 , 9.400± 	6.933± 	4.6001 	2.767± 	2.387± 	4.100± 	4.567± 
0.0416 ~2.597~ 1.823 	1.137 _1.364 	0.6928 	0.5925 	0.8630 	0.5508 	1.212 
p= < 0,0001; F=:11.08; r'= 0.8330, Df- 29 
The doses of NO in organs was calculated in pmol'mg protein while in serum pmol'ml of serum. All the values are represented as Mean±SE 
~vith p value (<0.05 was considered as significant), F value, r value and Df value. 
Table,1,4,7, Malondialdehide (MDA) level in Wistar rats after exposure with different doses of antILens of Fg•Ag. (ie-A(g and GF-Ag for 2 
days 
Immunization 	Control 	F. gigantica 	Antigen 	G, evplanatum 	Gignntocotti[e-Fasciola 
(pg) 	 Antigen (µg) 	 Antigens (rig) 
100 	150 	SO 	100 	1S0 	SO 	100 r LSO 
	
2.487± 	2.347± ; 2.160± 	1.990± 	2.6601 	2.590± 	2.790± 	2.830± 	2.640± 	1.943± 
0.2167 	0.2021 	0.0964 	0.0866 	0.3717 	0.1626 L 0.2511 	0.0954 	0.1422 	0.1198 
p 	F= ?.731; r'= 0.5514: Df= ?9 
0.0840± 0.2300± 0.2333± 0 	r 0.2633± J 0.4667± 0.2100± 0.3067± 0.1933± 0.2967± 
0.00611 0.0208 0.0145 0.0252 0.0176 0.024 0.0116 0.024 0.012 0.0145 
_ 	< 0,0001; F-- 2919; r'= 0.9293; Df 29  
1.2031 	0.6167± 	0.1861± 	1.083+ 1 0.7933± 	0.9400± 	0.590± 	0.6067± 
0.286 	0.1919 	0.03480 	0.0524 	0.0296 	0.0379 	0.0551 	0.0176 
F= 	r`= 0.9476: Df ?9 
1.170± 	0,5433± 	0.9367± 	1.0531 	1.030± j 0.8700± 	0.6733± 	0.4300± 
0.1739 	0.0353 	0.0338 	0.0857 	0.08737 	0.0351 	0.287 	0_2854 
p= 0,007?: F- 3.691; r 0.6242: Df=- 29 
Kidney 	0.38331 	0.7133± 	0.370± 	1.367± 	07433±05467± 	-~V ~v- 	07867± 0.490± ~ 0.8561± 0.4933_+  
0.02906 ] 0.023 	0.0764 	0.260 	0.0409 	0.0521 0.0436 	0.0504 	0.073 	0.049 
p=<0.0001;F=9.606;r=0.812I;Df ?9 
The doses of MDA in organs was calculated in nmol'mg protein while in serum nmol ml of serum. All the values are represented as MeanwSE 
with p value (<0.05 was considered as significant), F value, r value and Df value 
Serum 
Liver 
Spleen 
	
0.3333± 	3.223± 
0.02603 	0.192 
Lung 	0.3333± 	0.690± 
0.0291 	0.0551 
Table,l,4,8, Protein Carlwnylation (PC) level in Wistar rats after exposure with different doses of antigens of Fg-Ag. Ge-Ag and GF-Ag for 14 
hours 
1 mmunization 	Control 	F. gigann'ca 	G, &planatum 	AntigenGigantocotyle•Fasciola 
Antigen (µg) 	 (pg) 	 Antigens (µg) 
PC 	--..-• 	5O[1 	150 	SO 	100 	150 	SO 	100 	150 
Serum 	1.5331 	1.723±0.11 2.16010. 	2.153±0. 	1.873±0. 	1.9131 	1.8671 	1.730±0. 	1.8331 	1.901 
	
0.2114 	619 	3931 	3968 	1507 	0.2573 	0.2573 	1650 	0.2313 	0.2517 
p= 0,8171; F= 0,5549; r`= 0.1998; Df= 29  
Liver 	2.533± 	9.667± 	9.733± 	10.13± 	3.6331 	13.301 	11.801 	8.967± 	9.233± 	8.733± 
0.2186 0.8212 0.636 ; 0.437 0.2963 	0.451 	0.3786 0.5239 	0.393 	0.1453 
_____ 	___ 	 p= < 0.0001; F: 49.86; r`= 0.9573; Df= 29  
Spleen 	3.833± 	31.73± 	34.40± 	32.37± 	32.70± ! 39.80± 	51.90± 	8,267± 	7.600± ! 9.733± 
0.4910 	1.714 	2.358 	2.829 	 0.8505 	2.641 	3.110 I72 	0.3055 L 2133 
p= < 0.0001; F: 70.09; r2= 0.9693; Df= 29 
Lung 	1.867±145.07± 	21.73± 	33.40± 	16.21± ! 30.13± 	37.07+ 	3.533± 	6.000± 	5.300± 
0.3528 	4.001 	3.670 	2.358 	8.109 	3.67 	2.034 	0.2603 	0.4041 	0.1732 
p= < 0.0001; F= 21.48; r 2= 0.9062; Df: 29  
Kidney 	1567±13973± 	27.37± 	44.70± 	28.17± 	31.77± 	48.67± 	1170±1207± 	14.73± 
i 	 0.3844 	7.323 	2.025 	1.739 	 4.092 	3.213 	1.273 	0.8505 	1.097 	0.8192 
{ 	 I 	 p= < 0.0001; F= 26.68; r2: 0.9231; Df= 29 
The doses of PC in organs was calculated in nmol'mg protein while in serum nmol!ml of serum. All the values are represented as Mean-SE with 
p value (<0.05 was considered as significant), F value, r value and Df value. 
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1.5-DISCUSSION 
The Immune response within the host against infectious agents was first 
supposed to be orchestrated by the phagocytic cells (Metchinnkof, 1905) and latter on 
concept of Immoral antibody response (Ehrlich, 1905) came into existence. These two 
mechanisms of immune protection were unified in a single paradigm as ThI and Th2 
immunity. Under Thl and Th2 paradigm the naive cell differentiate in either'hhl cell 
subset or Th2 cell subset, elicited by the local cytokine milieu, route and dose of 
antigen administration, type of antigen presenting cells stimulating T cells and the 
affinity of T cell receptors with the MHC (Major Histocompatibility Complex) Class 
molecules (Seder and Paul, 1994; Constant and Bottomly, 1997). Thl cells are 
responsible for the Thl type of response chiefly signatured by pro-inflammatory 
cytokines TNF-a and LEN—r which stimulate phagocytosis (Szulc and Piasecki, 1988; 
Livingston et at., 1989), oxidative burst (Diamond et at., 1991; Dellacasagrande et al., 
1999; Marodi et al., 1995) and intracellular killing of microbes and stimulate antigen 
presentation to the T cells by upregulating the class I and class 11 MHC (Volk et al., 
1986; Male et al., 1987). IFN-y also induces other cell type to secrete other 
pro-inflammatory cytokine such as TNF-a and chemotactic cytokines, called as 
chemokines (Nickoloff and Naidu, 1994). The ml response mediated by high level of 
IFN-y is the outcome of inflammatory reactions including rubor (redness), tumor 
(swelling), dolor (pain), and color (warmth) (Spellberg and Edward, 2001). However, 
Th2 cells stimulate B cells to produce antibody and class switching by IL-4, [L-10 
and IL-1 3 (Lundgren et al., 1989; Punnonen and de Vries, 1994; Lai and Mosmaim, 
1999). In addition Thl and Th2 cells cross regulate each other by direct suppression 
of IL-4 by IFN-y and vice versa. The most potent anti-inflammatory cytokine is the 
IL-10 which suppresses secretion of pro-inflammatory cytokines (Fiorentino et al., 
1991; Cassatella et al., 1993), suppress oxidative burst (Romani et al.. 1994; Kuga et 
al.. 1996) and phagocytosis (Laichalk et al., 1996) and intracellular killing (Oswald et 
al., 1992; Cenci etal., 1993) and causing T cell anergy, likewise, IL-4 and IL-13 also 
have similar functions. The Thl cell and Th2 cell proliferation have cytokine specific 
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requirements; naive T cells differentiate into Thl cell type by IL-2 induced activation, 
while development of 'Ih2 cells requires IL-4 (Kurt-Jones et al., 1987, 
Femandez-Botran et al., 1986). 
In the present study, the subcutaneous antigen exposure of the Wistar Rats 
elicited predominantly immunosuppressive immune response. The level of 
anti-inflammatory cytokines (IL-10, IL-4) was significantly increased at the different 
doses of 411 the antigenic exposures while the level of pro-inflammatory cytokines 
(IFN_y and TNF-a) though initially appeared to be stimulated but it was suppressed at 
the higher dose after 24 hours as well as 22 days of antigenic exposure which was in 
favour of the fact that helminth parasites derive the Th2 type of response. The low 
antigenic dose may not be sufficient to exert enough stimuli to amplify a Th2 
response because it is well known that antigenic dose is also determining factor for 
the fate of naive T cells. The development of strong immune response after 24 hours 
found to be contradictory to the fact that the in vitro human T cell phenotype is 
determined within 48-72 hours after activation of naive T cells (Sornasse et al., 1996; 
Nakamura in al., 1997a). This fact is also supported by the in vivo study where the 
activated T cells in lymph nodes do not proliferate into effective mature T cell type 
until they don't get exposed to the specific cytokine in peripheral effector sites. This 
phenomenon takes 2-3 days following activation (Doyle et al., 1999). The 
development of mature T cells after 24 hours of exposure might be due to rapid 
activation of naive T cells and quick movement of the activated 'f cell at the effector 
site and may the due to the animal model we used in our study. The other reason 
might be the already presence of active T cells in the periphery. The early 
development of immune response might be supported by the production of high level 
of IL-10 in response to the concurrent infection with Ascari.s lumhricoidis and 
Trichuris trichura, separately or during co-infection (Figueiredo et al., 2010). More 
recently IL-10 has also been considered as regulatory cytokine. Helminthes also 
regulate the immune response by the induction of regulatory cytokine TGF-ii and 
IL-I 0 which suppress the Thl immune response (Song et al., 2011; Whelan et al., 
2011). These studies have shown that in individuals infected with S. ransom high 
level of 1L-10 is secrete by the peripheral blood mononuclear cells (PBMCs) (Araujo, 
2004a) and thus PBMCs are the major source of serum IL-10. Children infected with 
A lumbricoides and Trichuris trichura constitutively secrete the regulatory cytokines 
(IL-10 and TGF beta) (Turner et al., 2008). A similar, condition was observed as well 
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in the present study where high level of IL-10 was found in response to both the 
F. gigunticu and G. erpplanatuni antigens as well as to their combined antigens 
(Giguntocotyle-Fasciolu antigens) as compared to the control rats. It is well known 
that the subcutaneous injection of antigens encounter the antigen presenting cells 
(Langerhance cells present beneath the skin) and peripheral mast cells. Mast cells are 
mainly involved in Th I driven host defense against bacteria and protozoan infections 
but the helminth antigens are able to impair the mast cell ability to mount ThI driven 
immune responses (Vukman et al., 2013) and thereby change the local environment of 
effector site that become suitable for the development of anti-inflammatory response. 
The high level of IL-10 in response to A. lumbricoides antigen as well as during 
co infection with T. trichura and together with other studies, it has been suggested 
that helminth parasites induce regulatory as well as immunosuppressive response 
inside the host (Figueiredo et al., 2010). 
The IL-4 cytokine is considered as a Th2 signature cytokine which is essential 
for in vitro amplification of Th2 response, B cell class switching to IgE production 
and cellular migration to peripheral tissues (van Panhuys et al., 2011). IgG antibody 
class switching to IgE cannot occur without the presence of IL-4 and IL-13 and in fact 
IL-4 is an important cytokine which trigger the naive T cell to differentiate into Th2 
cells (Spellberg and Edward, 2001). Not only the CD4" effector T cells, but also 
basophils. mast cells. eosinophils and NKT cells are involved in IL-4 production and 
thus Th2 promoting cytokine environment is developed by other IL-4 producing cell. 
After exposure with the local cytokine environment CD4+ cell get activated and 
produce ample amount of Th2 cytokines. In the present study the level of IL-4 was 
increase in dose dependent manner after inoculation of rats with F. giguntica and 
G. explunutunm as well as their combined (Gigantocotyle-Fasciola antigens) somatic 
antigens after 24 hours and 22 days. The increase in 11-4 level was very much 
significant at the higher doses of antigenic exposure after 22 days than 24 hours which 
showed that the continuous exposure was much more potent to stimulate high amount 
of IL-4 secretion. The enough change in IL-4 level at different antigenic exposure 
after 22 days than 24 hours and very little difference in IL-10 level after 22 days than 
24 hours of antigenic exposure makes the situation controversial over the role of 
IL-l0 cvtokine in our study i.e. it is not clear in the present study whether the IL-10 is 
promoting a Th2 response or acting as a regulatory cytokine over ThI/Th2 paradigm. 
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The IFN-y is characteristic cytokine during Th I response which is orchestrated 
by the exposure of active CD4+ cells with IL-12 in local environment. In the present 
study after 24 hours of antigenic exposure a significant increase in IFN-y level was 
observed at all the antigenic exposure of F. gigantica antigen and no significant 
change was observed against the G. explanatum antigens while a significant increase 
was observed at the lowest dose of Gigantoeotyle-Fasciola combined antigens after 
that significant decrease in IFN-y level was observed at higher doses in a dose 
dependent manner. In contrast to the 24 hours of antigen exposure, daily antigenic 
exposure for 22 days gave much robust results towards the Th2 type of response. 
After continuous antigenic exposure for 22 days the IFN-y level after the initial 
increase at lowest dose, dropped at higher doses of Fg-Ag in dose dependent manner. 
Similar observation was found in case of Ge-Ag while GF-Ag was found more 
promising because there was no significant change in cytokine level at any of the 
antigenic dose after daily antigen exposure of rats for 22 days. The present finding 
suggests that the dose as well as duration of antigenic exposure is also important for 
Thl/ Th2 determination with respect to the two trematodes understudy. The present 
findings are in agreement with the previous study that short term exposure of 
macrophages with helminthes produce more IL-12 and the CD4+ T cell mainly 
produce IFN-y while during chronically exposed host the macrophages switch over 
the production to IL-6 and PGE (ProstaglandinE) and less IL-12 and IFN-y 
(Rodriguez-Sosa et al., 2002).The insignificant change in IFN-y under combined 
antigenic exposure may suggest that the concurrent infection can strongly inhibit the 
Thl cytokines by ample production of Th2 cytokines thus suppressing the 
pro-inflammatory conditions. 
TNF-a is also considered as a Thl type of cytokine which is important 
contributor in some Th 1 mediated autoimmune disorders (Vukman et al., 2013). In 
the present study, it was found that the level of TNF-a was inhibited significantly 
after 24 hours of antigen exposure at the different doses in comparison to Th2 
cytokines. After 22 days of continuous exposure of rat to parasite antigens, the level 
of TNF-u was increased at the lower dose of F. gigantica, G. explanutu,n and their 
combined antigens (Giganiocottvle-Fusciolu antigens). The TNF-u level was 
decreased significantly from lowest dose to the highest dose. The overall minimal 
level was found under the combination of two antigens which again suggests that the 
combination of the two antigens might promote strong Th2 type of response. The 
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elevated TVF alpha level at lower dose after a long course of antigenic exposure i.e. 
22 days daily, can be supported by the finding of Girones et al. (2007). According to 
this study (loc. cit.) it was found that besides the increase in IL-4 level, [NF-a is also 
increased at 10 week of Fasciola infection in Wistar rats, which does not correspond 
to the Th2 response. TNF-a is also involved in regulation of Th2 response and 
apparently regulating the worm expulsion (Artis et al., 1999). 
It can be concluded that the level of Wistar rat's immune response against 
F. giganlica antigen (Fg-Ag), G. exp/anatum (Ge-Ag) and Giganlocoryle-Fasciola 
(GF-Ag) combined antigens could he initially somewhat mixed type i.e. Thl and Th2 
with ultimately Th2 dominated behavior at particular dose as well as type of antigen 
following prolonged exposure of host to parasite antigens. 
An increase in Nitric oxide (NO) production is very common during parasitic 
infections and it is mediated by the production of inducible nitric oxide synthase 
(iNOS) in response to the specific parasite antigen or pro-inflammatory cytokine 
during infections. Pro-inflammatory cytokines such as IFN-y, TNF-a and ILl- and 
certain pathogenic products are involved in NO production (Almeida et al., 2000; 
Lycon, 1995: Tachado et al., 1997). Suppression of NO production is achieved by the 
expression of anti-inflammatory cytokines such as IL-4, [L-10, and TGF-(3 through 
down regulating iNOS via direct or indirect inhibition of TNF-a (Bogdan et al., 1994; 
Oswald et al., 1992). Conversely, NO also exert inhibitory effect on 1FN-7 and TNF-
a. It is found that in absence of NO. IFN-y and TNF-a are highly elevated (Florquin 
et al., 1994; Wei et al., 1995; Huang et al., 1998). NO also has immunosuppressive 
property and thus may limit the Thl cytokine production by anti proliferative effect 
on T cells (Loc cit.). Recently it has been found that NO also has host protective 
activity against parasites. For example, NO act to limit early hepatic damage caused 
by the egg deposition of S. mansoni via inhibiting 'FNF-a because during egg 
deposition the immune response is characterized by the Thl cytokinc 'INF-a 
(Rosa-Bnmet et al., 1999). In Brugia NO is also involved in parasite killing by the 
activation of macrophage via IFN-y induction (Rajan et al., 1996; Taylor et al., 1996). 
NO is produced preferentially by the Thl cell subset of T helper cells 
(Taylor-Robinson et al., 1994) and thus NO may be the preferential marker for Thl 
response. But it has also been found that NO inhibit the ThI response and production 
of the 1hl cytokinc IFN-y in certain mice strains (Wei et al., 1995) which could be 
down regulated in autocrinc manner while promoting Th2 response, possibly leading 
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to enhanced IgE production and IgE mediated diseases such as asthma (Barnes and 
Liew, 1995). NO exert immunosuppressive response in vivo since NOS-2 gene 
knockout mice enhanced Thl response to Leishmania infection (Loc cit) and 
exacerbated severity in autoimmune encephalitis (Sahrbacher, 1998). 
In the present study as we discussed that major cytokine secreted in response to 
the Fasciola gigantica and (iigantocotyle explanatum and their combined antigens is 
Th2 dominated and the level of serum NO was elevated significantly from control 
which suggests that the NO may be involve in the promotion of Th2 type of response 
and inhibition of Thl response. If this speculation is not true then high level of serum 
NO should promote the lipid peroxidation and protein carbonylation in serum which 
did not happen in the present study. It has been reported that the NO may exert 
cytotoxic effect through a number of different mechanisms (Lyons et al., 1995; Liu 
and Ilotchkiss, 1995). NO is highly reactive with the superoxide ion leading to the 
formation of potent oxidizing agents such as peroxinitrile, which leads to lipid 
peroxidation of cell membrane, change in the protein structure in the form of 
carbonylated proteins, leading to protein mal-functioning. In the present findings the 
level of MDA which is the marker for lipid peroxidation and PC (protein 
carbonylation) did not change significantly in serum after 24 hours as well as 22 days 
of antigenic exposure, which suggests that the NO in the system under our study did 
not create the potent oxidative stress and pro-inflammatory environment within the 
experimental host and thus becomes suggestive for the development of 
anti-inflammatory environment. But the level of MDA in different organs such as 
liver, spleen. lung and kidney was significantly increased after different antigenic 
exposures. Among all these organs the liver found to be the most affected organ in 
terms of lipid peroxidation which suggests that the parasites niche suitability could be 
present in its gene pool. In liver, NO level was significantly increased after 24 hours 
along with high level of MDA and PC (at certain doses) which suggests that the NO 
act as a cytotoxic mediator which causes the lipid peroxidation and protein 
carbonylation in liver cells. The increase in liver NO level was also highly significant 
after 22 days of antigenic exposure but the level of serum MDA was not increased to 
a great extent as after 24 hours. The high NO level in liver might be due to the 
localized effect. In spleen, decrease in NO level from F gigantica exposed rat to the 
G. explananmr and their combined antigens (Gigantocotyle-Fasciola antigens) which 
was in accordance with the decrease in lipid peroxidation from F. gigantica to 
68 
f 105: Discussion 
G. explanarum and their combined antigens while lungs and kidney the trend of NO 
and MDA was not in dose dependent manner but the level of NO was significantly 
high at certain doses (in case of lung) but in case of kidney NO level was significantly 
elevated at different treatments. The MDA level in lungs and kidneys was not in 
correlation with the NO level in these organs. The overall cumulative observations 
suggest that NO is not enough to promote lipid peroxidation in lungs and kidneys and 
thereby did not promote pro-inflammatory effect in these organs. 
It is well defined that the parasitic infections, hepatic surgery and haemorrhagic 
shock lead to the production of ROS and lipid peroxidation (Bilzer and Gerbcs, 2000 
and Jaeschke, 2000). Nitric oxide is not a strong oxidant and cannot extract bis allelic 
hydrogen from unsaturated fatty acid to begin the peroxidation chain reaction 
(Nakamura et al., 1997b). But the reaction between nitric oxide and superoxide ion as 
well as reaction between nitric oxide and molecular oxygen generate the peroxinitril 
and nitrogen dioxide, respectively, which initiate the process of lipid peroxidation 
(Hogg and Kalyanaramon, 1999). However, the ratio of NO and 0- actually determine 
its protective or deleterious role and therefore nitric oxide is also involved in 
scavenging the superoxide ions via the formation of peroxinitril (Billiar, 1995). It has 
also been reported that the nitric oxide inhibit the process of lipid peroxidation by 
certain other mechanisms. Several enzymes, for example cyclooxigenase, 
lipooxigenase and cytochrome P450 type enzymes, have property to induce oxidation 
of unsaturated fatty acids. Ti has been suggested that the nitric oxide inhibit these 
enzymes to block the process of lipid peroxidation (Kanner et al., 1992). Nitric oxide 
also inhibits glutathione peroxidase and thereby enhances the lipid peroxidation 
(Asahi et al., 1997). It the present study the level of serum nitric oxide was 
significantly elevated while the increase in MDA level was insignificant after the 
exposure with F. gigrrnica and G. eap(armrum as well as their combination for 24 
hours and 22 days. These findings suggest that the nitric oxide inhibit the serum lipid 
peroxidation. Alternatively, it also suggests that the level of serum oxidative stress 
may not be enough either to fort the peroxinitrile or antioxidant system to scavenge 
the free radicals which cause oxidative damage. The level of nitric oxide and MDA 
was significantly high in liver but in spleen only NO level was found to be 
significantly high. The high level of liver MDA can be supported by the finding that 
the nitric oxide synthase exert the antimicrobial activity against egg stage of 
S. mansoni and also causes severe liver pathology (Abdellahi et al., 2001). It has also 
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been found that the liver of sheep infected with Fasciola hepatica and Fasciola 
gigantica, face extensive oxidative stress which leads to the high level of MDA 
formation. a marker lbr cellular damage (Deger et al., 2008). In spleen the level of 
NO was significantly elevated at most of the antigenic exposure while no significant 
change was observed in spleen MDA level except at the lowest dose of Fg-Ag which 
suggests that in spleen the antigen inoculation did not cause lipid peroxidation and 
therefore can be assumed as the anti-inflammatory potential of NO in spleen where 
high level of CD4' T cell are normally concentrated. NO level was elevated only at 
certain dose of antigenic exposure in lungs and there was not much correlation found 
with the MDA level in the same organ after 24 hours and 22 days of antigenic 
exposure. In kidney, NO level was significantly high in comparison to control but no 
significant change was observed in MDA level after 24 hours of antigenic exposure 
except at some doses of antigens. But after 22 days of antigenic exposure, the liver 
showed same pattern as 24 hours exposed rats. However, in spleen, the NO revel was 
significantly decreased from lower dose to higher dose in case of Fasciola antigens 
while no change was observed in Gigantocotyle antigen and in combination of both 
the antigens after 22 days of daily exposure. In spleen. lipid peroxidation was lound 
with same pattern as NO with high level of MDA at lowest doses of F. gigantica 
antigens and insignificant change at rest of the antigenic exposure which suggests that 
the NO may exert deleterious effect on spleen by lipid peroxidation at certain dose 
while the low level of NO and MDA at most of the antigenic exposure may suggest 
the localized role of NO. Likewise we found no correlation between lung and kidney 
NO and MDA level after 22 days of antigenic exposure. 
Protein carbonylation is the consequence of high oxidative stress which changes 
the structures and functions of protein and has deleterious effect while low level of 
protein carbonylation is essential in some ROS dependent signal transduction 
pathways (Wong et al. 2010). The protein carbonylation in serum was not in 
accordance with the high level of NO in serum i.e. the oxidative stress in serum was 
not enough to cause significant protein carbonylation. While in liver and kidney the 
level of protein carbonylation was significantly elevated whereas spleen and lung did 
not show any marked difference after 24 hours of antigenic exposure in general. In 
liver, high PC level was found only at Fg-Ag and higher doses of OF-.Ag while the 
Ge-Ag did no cause significant protein carbonylation in liver, In kidneys, most of the 
antigenic exposure lead to high PC level as compared to control, while no marked 
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difference was observed in spleen and lung at most of the doses. After 22 days of 
antigenic exposure PC level was significantly elevated in all the organs except GF-Ag 
exposed rats. The overall observations gathered on the level of protein carbonylation 
again suggest the predominant anti-inflammatory ann of immune response in Wistar 
rats after the immunization with different trematodes antigens. 
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CHAPTER 1 
2.1-INTRODUCTION 
The Rheumatoid arthritis (RA) is an autoimmune disorder of unknown 
etiology (Wang et al„ 2011). It is chronic intlamtnatory disease, characterized by the 
progressive damage to cartilage and hone, inflammation of synovium, inflammation 
of synovial tissues etc. that leads to disability (Aletaha et al., 2011), and the 
immunological implications including infiltration of different immune cells like 
monocytes and activated Icukocytes into synovial joints leads to pannus formation 
over the articular cartilage as well as over expression of pro-inflammatory mediators 
collectively lead to the cartilage and bone damage (Karmakar et al., 2010). 
About 1-2% world population suffered from this disease (Akhter et al., 2011; 
Deborah et al., 2002). It is found that the annual incidence of RA is about 1-2% 
(Gabriel, 2001). The incidence of RA is also gender dependent and it is more frequent 
in females (0.5 to 3.8%) than males (0.15% tol.37%) (Malaviya et al., 1993). 
Inflammation and joint destruction is the outcome of pro-inflammatory 
environment in affected site. The degree of balance between pro-inflammatory and 
anti-inflammatory response determines the extent of disease. The immune system is 
evolved to protect the organisms from any invading pathogen as well as endogenous 
dangerous substances and signals (Janeway et al., 2001). The process of protection 
from these agents is under strict control of certain regulatory mechanisms and 
deviation from the normal process may lead to excessive response of body to 
infectious agents as well as to autoimmune disorders such as RA. In RA both innate 
as well as adaptive immune response plays an important role in disease progression. 
Rodent models have been used as supporting evidence for the involvement of 
adaptive immune response, for example Collagen Induced Arthritis (CIA) which 
mainly consists of Thl and T1i2 type of immune mechanism (Billiau and Matlhys, 
2011). The production of ditlerent pro-inflammatory cytokines, chemokines and 
matrix metalloproteinases (MMPs) by innate immune cells cause damage to the 
cartilage and bone. Macrophages are predominantly involved in RA pathology along 
with other cells such as neutrophils, mast cells, NK cells etc. In RA several cytokines 
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have direct or indirect effect on macrophages which in turn release several mediators 
as well as express certain cell markers which exert a pathological condition during 
RA progression (Drexler et al., 2008). For example, IL-1(3 is a pro-inflammatory 
cytokine which is involved in hone and cartilage erosion rather than synovites and it 
also activate macrophages to release other pro-inflammatory cytokines, reactive 
oxygen species, nitric oxide, prostaglandin etc. (Loc. Cit.). TNF-u is an important 
cytokine which activate macrophages and is also produced by the same. This cytokine 
is also involved in synovilis. The role of IL-10 in RA is controversial. In certain cases 
IL-10 upregulate IFN-/ inducible genes which promote the inflatnmatory conditions 
(Antoniv and Ivashkiv, 2006). But it has been found that the IL-10 therapy in CIA 
mice inhibit disease progression (Saidenberg-Kermattach et al., 2003). 
Immune cells like macrophages and neutrophils also secrete certain MMPs at 
inflamed site. These MMPs also have very crucial role in the disease progression. 
Under normal condition the role of matrix metalloproteinases is very important and 
their secretion is always under check and balance. In healthy condition the MMPs are 
involved in development, morphogenesis, tissue repairs and remodeling through 
extracellular matrix degradation and are controlled by certain cytokine, growth 
hormones and tissue inhibitors of matrix metalloproteinases (TIMPs). In RA, the 
1L-1 p and TNF-a promote the secretion of MMPs which enhance the disease severity 
by excessive damage to the cxtracellular matrix, cartilage and bone (Goldring, 2000). 
Different type of MMPs, including MMP-I. MMP2, MMP13, MMP9, MMP8 etc. are 
expressed the extent that collectively damage the structural collagen, articular 
cartilage, adjacent tendon and bone as well as non collagen matrix molecules that 
contribute to joint integrity and function. 
During disease progression there is a production of free radicals which create 
the stress conditions. These free radicals are the reactive oxygen species in the form 
of hydrogen peroxide, superoxide ions, and their reactive products. In RA, the ROS 
leads to the destruction of cartilage and extracellular matrix either directly or 
indirectly (Lott, 2003: 1-Ienrotin et al., 2003). But the human body has an ( intrinsic 
mechanism to cope with the oxidative stress by its antioxidant system. The 
antioxidant compounds can inhibit and scavenge the ROS (Sies, 1997). 
Excessive oxidative stress is thought to have an important role in the pathogenesis 
of rheumatoid arthritis (Kalpakcioglu and Senel. 2008). 
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ROS are highly electrophilic compounds whose most suitable target sites in 
ical system are DNA. proteins and lipids. It has been demonstrated that the 
are generated by the macrophages. neutrophils. lymphocytes and endothelial 
titer stimulation (Knight. 2000). Hence, it is imperative that ROS also have 
l role in disease progression in RA (Lunec, 1990). The increase of ROS level in 
imation and depletion or diminishing of antioxidant enzymes can initiate the 
)eroxidation and protein carbonylation. Membrane lipid peroxidation may lead 
cellular damage and can activate the signal transduction elements (Yadav and 
na. 2013). ROS have direct oxidative attack on different proteins as well, and 
:ad to the formation of protein carbonyl derivatives, aldehyde and ketones 
t and Stadiman. 1997). Thus the change in protein structure will cause 
anal disintegrity in protein molecules and therefore normal physiology gets 
ted. 
Nitric Oxide (NO) is an important messenger molecule in inflammatory 
ions (Kerwin and Heller, 1994). It has been found that NO may have either 
or protective role (Palmer et al.. 1992 and Szabo and Thiemermann, 1994). In 
NO induce the production of pro-inflammatory cytokines, 1I.-1 f , TNF-a, IFN-y 
collagenase (Brenner et al., 1997. Ajuebor, 1998 et al.; Diefenbach et al., 1998 
Mclnnes et al.. 1998). Decreased production or suppression of NO reduces the 
:asc severity. Antioxidants have property to scavenge the NO and thus inhibit the 
;ease severity (Khanna et al., 2007). 
The production of above described inflammatory mediator is under the control 
.f signal transduction pathways. These signal pathways get activated under the 
trthritogenic stimulus and initiate a chain of reaction that includes the transcription 
;actors. NFkB and AY1. These transcription factors control a number of genes 
encoding various mediators like cytokines, MMPs, chemokines, adhesion molecules, 
T cell differentiation etc. The transcription factor NF-kB regulates the expression of a 
wide variety of genes. RcIA. ReIB. c-Rel, NF-kBl and NF-k132 %%hick are the 
members of NF-kB family. These members activate characteristic sets of genes in a 
stimulus-type manner in particular cell thee, thus regulating the transcription of genes 
(Silverman and Maniatis. 2001; Dejardin et al., 2002; Ghosh and Karin, 2002: Li and 
Verma, 2002: Udalova et al., 2002). The NF-kB remains in an inactive form due to 
natural inhibitor of NF-kB proteins (IkB), but cellular stimuli including cytokines, 
mitogens and stress activate 1k13 via activating NF-kB kinase (IkB kinase (IKK) 
F2(1 Intreóctios 
complex) and subsequent degradation of 1kB (Ublar and Whitehead, 1999; Mullat ct 
a]., 2006). The activated NP-kB translocates to the nucleus mid triggers the 
transcription of genes containing the consensus kB sequence (Inc. cit). Such genes 
include those encoding certain cytokines and chemokines. adhesion molecules, 
M%lPs. iNOS, COX-2, VEGF, etc. Most of these genes have been reported to have 
important rote in the progression of BA (Li and Venua, 2002). 
There are many therapeutic interventions available to treat the IRA. these drugs 
include nonsteroidal anti-inflammatory drugs (NSAIDs), glucomrrieoids (GC) and 
disease rnodifying antirheumatie dings (DMARDs). As the name suggests NSAID 
inhibit inflammation but their effect could not completely eleviate the disease 
symptoms. Moreover these drugs have many side effects as well on kidney, 
gastrointestinal tract (Gil) and central nervous system (O'Day, 2006). the OCs have 
potent immunosuppressive property but there prolonged use creates many secondary 
complications including irnpairment of calcium absorption, leading to decline in bone 
mineralization (Biljsma, 2006). DMARDs have proven as good therapeutic drugs as 
they slow dkeoae progression but even at a very low dose they cause toxicity to liver. 
Gil, skin and mucus menrbrane, hetnalopuiclie and respiratory system (Rau, 2006). 
Due to the unavailability of Dater therapeutics for RA, them is a strong need to 
develop a batter therapeutic intervention wh-ch can control or modify inflammatory 
response without creating the side effects and disturbing the normal immunological as 
well as physiological processes. These altcma:ive treatments can only be developed 
after unraveling the immunological mechanisms underlying the disease progression 
(McDougall, 2006). 
Experimental models do not mimic completely with the RA of human but their 
role is pivotal in understanding the mechanism of RA development and the efficacy of 
different drugs against the disease. For example, the TNT-u therapy in clinical 
practices was evolved after studying the neutralization of TNF-a in arthritic mouse 
(Taylor and Feldmann, 2009). 
Hypotivis ofthe present work 
it is well known that the host immune response against helmintheq is dominated 
by the Th2 type of response which is anti-iollammatory in nature (Hewiston or al., 
2009). This 7h2 response is characterized by the high level of anti-inflammatory 
cytokincs such as IL-10, IL-4, ]L-5, IL-13. Though the lierflukes, F. g(gantica and 
G. exp(unaium, are responsible for huge economic losses but at the rn 	" 
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might also he providing some protectior against the autoimmune problems including 
ILA since the animals infected with F. hepmka predominantly exhibit Th2 type of 
immune response evident from the cytokine IL-4 and ILS domination, while IFN-y, 
1L-2 were suppressed (0'NL'1LL et aL, 2000). this T14 dominated immune response 
can be used for therapeutic intervention in RA where immune response is dominated 
by Thi type. 
Aims and Objectives 
In context of the immune response against the helminth parasites, it has Seen 
decided to use F gigantica and C. explanatum derived somatic antigens (whole 
soluble homogenate) to see whether they have any inununosuppressive effects on the 
collagen induced arthritis (CIA) in Wistar Rats 
Thefirst objectives of the study was the cstahlisluncnt of laboratory model of 
Collagen Induced Arthritic (CIA) using Wistar Rats. and then ascertain the Thl/Th2 
immune response, followed by an evaluation of the status of the transcriptional factor 
and matrix metatloproteinases (MMPs) during the disease progression and finally the 
analysis of certain biochemical markers which could indicate either the disease 
progression or its remission. 
It may not be out of place to mention that the present study was carried out in a 
moderately equipped laboratory with limited resources, therefore, a limited number of 
parameters have been investigated which could provide some baseline inforrnation 
and meaningful inferences for practical application, if any. 
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CHAPTER 2 
2.2-REVIEW OF LITERATURE 
verview of Rheumatoid Arthritis 	 ' J  
An exhaustive survey of literature as carried out with a major focus on the 
Epidemiology, Pathology, Immune mechanism, Antioxidant system and Regulatory 
path\\ays during autoimmune disease prognosis with main emphasis on Rheumatoid 
arthritis (RA) initially and later on the role of parasite derived antigens undertaken. 
RA is a systemic autoimmune disease of unknown aetiology (Wang et al., 
201 1).The disease is characterised by articular inflammation, formation of an 
inflammatory and invasive tissue and rheumatoid pannus that eventually leads to the 
destruction of joints (Fig.'!) (Lee and Weinblatt, 2001). The genetic background 
predisposes to the disease, but also person-related and environmental factors, such as 
age, gender, infectious agents, smoking and dietary factors are thought to play a role 
in the disease pathogenesis (Malaviya etal., 1993, 2010). 
Bone Svnovial Fluid 
Joint Capsule  
, novium 
Swollen Joint Capsule 
Bone Loss 
(Generalized) 
Figure.!. A generalized schematic diagram of non arthritic and arthritic joint. 
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History of Rheumatoid arthritis 
Examination of skeletal remains from antiquity in Europe and North Africa 
shows various forms of arthritis, including osteoarthritis. ankylosing spondylitis and 
gout (Aceves-Avila et al., 1998). But characteristic rheumatoid lesions with marginal 
erosions at the bone cartilage interface of the small joints are strikingly absent. In 
contrast, palaeopathological studies of specimens dating back several thousand years 
show clear evidence of rheumatoid arthritis (RA) in Native American tribes in North 
America (Rothschild et al., 1988). Prevalence of RA in the same regions remains 
extraordinarily high till today, with over 5% of individuals affected in some groups. 
First evidence of RA in Europe appeared in the art, especially by the Dutch 
Masters (Fig. 2), in early 17th century and Sydenham published the first case report in 
1676. (Firestein, 2003) 
I~ igure.2. S clling of the metacarpal-phalangeals and proximal interphalangeal joints 
(arrows) are the suggestive findings which appeared in Dutch art in 17th century. 
(image courtesy: Firestein, 2003). 
Although intermittent cases were subsequently reported, the disease was not 
fully recognized until it was defined by Garrod in 1859. He named it 'rheumatoid' 
arthritis to distinguish it from the two well-known forms of arthritis, rheumatic fever 
and gout. By the early 20th century, RA was viewed as separate from osteoarthritis 
('arthritis deformans'). In 1957, Charles Short described RA definitively and clearly 
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set it apart as a defined clinical entity which was distinct from the seronegative 
spondyloarthropathies, crystal-induced disease. osteoarthritis, systemic lupus 
erythematosus (SLE) and many other conditions. 
Classification of Rheumatoid arthritis 
American Rheumatism Association (ARA) (1987) gave the currently accepted 
classification scheme for rheumatoid arthritis (RA) criteria (Table 1). This criteria was 
developed to replace previously existing classification scheme that had not been 
revised since 1960s. The newer criteria are simpler to apply and with more sensitivity 
than earlier ones. A patient fulfilling four of seven criteria is said to have RA. 
Table.!. American Rheumatism Association (ARS) Criteria 
The 1987 ARA criteria for rheumatoid arthritis classification (Arnett et al., 
1988) 
1. Morning stiffness Morning stiffness in and around the joints, lasting at least lh 
before maximum improvement 
2. Arthritis 	in 	three Soft tissue swelling or fluid observed by a physician, present 
or more joints simultaneously for at least 6 weeks 
3. Arthritis of hands Swelling of wrist, 	MCP (Metacarpophalangeal) or PIP 
(Proximal interphalangeal) joints at least 6 weeks 
4. Symmetric Simultaneous improvement of the same joints area on both 
arthritis sides of the body for at least 6 weeks 
5. Rheumatoid Subcutaneous 	nodule 	over bony 	prominences, 	extensor 
nodules surfaces or injuxta-articular regions 
6. Rheumatoid factor Detected by a method positive in fewer than 5 % of normal 
controls 
7. Radiographic Radiographic changes typical of rheumatoid arthritis on 
changes posteroanterior hand and wrist radiograph, 	which must 
include 	erosion 	or 	unequivocal 	bony 	decalcification 
localized in or most marked adjacent to the involved joints 
(osteoarthritis changes alone do not qualify) 
Epidemiology and Incidence 
Rheumatoid arthritis has a worldwide prevalence and affect approximately 1% 
(Akhter et al.. 2011), 1-2% (Deborah et al., 2001). About 0.5-1% of total population is 
affected by the RA annually (Gabriel, 2001). In East Asia lower incidence of RA was 
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reported (Shichikawa et al., 1999). Incidence of RA is higher in females than males, 
0.5% to 3.8% in adult females and 0.15% to 1.37% in adult males (Malaviya et al.. 
1993), and it is 2-3 times more frequent in females than men. 
The occurrence of' RA is not the same throughout the world (Fig. 3). However, 
there are some interesting exceptions and its prevalence and incidence vary from one 
population to another (Del Punete et al., 1989; Mijiyawa, 1995) and from time to time 
(Silman, 1992: Spector, 1993). Firestein (1994) thought the prevalence of RA is 
constant across the globe, regardless of geographical location and race, but some 
exceptions are present over there. In China incidence of RA is lower (about 0.3%). 
while it is much higher in Pima India in North America (about 5%). In individual 
patients, it takes a variable course with remissions and exacerbations, and has a 
variable outcome, from a remitting disease leaving no damage to a severe disease 
bringing disability and even death (Rasker and Cosh, 1992). 
Prevalence rates are low in the less developed and rural parts of the world and 
it has been suggested that RA is a modern disease. Its appearance appeared to 
coincide with industrialisation or urbanisation. For example, a study in South Africa 
found a low frequency of RA among Bhantu-speaking people in their traditional rural 
environment but higher rates in the same ethnic group living in the modern urban 
townships of Soweto and similar to Caucasians living in nearby Johannesburg 
(Silman and Pearson, 2002). However, this observation did not coincide %--ith apparent 
influence observed in a study comparing rural Chinese with those living in the highly 
industrialised society of' Hong Kong. The frequency of RA was low in both the 
Chinese populations studied (Loc. cit.). Other factors such as diet and a lower or 
different genetic susceptibility may explain these apparently contradictory findings. 
Factors Affecting Arthritis Risk 
The intensity of arthritis is associated with certain factors. Non-modifiable 
(those that cannot be changed) include Icmale gender, advanced age and genetic 
predisposition and modifiable risk factors (those that may be changed/prevented) 
include physical activity levels, infection, obesity, joint injury and certain occupations 
such as those with monotonous and repetitive knee bending or other wearisome joint 
movements (Worthington et al., 2006). Awareness of these risks is important in order 
to identify groups at higher risk and for effectively therapeutic target intervention 
efforts. 
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Figure.3. Prevalence of RSA in various populations. Courtesy; Silman et al. 2002 
Non-Modifiable Factors 
• Female Gender: RA in women aged 15 years and older account for 60% of 
all arthritis cases. In 1995, US faced at least 26.4 million women suffering from 
arthritis, listing it as the leading chronic condition among women. By 2020, it is 
estimated that about 36 million women will be affected by arthritis. 
• Advanced Age: Older age is associated with a higher risk of arthritis as half 
of all the adults at age of 65 year or older are affected with arthritis. 
• Genetic Predisposition: Genetic predisposition is known to affect risk for 
certain types of arthritis. The exact role of these genetic factors is still unclear, but 
there is evidence that certain genes are known to be associated with a higher risk of 
some types of arthritis. Rheumatoid arthritis, ankylosing spondylitis, and lupus 
erytheinatosus are most associated with a genetic influence. 
Modifiable Factors 
• Activity Levels: Physical inactivity can intricate the issues associated with 
arthritis. Pain from arthritis can lead to a dereliction of the affected joints, which in 
turn can cause muscle atrophy. as well as joint capsule and tendon contracture. This 
results in decreased flexibility and ultimately a loss of independence. Regular, 
moderate physical activity helps in maintaining the joint health and can improve 
aerobic capacity and alleviate depression. It has been reported that an appropriate 
exercise program will help reduce pain and improve functional ability in people with 
arthritis. 
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• Overweight and Obesity: Overweight and obesity increases the risk of' 
arthritis, particularly osteoarthritis of the knee and hip. Contrarily, weight loss has 
been shown to be effective in the management of arthritis. A weight loss of II pounds 
(approximately 5 kg.) is associated with a 50% decrease in the risk of developing 
symptomatic knee osteoarthritis. 
• Other: Injuries, occupational injuries and infection are other risk factors for 
arthritis. Primary prevention aimed at preventing Lyme disease, carpal tunnel 
syndrome and injuries to the joints can reduce the occurrence of arthritis. 
Clinical course of the disease 
There are mainly three forms of clinical presentation into which most cases of 
R:\ can broadly be recognized (Fig.4.) 
•• A chronic progressive form in which the disease begins with minimal joint 
involvement and then progresses slowly over a period of years to multiple joint 
diseases with severe functional limitation. This is the most common pattern of 
arthritis. 
:• An intermittent course punctuated by acute episodes of arthritis with periods of 
remission in between. 
•• Progressive disease is the most common pattern. 
•:• An explosive onset with multiple joint involvement and acute synovitis which 
may go into partial remission after 3 years or so. This pattern of RA is more 
commonly seen when RA begins in the elderly patient. 
Structural damage in RA 
Rheumatoid arthritis is characterised by the progressive damage in bone and 
cartilage which ultimately leads to the disability (Pincus, 1995; Scott et al., 2000). 
Radiographic evidence shows that many patients have substantial joint damage 
within first 2 years of onset of disease and bone erosion can be seen even in firts 
few month of the disease by magnetic resonance imaging (McGonagle et al., 1999; 
Kalarlund et al., 2000). In RA, articular cartilage damage begins at the cartilage 
pannus interface, with progressive erosion into the sub-chondral bone. Focal erosion 
and juxta-articular cartilage damage is also found in RA. Besides joint, RA also has 
extra impact on axial and appendicular skeleton and leads to the reduction of 
mineral density in bone and subsequently increasing the risk of fracture (llooyman 
et al., 1984; Spector et al., 1993). The exact etiology of RA remains unknown but 
the first sign of joint disease appear in the synovial linning layer with proliferation 
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of synovial fibroblasts and their attachment to the articular surface at the joint 
margin (Lipsky PE-Harrison, 1998). 
Time  
Figure.4. Three pattern of clinical progression of Rheumatoid Arthritis. 
Immune mechanism in RA 
Immune system is evolved as a defensive mechanism of the body against the 
pathogenic organism and other foreign agents. In general immune system protects the 
organism from pathogen and their products as well as endogenous antigenic products 
(Janeway et al., 2001) particularly to protect from the autoimmune disorders like RA, 
type l diabetes, encephalomyelitis etc. Recognition of these immunogenic and 
antigenic substances is very important phenomenon to check the deleterious effect. 
Under normal condition our immune system eliminates them very consciously and 
beautifully. But under abnormal condition like the inflammation regulatory process, 
the immune system gets affected due to the defect in any cellular or chemical pathway 
of immune system which causes excessive response against pathogen or self antigen 
like in autoimmmne disorders. 
In case of RA deviation from normal cellular mechanism and signaling 
pathways derive the chronic inflammatory conditions. Several studies suggest the 
involvement of both innate and adaptive immune response in RA pathophysiology. 
Several models have been developed to study the immune mechanism and the 
pathology of the RA. These models support both the innate and adaptive immune 
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mechanisms involved in RA. such as collagen induced arthritis (CIA), which is 
mainly ThI and Thl7 driven (Cho et al., 2007). Predominant cytokine profile toward 
Th2 response has also been found in CIA DBA/ I mice (Mauri, 1996). Anti CTLA-4 
(cytotoxic T lymphocyte-4) antibodies (Abatacept) and anti CD-20 (Rituximab) 
antibodies stimulate B cells and T cells in RA (Kremer et al., 2003 and Edward et al.. 
2004). Role of CD4+ T cells in RA pathogenesis is inferred by the strong HLA-DR 
(Human Leukocyte Antigen-DR: a MHIC class II cell surface receptor) association 
(Carlsen et al., 2008). 
The clinical picture of pain, stiffness, swelling, and joint destruction seen in 
RA is a result of chronic inflammation of the synovium, characterized by interactions 
of fibroblast-like syynoviocytes with cells of the innate immune system, including 
macrophages. dendritic cells, mast cells and NK cells, as well as cells of the adaptive 
immune system, B and 1' lymphocytes (Tak et al., 2000) and also presence of immune 
complexes, proteins of the complement system, autocrine and paracrine-acting 
cytokines as well as chemokines that have inflammatory, homeostatic and even 
anti-inflammatory properties (Charo and Ransohoff, 2006). 
Innate immune System 
Among many mechanisms which have been proposed and demonstrated to be 
involved in RA disease, innate mechanism is the primitive pattern recognition system 
which provokes the inflammatory response through interaction of the Fe receptors 
with immune complex, probably with TLR (Toll like receptors) receptors by bacterial 
products. It is the first line of defence system of the body during any infection or 
inflammation. When any' pathogen or its products enter inside the body, the body's 
defence mechanism evoked first by the innate cells like macrophages, monocytes, 
neutrophils, T cells, B cells, NK cells, mast cells, eosinophils etc. The antigen derived 
or primed T cells and B cells are produced in response of either xenoantigens or 
autoantigens. The later are the major cause of autoimmune diseases including 
rheumatoid arthritis. During innate immune amplification in disease, the cytokine 
secreted, play an important role in pathology of the disease, as they are involved not 
only in the stimulation of different innate cell types but also force them to secret 
different cytokines and chemokines during disease progression. In RA, these cytokine 
network are involved in autocrine and paracrine loop and stimulate the synovial 
intimal linings. The pathophysisological environment, cause the permanent changes in 
some cell types which lead to the destruction and disease. The cytokines, chemokines, 
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matrix metalloproteinases secreted by the innate immune cells cause destruction to the 
bone and cartilage in RA. the induction of the innate immune response in disease 
may be contributed by cigrate smoking. bacterial products, viral component and other 
environmental stimuli. The individuals who are prone to produce the autoreactive 
antigens encode variety of genes which are implicated in the RA. These genes are 
class II major bisrocompatibility complex genes, cytokinc promoter polymorphism 
genes, population specific genes (PAD 14 in Japanese and Koreans), protein tyrosine 
phosphatase gene-22 (PTPN-22) and other unidentified genes. Abnormal selection of 
T cells may lead to the auoreactive T cell development which also contributes to the 
RA. 
The most abundant cells in RA are fibroblast (type B synoviocites), 
macrophages (type-A synoviocytes), and infiltration T lymphocytes. Osteoclasts, 
plasma cells, dendritie cells, mast cells, B lymphocytes are also numerous (Maruotti 
et al., 2007). The recruitment of these cells is upregulated by the integrin and selectin 
on the endothelial lining of synovium through the chemotactic gradient alone with 
other chemoattractants secreted by neutrophils. 
The involvement of different cell types and cytokine network during the 
disease progression and the therapeutic targets in different innate immune pathways 
has been reviewed as follows: 
Monocytes and Macrophages 
Macrophages are the key component of innate immune system and they are 
derived by the myleomonocytes. Macrophages are the differentiated forms of 
circulating monocytes. Their important role in killing the invading pathogens is by 
phagocytosis and clearing the apoptotic products. Activation of macrophages by self 
or non self antieens lead to secretion of different cytokines including TNF-a and TLA, 
which attract other cell types to migrate towards the inflammation site (Murphy, 
2008). Macrophages play a central role in RA disease progression as the studies 
suggest that the drugs like methotrexate and cytokine inhibitors suppress the 
inflammatory cytokine expression by the macrophages (Lavagno et al., 2004). 
Decreased infiltration of the macrophages in the inflamed joint after the drug therapy 
has revealed the importance of these cells (Mulherin et al., 1996b and Wijbrandts, 
2007). Besides huge infiltration in the synovial tissues, these macrophages also get 
accumulated in the form of foam cells in subendothelial areas and lead to 
atherosclerosis. Increased chentotaxis (Mantovani et al., 2002 and Vcrgunst, 2005) 
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and reduced migration is supposed to be the major mechanism of the macrophage 
movement at the site of inflammation (Polzer et al., 2008). Proliferation of 
macrophages has also been found in the area of inflammation (Jutila et al.. 1986; 
Ceponis et al., 1998; Liva et al., 1999 and Rekhter et al., 1995). It has been 
investigated that the increased apoptosis of synoviocytes might lead to the 
amelioration of the joint destruction and inflammation (Liu, 2004). Reduced 
expression of pro-apoptotic Bcl 2 family member (Bim) and increased expression of 
I L I -(3 has been seen in macrophages in both experimental arthritis and patients. 
Subsequently. the administration of Bim mimict successfully reduces the incidence of 
arthritis (Loc. cit.). 
There is a great heterogenicity among the macrophages and monocytes. The 
monocyte population can be defined in to two groups based on their surface markers 
that is. CD14'. CD16 and CD 14""", CD 16* subset (Geissmann, 2008). In RA it is 
found that the level of CD 141"" and CD 16+ are elevated in both the peripheral blood 
and synovial tissues (Batten et al., 2000). CD 141"" and CD 16+ monocytes produce 
more TNF-a in response to the microbial LPS (Lipo Polysachrides) in comparison to 
the CD 14', C D 16 cells (Beige et al., 2002 and Ziegler-Heitbrock, 2007) which 
suggests that after migration CD14'°" and CD 16+ become highly responsive 
macrophages. While ('l)14` and CD16" cells produce chemokine receptors CCR2 
which bind monocyte chemotactic protein-I and thereby promote the monocyte 
migration toward the site of inflammation. It has been found that the synovial fluid is 
rich in chemokines, therefore. CD 14+ and CD16' and CCR2 monocytes migrate 
towards the joint in RA. Since the monocytes of synovium migrate from the 
peripheral blood, the analysis of these monocytes in blood is an important tool to 
monitor the severity of RA (Geissmann et al., 2003). The growth factors, IL-I, IL-6. 
IL-10, IL-13, IL-15, IL-18. TNF-a and granulocyte macrophage colony stimulating 
factor (GM-CSF), monocyte chemoattractant protein (MCP-1), chemokines (IL-8), 
macrophage inflammatory protein (MIP-1), neopterin and metalloproteinases are 
detected in the inflamed joints (Kinne et al., 2000). The activation of the monocyte 
lineage cells is not restricted to synovial macrophages as it extends also to 
polymorphonuclear cells and circulating monocytes (Loc. cit.). Macrophages 
activated through the alternative pathway have been exposed to IL-10, IL-4, IL-13, 
tumor growth factor (TGF)-f3 or glucocorticoids. These macrophages secrete anti-
inflammatory' cytokines and are resistant to re-activation. Alternatively activated 
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macrophages are also involved in enhancement of cell survival and proliferation. 
matrix synthesis and stabilization, antigen presentation and angiogenesis (Fig. 5). 
Macrophages activated by either pathway induce the phagocytosis of apoptotic cells 
and debris (Optcrman and Korsmeyer, 2003). 
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Figure.5. Ubiquitous role of TNF-u secreted by activated mcrophages (Opferman and 
Korsmeyer, 2003). 
Dendritic cells (DCs) 
Dendritic cells are the antigen presenting cells which present antigen to the T 
cells and play a central role in innate and adaptive immune response. After activation 
with different pathogens, mainly via the activation of TLRs by the exogenous and 
endogenous stimuli, the immature DCs differentiate and also mature by the changes in 
cytokine and chemokine receptors at their surface by TLR signalling. These mature 
DCs migrate toward the lymphoid organs where they present the processed antigen to 
the naive T cell vial MHC Class II. Mature DCs also express the stimulatory 
molecules CD80. CD86 which bind to the CD28 of T cells and thereby complete the 
antigen specific effector T cell maturation. Besides the antigen presentation to naive T 
cells in lymphoid organs. DCs also present antigen and produce pro-inflammatory 
cytokines like, TNF-u, IL-1(3, IL-6 in local tissues and so induce the inflammation. 
DCs also secret the I helper cell subsets (hi, Th2 and Th 17) inducing cytokines 
(Murphy et al., 2008). DCs also help in clearance of the endogenous self antigen in 
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thymus by depleting the most reactive and aggressive self antigen while in periphery 
autoreactive T cells and immature DCs, bearing self antigen lead to apoptosis or 
development of regulatory T cells (Loc. cit.). Deviation from the natural habit of these 
DCs function leads to the autoimmune disease conditions (Skoberne, 2005). In view 
of the central role of DCs in innate and adaptive immune response against 
endogenous and exogenous antigens, a selective depletion of pDCs (peripheral DCs) 
develops severity in collagen induced arthritis in murine model (Jongbloed, 2009). In 
contrast the follicular DCs are required for development of arthritis in murine model 
(Victoratos et al.. 2009). These findings suggests that the follicular DCs are the main 
culprit for the breaking the body's immune tolerance against self antigens. It has been 
investigated that the adaptive transfer of DCs, activated by TLRs, reduces the CIA 
after immunization (Jaen, 2009). Hence, the modification of DCs function can 
develop the skewing type of T cell response i.e. T regulatory phenotype. 
T-cells 
T-cells develop from bone marrow derived common lymphoid progenitor stem 
cells. The naive T cells migrate to the thymus where the actual maturation of T-cells 
occurs. The T cells are further divided on the basis of cell surface marker i.e. CD4' 
and CD8i . T cells bearing CD4+ are called T helper (Th) cells designated because of 
its role to assist and help other immune cell for pathogen clearance while CD8* 
bearing cells are called cytotoxic T cells because of its direct cytotoxic role in killing 
intracellular pathogen. Th cells are further divided into Type 1 (Thl), Type 2 (ITh2) 
and Type 3 (Th3) effector cells. Thl cells are characterized by the expression of 
chemokine receptors CCR5 and CXCR3 and by the secretion of IFN-y and IL-2. 
These cells help cytotoxic T-cells in the clearance of intracellular pathogens, activate 
macrophages and are considered to be the effector cells in several cell-mediated 
autoimmune diseases. Th2 cells express CCR3, CCR4 and CCRS and secrete IL-4, 
IL-5, IL-6, IL-10 and IL-13 cytokines. Th2 cells are involved in humoral immunity by 
activating B-cells to produce antibodies, which help to destroy extracellular 
pathogens, which are unable to be phagocytosed. Th2 cells also have a central role in 
allergic reactions (Figure 5). TO CD4 T-cells originate from the mucosa. activated by 
mucosal antigens and secrete TGF-(3. These cells induce B cell antibody class 
switching towards IgA production and can enhance their own differentiation by 
secreting TGF-13. The chemokine receptor expression of Th3 cell is not known. 
Cytokines secreted by Th2 and Th3 cells play anti-inflammatory roles in suppressing 
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type 1 responses. An additional type of regulatory T-cell, which is driven by IL-10 
and secretes both IL-10 and TGF-I3, has been termed as Treg cell (Groux et al.. I997). 
Autoimmune diseases are believed to arise when cells of specific tissues 
become targets of T-lymphocytes directly or indirectly and/ or of autoantibodies. 
T-cells are important promoter and initiator in the tissue damage seen in these 
disorders. The mechanisms by which T-cells cause the destruction of tissues which 
includes direct damage through cell-mediated cytotoxicity processes or indirect 
dama ze mediated by non-lymphocyte mechanisms (Opferman and Korsmeyer. 2003). 
T-cells in RA 
The exact mechanism of "I'-cells in the pathogenesis of RA is still not 
completely understood. It is assumed that "I'-cells play a role in RA in association of 
disease susceptibility and outcome with I ILA-DR antigens (van Zeben et al,, 1991). A 
high number of CD4+ T-cells have also been found in the synovial membranes of 
patients with RA (lannone et al., 1994). Further evidence in favour of T-cells in the 
pathogenesis of RA has been described from animal models in which a single T-cell 
clone was able to transfer the disease (Kiareskog et al., 1983 and Taurog et al., 1983). 
In addition, the role of T cells can be understood by the finding where the depletion of 
T-cells in non-obese diabetic-severe combined immunodeficiency (NOD-SCID) mice, 
that are engralied with synovial tissue isolated from patients with active disease, 
shown a decreased production of macrophage derived cytokines (IL-l(3, TNF-u and 
IL-15) which suggests that the decrease in cytokine production is due to the 
disappearance of synovial CD684 macrophages that depend on T-cells for their 
survival (Weyand and Goronzy, 2000). The beneficial effects of CD4 blocking agent 
on disease symptoms in patients further support the role of T-cells in RA (Choy et al., 
2002). 
However, since the most striking feature of T-cells in RA is hyper 
responsiveness, but the primacy of T-cells in early and chronic RA pathogenesis has 
been questioned (Smeets et al., 1998). The hyper responsiveness T-cells in RA is 
reflected by a reduced response to mitogens and decreased calcium-influxes (Kingsley 
et al., 1987: Allen et al., 1995), defects in TCR mediated signalling (Maurice et al., 
1997). lowered T-cell proliferation rate (Cush and Lipsky, 1991) and under 
expression of T-cell derived cytokines, such as IFN-y and IL-2 (Firestein et al., 1988; 
Dolhain et al., 1996). 
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Most of the T-cells infiltrating the rheumatoid synovium express CD45RO and 
CD4, indicating that they are of helper and of memory subset. Instead only ten to 
fifteen percent of T-cells in the RA synovium contain granzyme A and perform, 
molecules specific for cytotoxic T-cells. This suggests that CD8 cells are infrequent in 
the RA synovium. whereas in RA SF CD4+ and CD8+ T-cells are equally present 
(Forre et al., 1982). TCR a/(3 is expressed on most of the T-cells in RA synovium and 
only a minority show TCR y/S expression, although it has been found that expression 
of TCR y/S is increased in the synovium and peripheral blood of patients with active 
disease (Jacobs and Haynes, 1992). 
B-cells in RA 
Bells develop from the same bone marrow derived common lymphoid 
progenitor stem cells as T-cells and differentiate and mature in the hone marrow or 
spleen before entering the blood stream. RA was originally considered as an antibody 
mediated disease (Johnson etal., 1973; Vaughan, 1973) but the precise role of B-cells 
in RA is not well understood. Nevertheless, the role of B-cells appears to be 
significant since B-cells act as potential link between the cells of adaptive and innate 
immune systems, and direct the cellular components, such as chemokines and 
cytokines in inflammation. The formation of T-cell and B-cell aggregates in the 
synovium, expression of co-stimulatory molecules, such as CD40 ligand, enhanced 
production of autocrine cytokines for B-cells (IL-6 and IL-l0) and abnormalities in 
the negative selection of B-cells are the indicators proposing enhanced B cell 
activation in RA (Schroder et al., 1996; Weyand et al., 2001). In RA patients, an 
overall high activation of B-cells and enhanced frequency of memory B-cells has been 
reported in peripheral blood (Bohnhorst et al., 2001; Lindenau et al., 2003), whereas 
in the synovium a reduced proliferative capacity and enhanced B-cell receptors have 
been found (Itoh et al., 2000; Reparon-Schuijt et al., 2001). 
Other cell type in RA 
Resides the major role by T cell, macrophages and dendritic cells several other 
cell types including neutrophils, mast cells and natural killer (NK) cells also play a 
significant role in RA pathophysiology. 
11 eutrophils 
In RA, joint inflammation and bone erosion are the two important 
phenomenons to develop RA pathology. Ncutrophils in inflamed synavial joints get 
primed and activated by substance P. GM-CS!', TNF-a, ILS (secreted by sensory 
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nerves, synovial cells. and macrophages/neutrophils respectively) and C9 and C5a 
complements. These activated/ primed neutrophils play an important role in RA 
pathology by producing good amount of chemoattractant in inflamed joints. These 
attractants induce the infiltration of different kind of immune cells, which cause both 
the inflammation as well as cartilage and bone erosion by secreting the matrix 
metalloproteinases and cytokines. Most powerful chemoattractant secreted by the 
neutrophils are LTB4 (Leucotrien B4), IL-8, growth related oncogene a (GRO a) 
(Edward, 1994). Neutrophils also secrete cytokines like IL1 (3, 1L8, TNF-u, TGF-13, 
under diseased condition and these cytokines have been found in the synovial fluid 
(Quayle, 1995; Beaulieu, 1987; Watson, 1993). Neutrophils also produce the potent 
proteinases and hydrolases and also generate Reactive Oxygen Species (ROS) at the 
site of inflammation, derived via NADPII oxidase and myeloperoxidase (Edward. 
1995) and secrete the granular enzymes within the joints, which implicate the RA 
pathology (Edward and Maurice, 1997). In vitro studies show that the high level of 
granular enzymes and ROS depolarize long chain hyaluronan molecule (responsible 
for lubricant property of synovial products) into smaller chain thus decreases the 
lubricant property (Loc. cit.), causing joint damage. In this way neutrophils indirectly 
cause cartilage damage. Mechanism of neutrophil cascade is shown in Figure.6. 
Mast Cells 
In human, `IC's are divided into two subsets called MC, and MCA 1- depending 
upon the expression of serine proteases in their granules (Irani et al., 1986). MCT 
contain tryptase and are mainly located in the intestinal and respiratory mucosa, 
which are the predominant sites for immunologically associated functions. MCCT 
contain both chymase and tryptase, together with other proteases such as cathepsin G 
and carboxypeptidase A, and predominantly found in connective tissue area of the 
skin. submucosa of stomach and intestine, myocardium, breast parenchyma, 
counjuctiva, lymph nodes, and synovium (Maruotti et al., 2007). A third subset 
without tryptase but with chymase has recently been identified and mainly resides in 
mucosa and submucosa of stomach, small intestine, submucosa and colonic mucosa 
(Irani, 1994). These subsets produce distinct cytokine profile (Loc. cit.) 
al 
P2C2: &viewofLiterature 
Enhanced adhesion to vascular endothelium -a--- TNF-ct 
II 
Migration into joints 
TN `r 	 / TNF-u 
Pnming and activation in synovial fluid 	Adhesion to cartilage/pannus 
fluid 	l 	 ; 	release 
Dapo1yrtierizstiQo of hjIeluronan 	Cartilage deatructic 
Figure 6: Mechanism for neutrophil cascade in RA highlighting the potential role of TNF a 
in disease pathogenesis (Edward, 1997). 
It is well known that the mast cells mediate important manifestations of 
allergic disease. Mast cells are cross linked with IgE and release different 
pro-inflammatory mediators, including histamine during allergic disease. Besides IgE 
cross linking, mast cells are also involved in phagocytosis, antigen presentation and 
intracellular killing. Mast cell possess receptors for complements, receptors for IgG. 
specific pathogen associated molecular pattern (Nigrovic and Lee, 2005). It has been 
found that mast cells have critical role in pathogenesis of murine synovitis in 
laboratory, which is quite similar to the RA (Lee et al., 2002; Corr and Crain, 2002). 
Increased number of mast cells was preserved at the site of cartilage erosion and 
blood vesicles (Godfrey et al., 1984; Bridges et al., 1991; Olsson et al., 2001). 
Increased infiltration of these cells is in correlation with the disease progression in 
early stage (Gotis-Graham et al.. 1998). It is observed that the normal synovium 
contain MC1-~- while inflamed synovium also possess MCI-. In course of RA. MC 
subsets increase in deeper synovial substratum in step wise tissue destruction. If 
resolution occurs. MC( r decrease and MC•t prevail in the superficial stratum (Loc. 
cit.) in association with lymphoid aggregates, whereas MC(~-r are found in the deeper, 
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more fibrotic areas. MC activation in svnovial tissues release histamine, heparine, 
chvmase, tryptase, cytokines, chemokines, prostaglandins, and leukotriens in RA 
(Schwartz et al., 1994). Their level increases in inflamed svnovial fluid (Malone et al., 
1986). MCs induce edema, destroy connective tissue and contain profibrotic cytokines 
and growth factors, which are responsible for matrix regeneration and pathologic 
fibrosis (Loc. cit.). Recruitment of MCs is mediated by several chemotactic factors 
such as SCF, transforming growth factors 3 (Gruher et al., 1994), C3a, C5a, serum 
amyloid A, RA synovial fluid. More over low molecular weight MC growth factors 
responsible for the local accumulation of MCs in RA tissues and fluids has been 
demonstrated in the experimental arthritis. Mouse lacking MCs are resistant to the 
inflammatory and erosive arthritis induced by arthritogenic serum, in contrast to the 
control mice (Lee et al., 2002). Human MCs secrete various cytokines and 
chemokines in the RA joint (Blue et al., 1993). Such as IL-6, IL-8 and tumour 
necrosis factors a (Matsushima et al., 1989) whose expression is mediated by the 
NF-k13 (Marok et al.. 19961. MCs activation also induces macrophages to increase 
IL-1 production (Yofte et al., 1984). Histamine, heparin in MC secretory granules 
activates monocytes, macrophages to release TNF a and IL-1 in RA tissue (Yoffie et 
al., 1985). MC mediators may exert an effect on cartilage and bone. Co-culture of 
chondrocytes with inactive MCs promote the proteoglycan degradation (Steven et al., 
1992). MC mediators may directly promote the differentiation and activation of 
osteoclasts (Chowdhary et al., 1992). Pathogenic pathway of mast cells in synovitis is 
represented in Fig.7 
Natural Killer Cells 
Natural Killer (NK) cells are innate immune cells which are very important for 
the host resistance against the viral infection (Biron et al., 1999). NK cells are similar 
to the T cells in functional aspects with different effect on the adoptive immune 
system. NK cells constitute about 5-15% of circulating 1' cells and are also found in 
the spleen, lungs, gastrointestinal tract and synovium. These cells are recognized by 
their cytotoxic morpholog\ as well as by expression of CD 16 (FCgamma Ill 
receptors) and of' CD56 (an adhesion molecule). NK cells are activated non-
specifically by many cvtokines including IL-12, IL-15, and IL-18 (Seaman et al., 
2000). Different pathway of NK cells activation may lead to varying pattern of 
cytokine profile, either toward 'l'h 1 or Th2 response (Loc. cit.). 
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Figure.7. The pro-inflammatory functions of mast cells in synovitis. Mast cell effector 
functions suggest their role in diverse pathogenic pathways in inflammatory arthritis, 
including leukocyte recruitment and activation, synovial fibroblast activation and hyperplasia, 
angiogenesis, and cartilage and bone destruction. Activated mast cells generate mediators 
potently capable of enhancing vasopenneability, inducing endothelial expression of adhesion 
molecules, recruiting circulating leukocytes, and activating infiltrating leukocytes as well as 
resident macrophages, and hence contributing to the early phases of inflammatory arthritis. In 
chronic synovitis, mast cells synthesize cytokines mitogens that activate synovial fibroblasts, 
recruit macrophages, and promote the growth of new blood vessels. implicating them in 
synovial lining hyperplasia and pannus formation. Further, mast cells may participate in joint 
destruction by inducing the production of matrix metalloproteinases (MMPs) from fibroblasts, 
by activation of chondrocytes, and by direct and indirect promotion of osteoclast 
differentiation and activation. Because activated svnovial fibroblasts demonstrate enhanced 
stem cell factor (SC'F) expression, a potentially important positive feedback loop is 
established in which SCF promotes mast cell survival and proliferation, leading to the 
mastoc}vtosis described in inflamed synoum. The importance of these pathways in vivo 
remains to be established. bFGF. basic fibroblast growth factor; IFN, interferon; IL, 
interleukin \ICP = monocyte chemoattractant protein; M-CSF. macrophage 
colony-stimulating factor; Ml P. macrophage inflammatory protein; PDGF, platelet derived 
growth factor; PMN. polymorphonuclear cell; RANK-L, receptor activator of NF-kB ligand; 
TNF, tumour necrosis factor (Image Courtesy: Nirgovic, 2005). 
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The available literature support limited role of natural killer cell in RA. A 
study carried out by Dalbeth and Challan (2002) showed involvement of NK cells in 
inflammatory joint disease. The authors (Loc. cit.) showed that a subset of NK cells 
which express high level of CD56 and other NK cells also have CD94;''NKG2A 
markers and secondly a little number of NK cells possess CD16+ and killer lg like 
receptors. It « as further suggested that the NK cells of synovial lining secrete high 
level of IFN gamma in response to IL-12 and IL-15 than peripheral blood NK cells. 
The high level of IFN gamma is suggestive for the inflammatory involvement of NK 
cell which mi2ht be the cause for joint destruction directly or indirectly. 
Adaptive immune involvement in RA 
Both B cells and T cells are involved in amplification and action of humoral 
immune system. Ilumoral immune system is mainly centred on the interaction of 
specific antibody against foreign antigen. These antibodies are present in blood and 
other body fluids: therefore it is called as humoral. 
B cells are the main cells during humoral immune response. These cells 
produce antibodies after the activation with foreign antigen. B cells play a central role 
by: a) transforming into the antibody producing plasma cells, b) helping in 
noncognate T cell activation, c) antigen presentation especially by memory B cells. d) 
cytokine production for the activation and survival of other mononuclear cells, e) 
secretion of chemotactic compound which direct the migration of leucocytes and 
granuloma formation at the site of infection, 0 besides differentiation into effector 
plasma cell, also develop into memory cells which have the immunogenic memory for 
future infection with same antigen. In RA. the whole physiological and 
immunological process of cellular mechanism is disturbed, and hence B cells are also 
not devoid of abnormal changes. Whole immunology of B cells gets disturbed during 
RA. It is found that the B cells are present in close proximity of T cells in synovial 
joint in RA patients: even they forte a germinal centre like structure (Takemura et al., 
2001 a). Furthermore. B cells are essential for the T cell activation in RA, and other 
cells are unable to substitute these requirements (Takemura et al., 2001 b; O'Neill et 
al., 2005). Increased expression of CXCL-12 (i.e. stromal cell derived factor or 
SDF-1) has been observed in synovium of RA (Seki et al., 1998) and thus B cell 
apoptosis is inhibited in these cells (Dechanet et at.. 1995). Effector B cells (plasma 
cells) migrate toward the SDF-1 (I lauser et al., 2002) which along with the IL-6, IL-5, 
TNF u and CD 44 li.,and increase the longevity of plasma cells. These findings 
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suggest that the B cells are not only essential for inflammation but there accumulation 
in synovium is also affected by deregulation of different cytokine, B cell survival 
factor and co stimulatory molecules in RA. 
In RA, production of autoantibodies by the plasma cells is also supposed to be 
linked with disease. But it is still not confirmed that whether these antibodies cause 
disease symptoms or only the by standard effect (Teng et al., 2007). the reason 
behind this controversy is that the transfusion of RF autoantibody does not develop 
disease (Harris et al.. 1961). Rheumatoid factor and anti cyclic citrulinated protein 
antibody (ACPA) have about 80% and 95% specificity, respectively, in RA patients 
(van Gaalen et al., 2005). Autoreactive B cells have tendency to bind any type of 
antigen which is already the part of antibody immune complex and present the 
different kind of antigen to T cells and activate them (Roosnek et al., L991). 
Additionally autoantibody can also activate the compliment system and bind to and 
activate the macrophages in synovium. As a result, immune complex. activated 
macrophages produce pro inflammatory cytokines that perpetuate the inflammation 
and induce joint damage. It can be summarized that the B cells have important role in 
RA pathology and disease progression, that include: initiation of autoimmunity by 
presentation of self antigens, the maintenance of autoimmune disease condition by T 
cells activation and chemo attracting other mononuclear cells, the production of 
autoantibody and development of autoreactive memory that prolongale autoimtnune 
disease. 
Cytokines 
Among many inflammatory mediators which play an important role in RA 
pathogenesis, cytokines and chemokines have most crucial position as they are 
involved in inflammation directly or through activation and direction of lymphocytes 
and monoeytes to the inflamed tissues and thereby contribute to chronic inflammatory 
conditions in RA patients. 
Cytokines are locally acting low molecular weight glycoprotein mediators that 
are involved in almost all biological processes in general but in inflammation and 
immunity in particular. These proteins form a complex network with various 
functions, acting either in a complementary, synergistic or antagonistic manner and 
create a balanced state sometimes via its inhibitory role during biological response in 
a tissue. For an efficient and healthy biological system these mediators act according 
to the need (Fig. 8). 
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Figure 8: Cytokine cascade in rheumatoid arthritis 
The cytokines bind to the specific receptors present on the cell and initiate a 
cascade of signal transduction pathways inside the cells. They are mainly produced by 
activated inflammatory cells although other cells like epithelial cells, chondrocytes 
and hepatocytes also secrete cytokines. 
It has been revealed that the cytokines mRNA and proteins are abundantly 
expressed in synovial tissues in patients with MA (Vervoordeldonk et al, 2002). The 
pro-inflamrnatory cytokines such as IL-I, IL-6, TNF-a and GM-CSF, and chemokincs 
such as IL-8, are mainly secreted by cells of the monocyte lineage as mentioned 
earlier. It has been shown that the absolute number of T-cells in rheumatoid SF 
(Synovial fluid) is low, yet the spontaneous production of cytokines at the level of a 
single T-cell is increased in the arthritic joint when compared to peripheral blood 
T-cells (Ronnelid et al, 1998). The increased expression of inflammatory mediators in 
rheumatoid joints is counteracted to some degree by body's instinct protective 
mechanism which involves the production of anti-inflammatory cytokines such as 
IL-l0 and TGF-13 and cytokine inhibitors such as the IL-1 receptor antagonist (IL-Ira) 
and the soluble TNT-a receptor (TNF-R) ((Loa et al., 1990; Cope et al., 1992; 
Firestein et al 1994; van Roon et al., 2001). But a pronounced chronic inflammation is 
the main characteristic of the RA joint. Cyiokines expressed abundantly in RA 
synovium are listed in following table.2. 
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Table 2: The pro-intlammatory cvtokines in RA 
CN•tokines Main producing cell in RA 	syynovial membrane 
Pro-inflammaton• 
Cvtokines: 
TNF-a macrophages + 
IFN-y T-cell + 
GM-CSF macrophages + 
LT T-cell + 
IL-la &(3 macrophages + 
L-2 T-cell +/- 
IL-6 FLS, macrophages + 
IL-12 macrophages, dendritic cell + 
IL-15 FLS, macrophages + 
IL-17 activated memory CD4+ T cells+ 
IL-18 macrophages + 
Cytokines: 
FN-(3 FLS 	 ? 
IL-4 Th2 cells 	 - 
IL-I I FLS 	 + 
IL-13 Th2 cells 	 + 
IL-10 Th2 cells, macrophages, 
B cells 	 + 
Regulator) 
Cvtokines 
IL-10 	 Th2 cells. macrophages. 
I3-cells 	 + 
TGF-R 	 macrophages 	 + 
Pro-inflammatory cytokines 
Tumour Necrosis Factor- a (TNF-a) 
TNF-a is a 17 kD glycoprotein composed of three identical subunits. It is 
secreted mainly by monocytes and macrophages, but also produced by primed 
Th cells, B cells and NK-cells, mast cells, polymorphonuclear leukocytes, astrocytes 
and smooth muscle cells. Its main function is to promote inflammation by inducing 
fever, shock, tissue injury, energy substrate mobilization, cachexia, bone resorption, 
differentiation and proliferation of hematopoietic cells and production of acute-phase 
proteins. Under stressed conditions, it is released instantly and has the ability to 
activate other pro-inflammatory cytokines, such as IL-1, IL-6, and chemokines, II.-8 
production (Tracey et al., 1987; Butler et al., 1995). 
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The primary sources of TNF-a, the monocytcs and macrophages are also 
stimulated by this cytokine in autocrine manner and cause the activation of these cells, 
it acts as a chemotactic agent for monocytes and induces the expression of adhesion 
molecules on endothelial cells, which further induce the migration of leukocytes to 
the site of I'NF-a release. TNF-a is also a inducer for matrix metalloproteinase-1 
(MMP-1) and PGE2 production (Dayer et al., 1985). TNF-a reduces the expression of 
MHC class II molecules on macrophages and acts as a growth factor for monocytes 
by inhibiting cell apoptosis (Mangan et al., 1991; Watanabe and Jacob 1991). 
Resting T-cells do not respond to TNF-a because they lack the receptor, TNF-R. 
Instead, activated T-cells increase the expression of the IL-2 receptor (IL-2R) and 
thus the clonal expansion in response to IL-2 as well as the production of IL-2 in 
response to TNF-a occurs. TNF-u also induce the over expression of IL2R on 
NK cells (Ostensen et al., 1987), increase the expression of adhesion molecules such 
as intracellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule 
(VCAM)-1 on endothelial cells, (Osborn, 1990). Additionally, TNF-a promote 
angiogenesis at the site of inflammation and the release of chemokines by a variety of 
cells. ZNF-a inhibit the synthesis of collagen by fibroblasts and stimulate the 
resorption of proteoglycans from cartilage (Osborn 1990) and thereby promote 
cartilage degradation. TNF-a inhibit viral replication in infected cells (Feduchi & 
Carrasco. 1991). 
Contrary to the pro-inflammatory potential, TNF-a also has indirect 
anti-inflammatory role by stimulating the release of corticotrophin, a hormone that 
stimulates the release of cortisol from the adrenal cortex. Cortisol indirectly down 
regulates inflammation ("I'ilders et al., 1994). 
Interleukin-1 (IL-l) 
IL-I is a 17-kd protein that is mainly secreted by monocytes and macrophages (Fig. 9) 
but is also produced by activated T cells, B cells and endothelial cells (Koch et al., 
1995). The IL-I signalling pathway is more complex than the TNF-a pathway. IL-1 
interacts with two types of cell-surface receptors ((Sims et al., 1988; McMahan et al., 
1991; Sims et al., 1993). 
Only type I receptors have a cytoplasmic tail which is capable of intracellular 
signalling cascade (Sims et al., 1993) while Type II receptors are decoy receptors that 
bind to circulating interleukin- I but do not initiate any intracellular signalling (Colotta 
et al., 1993). 
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The type II receptor is expressed primarily on monocytes. B cells and 
neutrophils. Soluble forms of both types of IL-I R compete with cell surface receptors; 
thereby decreasing IL-1 mediated cells activation. Additionally, interleukin-1 activity 
is inhibited by a naturally occurring antagonist, interleukin-l—receptor antagonist that 
binds the type I receptor with high affinity without triggering a signal (Svenson et al.. 
1995). The biological activity of 1L-1 depends upon the precise quantities of many 
interacting molecules. Studies suggest a strong role of IL-1 role in joint damage in 
arthritic animal models. For example, injection of IL-I into the knee joints of rabbits 
results in the cartilage degradation (Pettipher et al., 1986) while the injection of 
antibodies against IL-1 ameliorates collagen induced arthritis in mice and decreases 
the cartilage damage (Joosten et al., 2008). Macrophages are the important source of 
IL-1 in the synovial tissue of patients with rheumatoid arthritis (Arend & Dayer, 
1995). IL-1 also stimulates the release of matrix metalloproteinases from fibroblasts 
and chondrocytes and thereby further enhances the damage (Fig. 10) (MacNaul et al., 
1990). 
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Figure.9. Role of IL-1 in activation of inflammation, pannus formation, cartilage breakdown 
and bone resorption. 
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Figure.10. IL- I pathway in pathogenesis of Rheumatoid arthritis. TNF-tumor necrosis factor, 
IL-interleukin. 
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Interferon- y (IFN-y) 
The biologically active IFN-y is a 34 kD homodimer glycoprotein which is a 
Type 1 cytokine. fhe receptors of IFN-y we ubiquitously present virtually on all cells 
of the body. The activated T-cells and NK-cells are the main source of IFN-y, but 
macrophages also secrete IFN-y which stimulates several functions of the 
macrophages including tumor cell cytotoxiciry (Pace et al., 1983), increased killing of 
intracellular pathogens (Torrico et al., 1991), antimicrobial activity (Nathan, 1992) 
and induction of MHC class I proteins (Basham & Merigan, 1983). IFN-y induces the 
production of IFN-(3, IL-la, IL-1(f, TNF-a, interferon-y inducible protein (IP-10) and 
IL-12 in human and murine systems and inhibits the expression of some cytokines 
and ehemokines, such as IL-8, IL-10 and MCP-I in human monocytes (Ohmori & 
Ilamilton, 1994). It also upregulates the expression of Fey receptors on phagocytes 
(Fertsch & Vogel, 1984) and adhesion molecules, such as ICAM-1, on endothelial 
cells (Dustin et al., 1986). IFN-y act as an antagonist to the Type 2 responses by 
inhibiting IL-4, which mediates the antibody isotype class switching and also inhibit 
macrophage derived IL-10 production (Chomarat et al., 1993). In vitro studies suggest 
the eytotoxic and apoptotic role of IFN-y at high concentration, whereas low 
concentration promotes T-cell proliferation (Siegel, 1988). IFN-y has synergistic 
effect with TNF-a in vitro (loc. cit.). However, this might critically depend on the 
state of differentiation of the cells, as TNF-a was found to enhance IFN-y triggered 
MHC class II expression in undifferentiated macrophages, while it inhibited in mature 
macrophages (Watanabe and Jacob, 1991). 
Interlcukine-2 (IL-2) 
IL-2 was originally known as "T-cell growth factor" that has both 
immunostimulatory and immunosuppressive effects on the immune system. TL-2 
produced by naive T cells upon stimulation by deudritic cell, act in auocrine manner 
and promotes the proliferation and their maturation into Type l lymphocytes, and 
hence promotes Thl cell mediated immunity. Additionally. IL-2 also promotes the 
proliferation of NK-cells and of y/S subsets of T-cells (Robertson & Ritz, 1990). IL-2 
act synergistically with IL-12 to facilitate NK-cells to produce IFN-y and TNF-a 
(Carson et al., 1995). 
IFN-y and IL-2 in RA 
Pro-inflammatory cytokines such as IFN-y and IL-Z, produced by T-cells, are 
expressed more in the joints of patients with RA as compared to peripheral blood 
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(Kusaba et al.. 1998) and the expression of IFN-y mRNA in RA synovial membrane 
has been shown to be increased when compared to the synovial membrane of patients 
with spondyloarihropathies (Canete et al., 2000). 
Local and site specific administration of IFN-y was found to promote 
development of CIA in mice, whereas systemic administration of LEN-y exerted a 
protective effect (N`akajima et al., 1990). Furthermore, in patients with RA, IL-1 by 
synovial macrophages and IL-1 and TNF-a induced matrix metalloproteinase 
production and glycosaminoglycan release by cultured cartilage fragments were found 
to be inhibited by IFN-y (Ruschen ci al., 1989). In vitro studies suggest that in case of 
human articular chondrocytes, IFN-y synergizes with TNF-a in prostaglandin F2 
production, but decreases 'INF-u induced secretion of cascinase, an indicator of the 
proteoglycan degradation enzyme, stromelysin. In vitro IFN-y also inhibits hone 
resorption (Gowen et al., 1986). In CIA, IFN-7 production declines with time 
(Mussener, 1997), whereas in man no difference in the expression of IFN-y can be 
found in synovial membranes with acute and chronic RA (Smeets et al., 1998). 
Anti-inflammatory cytokines 
Interleukine-4 (IL-4) 
IL-4 is a 20 kD anti-inflammatory Th2 cytokine that is produced by activated 
T-cells, NK-cells, basophils, cosinophils and mast cells. It is a signature cytokine that 
promote naive T helper cells to differentiate towards the Type 2, which is antagonist 
to the Type I immune response. IL-4 promotes the growth and differentiation of 
cytotoxic T-cells and mast cells, and acts as maturation promoting factor for 
CD4`/CD8- cells in thymus but acts as a growth inhibitor for immature thymocytes 
(Trenn et al., 1988). IL-4 also promotes B cell antibody class switching towards [gF, 
and IgG4 (1gG1 in mouse). In monocytes and macrophages, IL-4 down regulates 
H202 production. cell mediated immunity and induction of IFN-y responsive genes. 
Furthermore, IL-4 increases the expression of MI-IC class [1 molecules. IL-lra and 
TNF-R, while down regulate the production of pro-inflammatory cytokines, IL-1, 
TNF-a, IL-6, IL-8 and IL-12. In vivo the overproduction of IL-4 has been associated 
with elevated IgE and allergic diseases, where IL-4 induces the rolling on and 
adhesion of circulating eosinophils to endothelial cells (Bochner & Sehleimer, 1994). 
lnterleukine-5 (IL-5) 
IL-5 is a homodimeric glycoprotein produced mostly by Th2 cells. In the 
mouse IL-5 induces the differentiation of activated conventional B cells into 
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Ig-secreting cells, as well as the growth of progenitors of CD5 ` B-cells and B-cells 
antibody class switching towards IgM. In human, the biological effects of IL-5 are 
best characterized in eosinophils. IL-5 induces terminal maturation of eosinophils, 
prolongs eosinophil survival by delaying apoptotic death, promotes chemotactic 
activity for eosinophils, increases eosinophil adhesion to endothelial cells and 
enhances eosinophil effector functions (Foster et al., 2002). 
Interleukine-13 (IL-13) 
IL- 13 has a low degree of sequence homology with IL-4 while sharing most of 
its biological functions including induction of IgE and IgG4 production by B cells and 
the upregulation of CD23. CD71 and MHC class II expression. It also induces the 
do«nregulation of monocyte and NK functions, yet distinct from IL-4 synergism that 
only IL-13 is required for worm removal. While being produced at high levels by 
Type 2 T helper cells, II.-13 can also be expressed by both naive T-cells and Typel 
cells. IL-13 has a critical role during established allergic inflammation, whereas it is 
responsible for the hyper secretion of mucus by mucus cells (Loc. cit.) and a major 
component in mucosal immunology. 
IL-4, IL-13 and IL-5 in RA 
IL-4 is believed to play a protective role in arthritis, although act as a 
regulatory cytokine because its virtual absence in synovial samples from patients with 
RA points to its lack of protective mechanisms rather than to its active regulation 
(Miossec et al., 1992; Cohen et al., 1995). In the CIA mouse. IL-4 delays the onset 
and diminishes the clinical symptoms, as well as preventing bone erosion and joint 
damage (Horsfall et al., 1997). In patients with RA, IL-4 has been shown to inhibit the 
production of Thl cytokines and induce the production of the natural 
anti-inflammatory cytokine IL-lra in ex vivo synovial tissue specimens (Chomarat et 
al., 1995). In vitro, IL-4 is an anti-proliferative cytokine for Type I helper cells and 
therefore, decreases the production of IL-1. TNF-a and TNF-R, and thus inhibits 
cartilage damage (van Roon et al., 1997). Furthermore, recombinant IL-4 has been 
shown to inhibit the spontaneous production of total IgG and IgM and IgM RF in non-
stimulated T and B cell cultures from patients with RA (Hidaka et al., 1992). IL-4 also 
inhibits bone resorption through an effect on osteoclast activity and survival RA 
patient (Miossec et al., 1994). 
Existing findings have shown the absence of IL-5 expression in SF and IL-5 
mRNA in the rheumatoid nodule (Bakakos et al., 2002; Hessian et al., 2003) however 
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the role of IL-5 in RA remains virtually unknown while IL-13 has been detected in 
the SF of patients with RA and recombinant IL-13 has been shown to reduce the 
production of pro-inflammatory cytokines by SF macrophages (Isomaki et al., 1996). 
Recently, Relic et al. (2001) have shown that IL-13 and IL-4 have a protective role on 
human synoviocytes against apoptosis. 
Regulatory cytokines 
IL-10 
Previously IL-10 was considered as aTh2 cytokine but recently it is thought 
that it has regulatory behaviour and help in balancing the anti-inflammatory and 
pro-inflammatory response. IL-10 is a Th2 cytokine in mice, but both Thi and Th2 
cells can produce it in humans (Ysscl or al., 1992). It is also produced by B-
lymphocytes, cosinophils, mast cells, monocytes, keratinocytes and a variety of 
tumour cells. 11-10 inhibits the production of pro-inflammatory cytokines secreted by 
macrophages and upregulates the production of anti-inflammatory molecules, such as 
LL-[ra and soluble p55 and p75 TNF-receptors. IL-10 also downregulates the 
expression of activator and co-stimulatory molecules, such as [CAM-1, CD80 and 
CD86, on dentritic cells and monocytes, and also downregulates production of toxic 
oxygen radicals, nitric oxide synthase and prostaglandin synthesis 2 by macrophage 
(Mertz et al., 1994). IL-I0 inhibits Thl cell proliferation by inhibiting the production 
of [L-2 and IFN-y (de Wall-Malefyt et al., 1993). IL-10 may also contribute to the 
T-cell anergy by down regulating interaction between antigen presenting cells and 
T-cells (Schwartz, 1996). 
IL-10 in [tA 
In patients with RA not much difference has been found in the number of cells 
spontaneously producing IL-6 or IL-10 in PB (Peripheral Blood) as compared to 
controls (Berg et al., 2001) while, high IL-10 level has been detected in the serum and 
SF of patients with RA (Moller et al.. 2002). IL-10 level has also been shown to 
correlate with titres of serum RheumatoidFactor (RF) and in vitro with the levels of 
spontaneous 1gM RF production (Cush and Lipsky, 1991). In CIA, systematically 
administered IL-10 reduces the production of pro-inflammatory cytokine, cellular 
infiltration, cartilage degradation and joint swelling (Persson et al., 1996). 
Matrix Metalloproteinasc (MMPs) and Tissue inhibitor of MMPs in HA 
MMPs also called as matrixins arc the enzymes which act outside the cellular 
environment and degrade the matrix and non matrix proteins. Under normal condition 
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role of MMPs is pivotal in extracellular matrix degradation for development, 
morphogenesis, tissue repair and remodelling and a very essential part of the normal 
cellular physiology. The expression of MMPs is very low in normal condition and 
their expression is controlled by the cytokines, hormones, growth factors, cell-cell and 
cell-matrix interactions (Nagase, 1999) and also regulated by tissue inhibitors of 
metalloproteinases (TIMPs) but when deregulated they contribute to many diseases 
such as arthritis, nephritis, cancer, encephalomyelitis, chronic ulcer fibrosis etc 
(Nagase eta)., 2006)_ 
MMPs have been divided into 5 categories 1) the collagenases (MMP-1,-3, 
-13) which degrade interstitial collagen (type 1, II, 111), 2) the gelatinises (MMP-2,-9) 
which degrade type IV collagen in basement membrane 3) the stromlysin (MMP-3, 
-10. -11) which degrade non collagen matrix protein, 4) the membrane type MMPs 
(MMP-14, -15, -16, -17, -24, -25) a diverse subgroup including MMP-7, -I 1. -12, -20 
and 5) MMP23. MT (Membrane type) MMPs are all expressed at low level in normal 
joint tissues however this expression is greatly increased in arthritic joints (Konttinen 
et al., 1999; Yoshihara, 2000). Cartilage is made of proteoglycans and type II 
collagen; tendon and bone consist of primarily type I collagen. In both OA (Osten 
Arthritis) and R4 inflammatory cytokines such as IL-I and THE a stimulate the 
production of matrix metalloproteases which can degrade all the component of 
extracellular matrix (Lewis et al„ 1997). The collagenases, MMP-1 and MMP-13, 
have predominant role in RA and OA because they are rate limiting in the process of 
collagen degradation. MMPI produced primarily by the synovial cells that line the 
joint and MMP-13 is the product of chondrocytes that reside in cartilage. In fact 
MMP-13 has five to ten times more activity than MMP-1 on type II collagen while 
MMP-1 is more effective against type III collagen and MMP-8 has greatest activity 
against type I collagen, Secondly, the level of MMP-1 is 10 fold higher than that of 
MMP-13 expression level (Elliott et al., 2003a). MMP-1 and -8 can be localised more 
superficially in cartilage surface while MMP13 is found in the deeper layers 
(Fernandes, 1998; Moldovan, 1997) In addition MMP-13 also degrade proteoglycan 
molecules, aggrecans, giving it dual role in matrix degradation. Expression of other 
MMPs, like MMP-2, MMP-3, MMP-9 is also elevated in arthritis and these enzymes 
degrade non collagen matrix component of the joint. Despite the subtle substrate 
specificity it is important that they are all effective in cleaving the Collagen triple 
helix. Once the collagen triple helix has been cleaved by the collagenase, the 
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gelatinase (MMP-2 and IMP-9) can further degrade the denatured collagen/gefiatin. 
The other MMPs such as stromlysine and matrilysin are involved in degradation of 
non collagen matrix component. Stromlysiu has broad specificity against molecules 
such as •fibroncetin. elastin, laminin, aggrecans and MMP-3 (stromlysin 1) activity 
may be linked specifically to the proteoglycan damage (Bonassar, 1995) and 
activation of pro-MMP-1 (Unemori, 1991). Matrilysin can also cleave proteoglycan 
and it can be activated by IL -I (i and TNF-n_ Of the six type membrane MMPs MT 
MMP-1 and MT MMP-3 have been documented in pathogenesis of arthritis. These 
MT MMPs damage tissues directly or indirectly. 
Thus the profile of MMPs expressed by connective tissues in arthritic joints is 
sufficient to completely damage the structural collagen that comprise articular 
cartilage, and adjacent tendon and bones as well as the noncollagen matrix molecules 
that contribute to joint integrity and function. 
Oxidative Stress and Rheumatoid arthritis 
In pathophysiological perspectives, oxidative stress plays a major role in 
myriad of human disease progression and development including RA. Reactive 
Oxygen Species (ROS) are produced in both normal (physiological) and diseased 
(pathophysiological) conditions in mammalian tissues (Plaa et al., 1976). In the 
normal and healthy condition the cells and tissues produce ROS relatively in a very 
low level which plays a very important role in maintenance and regulation of cell 
redox status, intracellular cell signalling and transcriptional regulators like NFkB 
activator protein I and hypoxia inducible factor la (HIP a), and ROS released by 
phagocytes involved in priming the immune response. 
The uncontrolled over production of ROS/free radicals induces several 
pathophysiologies. causing tissue damage (Mapp et al., 1995). This oxidative stress is 
being developed due to generation of free radicals or ROS. These ROSs are present in 
the form of superoxide, hydrogen peroxide, hydroxyl radicals and their reactive 
products. In RA, neutrnphils are the main source of ROS production in synovial fluid. 
Activation of neutrophils by exogenous and endogenous factors results in their 
production of superoxide radicals, H202 and highly reactive hydroxyl radicals. These 
ROS act as a mediator in tissue damage in RA (Kamanli et al., 2004). High level of 
ROS is capable of DNA damage, lipid peroxidation and protein oxidation (Mirshafiey 
and Mohsenzadcgan, 2008). Lipid peroxidation (LPO) in the cell membrane leads to 
the disorganization of cell structure and function and further decomposition of 
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peroxidised lipid yield variety of end products, including maiondialdehyde (MDA) 
(Gambhir. 1997). Thus MDA level is used as a marker of LPO in inflammatory 
conditions (Romero et a)., 1998). High level of MDA has been demonstrated in 
synovial fluid and serum of RA patient (Lune et al., 1981). Superoxide anion (OZ) is 
the main ROS, which play a pivotal role in inflammation, particularly in inflanunnatory 
joint diseases (Henrotin, 2005). Over expression of ROS can be an important mediator 
in tissue damage, damage to the cell, including lipid and membrane, protein and DNA 
(Valko, 2007). 
Along with cellular and humoral immune system, antioxidant mechanism 
plays a very important role in arthritis prevention, damage control and adopts the 
body against stressful situation. Antioxidants are the compounds which scavenge and 
suppress or inhibit the free radical formation or suppress their formation (Sie, 1991). 
These antioxidants present in serum and tissue form a complex but well orchestrated 
system called as antioxidant system. A number of the antioxidant compounds are 
produced to safeguard the cellular processes against the stressful conditions that 
includes intracellular enzymes, namely superoxide dismutase, glutatltione peroxidase, 
catalase and other peroxidase, thioredoxin reductase, and the sequestration of metal 
oxide co factors like Fe and Cu by binding to protein and endogenous antioxidants. 
SOD is the first discovered free redical scavenging enzyme which is involved in 
dismutation or breakdown of superoxide ions and converts them into less toxic 
hydrogen peroxide. H202 interact with glutathione and ultimately form water and 02 
and thereby prevent the formation of highly toxic peroxynitrite (ONOO-) and 
hydroxyl radical (HO) (Afonso, 2007). Two forms of SOD exist inside the body-
active and inducible form (MnSOD) that resides in mitochondria. Induction of 
MnSOD is performed by the cytokines through NFkB and requires a cofactor a 
RNA-binding protein called nuclear phosphosmin (Dhar et al., 2004). Glutathione 
peroxidiase, regulated by p53 and hypoxia, is a primary mitochondrial defence 
compound from hydroxyl ions (Tan et al., 1999; Bierl. 2004). Catalase is also 
involved in degradation of hydrogen peroxide and probably involved in cytosolic and 
extracellular protection as it is absent in mitochondria of most of the cell. Another 
important antioxidant enzyme; thioredoxin reductase is present for detoxification of 
free radicals, especially in cardiac tissues (Yamamoto, 2003). Oxidative stress in itself 
and several inflammatory cytokincs like TNF-a are the inducer of thioredoxin. 
Activated thioredoxin regulate the protein redox and facilitates protein DNA 
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interaction. Expression of thioredoxin has been demonstrated in case of rheumatoid 
arthritis particularly in synovial fluid and tissues (Turoczi et al., 2003: Das, 2004; 
Maurice et al., 1999). Sowers et al. (1999) reviewed that the endogenous antioxidants 
protect the cellular system from damaging effect of reactive nitrogen species (RNS) 
and ROS. Erythrocytes are well equipped and have capability to detoxify and 
neutralise the extracellular oxidative stress by SOD, CAT and GSH, GPx and GSI 
(Valko et al., 2007) and in absence of scavenging ability these ROS cause widespread 
lipid, protein and DNA damage (Jaswal ei al.. 2003). Vitamins play an important 
function of antioxidants. Dillerent vitamins namely vitamin A (retinol and 
metabolites), vitamin C (ascorbic acid) and vitamine E (a tocopherol) and water 
soluble provitamin A (p carotene), are the free radical scavengers, which control the 
production and propagation of free redicals and influence lipooxigenase activity. 
Among all vitamin C react with superoxide, peroxyl, hydroxyl radicals and can 
prevent lipid peroxidation by traping soluble peroxyl radicals before their diffusion 
into lipid membrane and act as a first line of defence compound during oxidative 
stress. It also recycles antioxidant like vitamin E which act as chain breaking reagent 
in lipid peroxidation due to its lipid-soluble properties. Epidemiological studies 
suggest the inverse relation between dietary antioxidants and RA incidence 
(Cerhan et al., 2003; Hagfors et al., 2003; Bae etal., 2003) and inverse relation is also 
present between antioxidant level and inflammation (Paredes et al., 2002; Mulherin et 
al., 1996a). It has been established that increased oxidative stress along with 
decreased antioxidant level in the sera and synovial fluid of RA patient is the marker 
of disease (De Leo et al., 2002; Ozturk et a1., 1999). Direct demonstration of ROS in 
vivo condition is very difficult, therefore, it is considered to be more practical to 
analyse their target sites like changes in lipid, protein and nucleic acid (Babior, 2000; 
Henrotin et al., 2003; Halliwell et al., 1995; Talc et al., 2000). Oxidative damage to 
hyaluronie acid (Grootveld, 1991 Rowley, 1984), lipid peroxidation products (Taysi 
et al., 2002), oxidised low density lipid proteins (LPL) (Dal L et al., 2000) and 
increased carbonylation of protein (Loc. cit.; Dalle-Donne et al., 2003), has been 
demonstrated in RA by studying the synovial fluid and tissues. High level of ROS 
induces the T cell hypo responsiveness through effect on protein and proteosomal 
degradation in case of RA (Cemerski et al., 2003). It has also been demonstrated that 
the antioxidants and oxidative enzymes ameliorate arthritis in animal models 
(Bandt etal.. 2002; Cuzzocrea et al., 2000). 
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In RA ROS and RNS damage cartilage's cellular element directly and 
extracellular matrix either directly or indirectly (Henrotin et al., 2003). ROS impair 
migration of chondrocgtes at the site of cartilage injury, unresponsiveness to the 
growth factors and RNS, NO in particular interfere with the interaction between 
chondrocyte and extracellular matrix (Clancy et al,, 1997). ROS and NO can also 
increase apoptosis of chondroeytes by the process of oxidation, nitrosylation, nitration 
and chlorination due to formation of altered protein and impaired biological function. 
Inhibition of proteoglycan synthesis, the sulfation of newly synthesised 
glycosarninoglycans and type II collagen is induced by ROS and RNS in general and 
NO and 0,  in particular. The oxygen radicals may lead to the low level of collagen 
fragmentation and collagen fibre cross linking. Fragmentation of hyaluronan and 
chondroitin sulphate is also caused by oxygen radicals (Rees et al., 2003; Rees et al., 
2004) and also damages the hyaluronan binding region of the proteoglycan core 
protein and therefore, interfering with proteoglycan-hyaluronan interactions 
(Panasyuk et al., 1994). ROS and RNS also induce upregulation of matrix 
metaloprotcascs and thereby damage the components of extracellular matrix. 
NO serves as an important signalling molecule in inflammatory conditions 
(Kerwin and Heller, 1994) and it is synthesized from the guanidino group of 
1, arginine by a family of enzymes termed nitric oxide synthases (NOS), and this 
process involves the incorporation of molecular oxygen into L-arginine. Inducible 
NOS (iKOS), endothelial cell NOS (ec-NOS) and brain NOS (bNOS), represent 
different isoforms of NOS (Marietta, 1993, Stuehr, 1997; Geller and Rilliar, 1998). 
Pro-inflammatory cytokines induce the expression of iNOS in a number of non-
hematopoietic cells, including fibroblasts (Nathan, 1992). The induction of iNOS may 
either be toxic or protective (Palmer et al., 1992, Szabo and Thieniermann, 1994; 
Salzman 1995, Kim et al., 1997). In arthritis, NO induces the production of 
proinflammatory cytokines such as'INF-a, IL-lp and IFN-y, as well as collagenases 
(Hierholzer et al., 1998; McInnes et al., 1998). NO also induces certain chemokines, 
which contribute to the disease progression in arthritis. Inhibition of NOS reduces 
arthritic symptoms (McCartney-Francis et al., 1993). Anti-oxidants of the body as 
well as a number of plant extracts scavenge NO and other free radicals. Plant-derived 
compounds are also able to suppress iNOS and increase SOD activity. For example, 
Quercetin, a llavonoid, ameliorates adjuvant arthritis (AA) in rats, and this effect is 
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associated with reduced production of various mediators of inflammation, including 
NO by macrophages. 
Molecular mediators of inflammation and arthritis 
Thr initiation and progression of arthritic inflammation requires signal 
transduction from the arthritogenic stimuli. Defined ligands bind to the appropriate 
receptors on the target cells, initiating a cascade of signals, including the activation of 
transcription factors that leads to the generation of a variety of mediators 
(e.g. cytokines, chemokines, MMPs and other enzymes) of inflammation and tissue 
damage and thus they are controlled at the transcriptional level in RA (Okamoto ct al. 
2008). Hence, cell signalling pathways and transcription factors are important 
components for development of arthritis. The roles of major signalling molecules and 
transcription lactors are summarized in table 3. 
Cell signalling pathways 
Mitogen-activated protein (MAP) kinases are central components of signal 
transduction pathways, lead to the enhanced expression of inflammatory mediators 
that are key player in the pathophysiology of RA (Fig. 11) and other inflammatory 
diseases (Sweeney and Firestein, 2004). Therefore, the members of the MAP kinase 
pathways are potential therapeutic targets in RA. MAP kinases comprise a family of 
praline-directed serine/threonine protein kinases. 7'he activated MAP kinases 
translocale to nucleus and facilitate the modulation of gene transcription via the 
induction and/or trans-activation of transcription factors (Robinson and Cobb, 1997; 
Chang and Karin, 2001). There are 3 major mammalian MAP kinase pathways i.e. the 
ERK pathway, the JNK/SAPK pathway, and the p38 pathway. Each pathway is 
specified by a specific isoforms of kinases that are differentially expressed in various 
tissues and play different roles. 
Extracetlular-signal-regulated kinase (ERK) pathway 
The ERK pathway also known as MAP kinase/ERK kinases (MEKs) is 
activated by the MAP kinase. MEK/ERK pathway plays an important role in 
lymphocyte activation and proliferation (DeSilva et al., 1998; Chen et al., 1999, Pages 
et al., 1999) in the production of pro-inflammatory cytokines, such as IL-l13, TNF-a, 
and [L-6 (Scherle et al., 1998; Tuyt et al., 1999; Dumitm et al., 2000; Schett et al., 
2000) in the production of MMPs (Broglcy ct al., 1999; Brauchle et al., 2000) and in 
the development of synovitis, pain, and tissue destruction in RA. MEK phosphorylate 
serine(theronine residue and is important in initiation of signalling (Cobb, 1999). 
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Therefore, MEK inhibitors are being exploited to inhibit diverse inflammatory 
pathways. For example. a selective MEK inhibitor shows anti-arthritic activity 
(Thiel et al., 2007). In this regard, medicinal plants being used might be an invaluable 
resource for novel MEK/ERK inhibitors. 
p38 MAP kinase pathway 
The p38 MAP kinase has a number of isoforms (p38a. b, c and d), out of them 
p38a is believed to be a critical regulator of the inflammatory response, including the 
release of cytokines by immune competent cells and the functional response of 
neutrophils to inflammatory stimuli (Ono and Ilan, 2000). p38 MAP kinase 
phosphorylates many transcription factors, including signal transducer and activator 
of transcription (STAT), downstream kinases and nuclear factor of activated T cells 
(NFAT). (Shi and Gaestel, 2002). 
Table.3. Function of the key molecular mediators associated with the 
pathogenesis of RA. 
Molecular mediator Function 
Signalling molecule 
ERK Production 	of 	pro-inflammatory 	cytokines 	and 
MMPs, lymphocyte activation and differentiation 
P38 Release of pro-inflammatory cytokines, Cox-2 and 
MMPs 
JNK Expression of cytokines, growth factors, cell surface 
receptors. cell adhesion molecules and MMPs 
Nuclear factor 
NF-kB Expression of cytokines (TIFF-a,IL-1(3,IL-6,IL-17, 
IFN-y, etc), chemokines(MCP-1, MCP-4. CCL18. 
etc.), 	adhesion 	molecules 	(E-selectin, 	ICMA- 
I,VCAM-1, etc.), MMPs, VEGF, NOS and COX 
AP-I Activation 	of 	cytokines 	production, 	T-cell 
differentiation, 	interaction 	with 	and 	trans- 
repression of the glucocorticoid receptor, and MMP 
expression 
COX: cvclooxveenase. ICAM: intracellular adhesion molecule. IFN: interferon_ IL: interleukin_ MCP• 
monocyte chemoattractant protein, MMPs: matrix metalloproteases, NOS: inducible nitric oxide 
synthase, TNF: tumor necrosis factor, VCAM: vascular cell adhesion molecule and VEGF: vascular 
endothelial growth factor. 
In addition, it regulates a variety of genes involved in inflammation, such as 
IL-1~3, TNF-u. IL-6, IL-8. COX-2, and MMPs (Ono and Han, 2000). The p38 
pathway also mediates certain cellular functions, including cell migration, cell 
survival and cell death (Hannigan et al., 2001; Kontoyiannis et al., 2002 and 
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Kotlyarov et al.. 2002). Inhibition of p38 MAPK suppresses production of 
inflammatory cytokines, paw swelling and the joint damage (Badger at al., 1996: 
Adams et al., 2001). 
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Figure. 11. Signal transduction pathway. Regulation of inflammation and joint 
degradation by modulating MAPKs, NF-KB, AP-1 pathway and STAT 
signalling activated by IL-1(3, TNF-a and IFN-y in various cell types. 
c-Jun N-terminal kinase (JNK) pathway 
JNKs phosphorylate and activate transcription factors and other cellular 
factors which regulate the expression of many genes encoding cell surface receptors, 
cell adhesion molecules (E-selectin), degradative enzymes (MMPs) and cytokines 
(TNF-a, IL-2). growth factors. Activated JNK can be detected in synovial fibroblasts 
and chondrocytes of arthritic patients but not from normal control and it has been 
implicated in chondrocytes injury and cartilage degradation (Clancy et al., 2001; Ilan 
et al., 2001). Furthermore, JNK inhibitors are involved in disease suppression in an 
animal model of arthritis (Gaillard et al., 2005). Certain Chinese herbs contain 
inhibitors of JNK that are used in CAM for the treatment of several inflammatory 
disorders including RA (Ehrman et al., 2010). A purified compound from Epimedium 
koreanum; Ikarisoside, has inhibitory effects on JNK and Akt (besides NF-kB) when 
tested for its effects on osteoclastogenesis using monocyte/macrophage RAW 267.7 
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cells. The molecules targeted here are involved in abnormal bone lysis in RA 
(Loc. cit.). 
Transcription factors 
Nuclear factor-kappaB (NF-kB) 
The transcription factor NF-kB regulates the expression of a wide variety of 
genes. ReIA, ReIB, c-Rel, NF-kBl and NF-kB2 are members of NP-kB family. These 
members activate characteristic sets of genes in particular type of cells, thus 
regulating the transcription of genes (Silverman and Maniatis, 2001; Dejardin et al., 
2002; Ghosh and Karin, 2002; Li and Verma, 2002; Udalova et al., 2002). NF-kB 
remains in an inactive form due to the inhibitors of NF-kB proteins (IkB), but cellular 
stimuli including cytokines, mitogens and stress, activate it and subsequent 
degradation of IkB via activating NF-kB kinase (IkB kinase (IKK) complex) occurs 
(Uhlar and Whitehead, 1999; Mullan et al., 2006). The activated NF-kB translocates 
to the nucleus and stimulates the transcription of genes containing the consensus kB 
sequence 5'-GGGPuNNPyPyCC-3' (where Pu denotes a purine and Py denotes a 
pyrimidine). Such genes include those encoding certain cytokines and chemokines, 
adhesion molecules, MMPs. VEGF, iNOS, COX-2, etc. Most of these genes have 
been reported to have important role in the pathogenesis of RA (Loc. cit.). VEGF 
involved in angiogenesis are attractive targets for therapeutic agents against RA 
(Lainer-Carr and Brahn, 2007). 
Activator protein-1 (AP-l) 
AP-1 is another transcription factor which transducer extracellular signals in 
immune cells. AP-1 gets activated in response to varied inflammatory stimuli. 
Activated AP-1 interacts with the binding site(s) in their promoter/enhancer regions 
leading to the expression of specific target genes encoding pro-inflammatory 
cytokines and MMPs (Benbow and Brinckerhoff, 1997; Foster et al., 2000; Harrison 
et al.. 2004). AP-1-mediated cytokine production in cooperation with transcription 
nuclear factor of activated '1 cells (NFAT) family (Rooney et al., 1995) where AP-1 
and NFAT form stable ternary complexes on DNA-binding sites. AP-1-tttediated 
activation of NFAT and integration of the signals via the receptor activator for nuclear 
factor-kB ligand (RANKL) and macrophage colony-stimulating factor (M-CSF) are 
essential for osteoclast differentiation(Takayanagi, 2005). AP-1 also regulates the 
differentiation of naïve T cells into T helper I (TM) or T helper 2 cells (Th2), and it 
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interacts and trans-represses the glucocorticoid receptor (Rincon et al., 1997; Brogan 
at al., 1999). 
Animal models of rheumatoid arthritis 
Animal models have contributed to the understanding of basic mechanisms of 
inflammatory diseases. Arthritis has been induced by various antigens and there is 
marked diversity among the numerous models. These include the generation of 
autoimmunity to cartilage components, nonspecific skewing of autoimmunity with 
adjuvants. and triggering with exogenous agents such as bacteria and viruses (van den 
Berg, 2009). Rodent models of rheumatoid arthritis (RA) have been developed in both 
mice and rats. Other species have also been used over the years, however rodent 
models are most common due to cost, homology at the genetic background, the 
capacity to use genetically modified strains. Most 1(A in animals is produced by 
treatment with an inducing agent, and even "spontaneous" models can he considered 
since they develop by the introduction or deletion of specific genes in animals with 
the proper immunologic milieu for susceptibility (Katmai et al., 2005). 
Rat models of rheumatoid arthritis 
The first model of polyarthritis was developed in rats when Stoerk et al. 
(1954) and Pearson and Wood (1959) found that injection of complete adjuvant 
within the rat induces polyarthritis, possibly by a mechanism involving heat shock 
proteins (HSP). This model was termed as the adjuvant arthritis (AA) model, and has 
been used' to test new drugs for inflammatory arthritis. Interestingly, IISPs have been 
involved in the pathogenesis of human RA as well (Res et al., 1988). It was recently 
found that AA could be induced by incomplete Freund's adjuvant (IPA) alone in the 
DA (Dark Agouti) strain of rats, More recently this model has also been reproduced in 
mice (Knight et al., 1992). Adjuvant arthritis has been used in the evaluation of 
efficacy of nonsteroidal inflammatory drugs (NSAIDs) such as phenulbutazone and 
aspirin during the early 1960s (Wooley, 1991, 2004), and later on COX-2 inhibitors 
such as celecoxib (Geis, 1999). AA in rats shares many features with human RA 
including synovial CD44 cells. T cell dependence and genetic linkage (Goodson et al., 
2003). One of the major differences between the AA model and human RA is that the 
inciting agent is known in the model, though the need for any specific antigen is 
controversial (Loc. cit.) 
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Collagen induced arthritis (CIA) 
Collagen-induced arthritis is an extensively studied animal model of RA 
because it shares both immunological and pathological features of human RA in terms 
of higher susceptibility in females, symmetric joint involvement, peripheral joints 
affected, synovial hyperplasia, inflammatory cell infiltrate etc. CIA is primarily an 
autoimmune disease of joints, requiring both T and R cell immunity to autologous 
type 11 collagen (CIL) for disease progression. This model is reproducible in 
genetically susceptible mice strains with MHC haplotypes H-2q or H-2r by 
immunization with heterologous type II collagen in complete Freund's adjuvant 
(CFA). Collagen from varied sources has been used including bovine, porcine, chick, 
and human, whereas response varies with strain and injection conditions. Not 
surprisingly, mouse collagen gives a poor response. Highly purified collagen prepared 
under a defined protocol must be used. The presence of minor contaminants or 
deglycosylated proteins yields either false positive results or may be less arthritogenie 
(Andersson and I-Iolmdahl, 1990). Rats injected with native type II collagen also 
develop polyarthritis but the mouse model is most commonly used for its applicability 
in genetically modified strains. 
The requirement for 'f cells in the development of CIA is clear, whereas the 
underlying mechanisms are not well known. Contrary to expectations, passive transfer 
of collagen-II specific T cells induces minor changes in the synovium, whereas the 
transfer of collagen-II specific -antibody results in severe inflammation, and 
co-transfer of antibody and 'I cells induce chronic condition (Nandakumar et al., 
2004). Although, T cells play a prominent role in the regulation and development of 
CIA, autuantibody to murine CIL appears to be the primary mechanism of 
immunopathogenesis in this model. During the early stages of disease progression, 
anticollagen antibodies bind to the joint cartilage and activate the complement 
cascade (Joe et al., 1999). Consistent with autoantibody being a major pathogenic 
factor is the fact that passive transfer of anti-collagen II sera produces an 
inflammatory arthritis not only in genetically susceptible strains to CIA, but also in 
CIA-non-susceptible strains. 	- 	~ 
Hclminth Infection and Autoimmune Disorders 
It is well established that the poteniJrobust immune response is very essential 
to protect the host from disease and inflammation. But, when disturbed due to any 
pathogen or other environmental stimuli, the response could manifest as disease 
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including autoimmune disease: RA, asthma, multiple sclerosis, inflammatory bowl 
disease, autoimmune type I diabetes etc. In these diseases our exacerbated immune 
system target specific tissues/organ causing inflammation mediated by different 
immune cells and their secreted products. 
Infection can exacerbate the autoimnrunity 
The autoimmune diseases are under complex genetic control with 
environmental factors also playing a role. The main challenge to the Hygiene 
Hypothesis comes from epidemiological studies in humans where not all infections 
can prevent autoimmune diseases in animal models. The vim!, bacterial and parasitic 
infections appear to trigger autoimmune pathology (Zaccone and Cooke, 2011). For 
example, Streptococcus A bacteria, Coxsackie B virus and Trypanosoma cruzi 
infections have all been associated with onset of autuimmune cardiomyopathy 
(Loc. cit.). The mechanism(s) by which infectious agents trigger autoimmmnity might 
have several possible routes. One way would be through homology between self 
antigen and an infectious agent where activation of the antigen presenting cell via 
pathogen associated molecular pattern (PAM?) engagement of pathogen recognition 
receptors (PRR) increases the ability of innate cells to present shared cpitopes and 
initiate autoreactivity through activation of a self reactive lymphocyte in the bone 
marrow or the thymus. Furthermore, infection of the target tissue or inflammation 
could mediate host tissue damage and release of large amounts of tissue specific 
self-antigens some of which may not have been expressed in the thymus or have been 
subject to posttranslational modifications in the periphery. This can lead to antigen 
and epitope spreading (Loc. cit.). Additionally, T cells specific for an infectious agent 
could provide help for a B cell response to a shared epitope between the infectious 
agent and self antigen leading to production of pathologically relevant autoantibodies 
(Weigle et al., 1981; Playfair eta!,. 1976). Experimentally these processes have been 
used to generate animal models of autoimmlmity where self or heterologous antigens 
are administered in high concentrations along with adjuvants. The possible 
mechanisms by which infections might initiate autoimmunity are shown 
diagrammatically in Fig. 15. 
Infection can be a boon in autoimmunity 
It has become evident that some infectious agents have evolved strategies to 
down regulate the host immune response that is achieved by various means including 
targeting host eytokines and chemokines and inducing immune regulatory 
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mechanisms. During this process organisms influence the immune response by 
favouring differentiation of one T helper subset over others or delay lymphocyte 
recruitment to sites of inflammation. These strategies facilitate survival of the 
pathogen while down regulating host pathology, in the context of a Thl or Th17 
mediated autoimmune response, polarization of the response to Th2 or induction of 
Tregs would prevent onset of autoimmunity (Loc. cit.). There is, however, a complex 
cross talk between infectious agents and the host immune response and it is an 
oversimplification to attribute everything to the effects of T helper cell subset 
differentiation. For example, Thl mediated autoimmune disease like type I diabetes 
in NOD mice is suppressed by bacterial infections (Martins and Agus, 1999; Zaccone 
et al., 2004) while in certain cases, following Mycobacterial infection, this may he 
due to Treg induction (Loc. cit.) but this is not the case following salmonella infection 
(Raine, 2006). It is important to examine more broadly the cytokines, molecules and 
cell signatures associated with infection that are advantageous in preventing 
autoimmunity. 
Emergence of autoimmune disease and Industrial revolution 
It is Ibund that the immune mediated diseases are more frequent in developed 
nations where industrial revolution is at its peak and it is less common in the 
developing countries, which proves the hygiene hypothesis. If we take the example of 
IBD, asthma, MS, TID, over last 70 years these diseases have become very much 
prevalent in industrialized and highly developed countries but there incidence is very 
low in less developed countries. IBD affect more than three million people in Europe 
and USA, while it was very uncommon before 1940s (Loftus, 2004). As IBD emerge, 
it was most common in urban areas (Ekbom et al., 1991), northern latitude 
(Sonnenberg et al., 1991; Shivnanda ct al., 1996) and with white collar job 
(Sonnanberg et al., 1990). Secondly, the children of migrants from less develop 
countries to developed countries become more susceptible to IBD (Jayanathi et al., 
1992; Carr and Mayberry, 1999). 'these findings suggest that the development and 
industrialization increase the risk of IBD in the population. Similar findings are also 
present in case of asthma. Children of developed countries are more prone to the 
asthma than undeveloped countries (Braman, 2006). Children of Mexico are less 
likely to report the asthma symptoms than the children of Mexican migrants settled in 
USA (Eldeirawi and Persky, 2006), which suggests that the environment in these 
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countries promote asthma (Asher et al., 2006). Similarly MS and Ti D are also much 
prevalent in developed countries than undeveloped countries (Elliot, 2007). 
Bacteria Virus 
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Figure 15: Induction of autoimmunity by bacteria and viruses. Microbial attack leads to a 
general activation of the immune system which might lead to autoimmunity via 
multiple pathways. (Courtesy: Zacoon, 2011). 
Palaeontological evidence suggests that our ancestors were colonized by the 
helminthes (Goncalves et al.. 2003). Palaeoparasitological findings dating back to 
10,000 years show the infection of nematodes (e.g. Trichuris trichiura, Ascaris 
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humbrocoicles. Enlerohius veruzicularis, Trichinella spiralis), cestodes (Tuenia spp., 
Diphylohothrium spp., Qyntenolepis nana) and trematodes (e.g. Fasciola spp.. 
Schistosomu spp.) were common. Human infection with these organisms is common 
in undeveloped countries than the developed nations (Crompton, 1999; Bethony et al., 
2006). The longstanding exposure permits selection of genetic traits that optimized for 
the presence of helminthes (Elliot et al., 2000). 
Before 1930, the colonization with helminthes was nearly universal (Elliot et 
al., 2007). But the change in life style and improvement in hygiene condition in 
developed countries, eliminated the helminth colonization. For example, in USA 
about 17% individuals were infected with the T. spiralis in the 1940, but now fewer 
individuals are infected per year, due to ingestion of exotic meat (Elliot et al., 2007). 
Even, E. vermicularis (pinworm) which has very simple life cycle has declined from 
United States (Vermund and MacLeod, 1900) and Europe (Gale, 2002). 
Table 4: Prevalence of common helminths 
Helminth Estimated number of people colonised 
Ascaris lumbricoicles 1.221 billion 
Trichuris irichura 795 million 
Ancivclo.rtonial nector 740 million 
Schistosonia spp. 200 million 
Wucheria hancrofti 120 million 
Strongvloides stercoralis 100 million 
Tuenia spp. 87 million 
Hymenolepis nana 75 million 
Note: 'These are the estimates of the number of people with active infection. The number of 
people potentially exposed or with sub-clinical helminth infection is much higher (Elliot et 
al.. 2007). 
It is a matter of fact that no one will condemn the loss of helminth parasites 
but loss of these parasite may have unforeseen consequences. It is well known that 
infection with these parasites may protect in deregulated immune mediated problems. 
Asthmatic problem is more severe in the individuals not infected with 
Ascaris lumbricoicles or ,Vectar (hookworm) sp. that infected people (Scrivener et al., 
2001). In atopic disease the positive skin reaction test to an allergen help in diagnosis 
of the diseases but it is found that the individuals infected with 
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Schistosoma huetnatobium have decreased skin test with dust mite antigen than non 
infected individuals (Van den Biggelaar et al., 2000). People living in Schistosoma 
endemic areas have less wheezing and Asthmatic medication than non endemic areas 
(Araujo et al.. 2004b). Van den Biggelaar (2004) also found that the children who 
have repeated medication against 7: Irichiura and A. lumbricodes had increased dust 
mite skin response than the children who did not take any medication against these 
parasites. 
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Figure.16. Decline in the number of U.S. cases of trichinosis reported to the Centers for 
Disease Control and Prevention over 30 years (from Summary of Notifiable 
Diseases — United States 2004, MMWR 53:1-79) (Loc. cit). 
Immune mediated deregulation are more prevalent in the area where helminth 
are eradicated (Eliott, 2000), which may be the reason for an increase in the cases of 
autoirnmune disorders. But it is not only the reason for disease development, some 
environmental factors and genetic factors also act over there and lack of helminth 
infection supports the problem in sideways. 
Brief immune mechanism during helminth infection 
Helminth infection is dominated by the Th2 type of immune response which 
includes both innate and adoptive immune response and can be clearly distinguished 
from the adaptive Th2 response (Anthony et al., 2007). Th2 type of immune response 
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in signature is dominated by expression of anti-inflammatory cytokines such as IL-4, 
IL-10, IL-13 and 	IL- 21. 
Innate immune cells in helminthes infection 
Basophils and Mast cells 
Innate immune cells are important for initiation, amplification and effector 
phase of Th2 response. Basophils, mast cells, macrophages and DCs play important 
role in innate immune system activation during infection. Basophils are readily 
detectable in the lungs, liver and spleen during ;Vippostron 'lus brasiliensis infection 
(Shinkai et al., 2002; Min et al., 2004). Basophils and mast cells are involved in 
initiation and promotion of Th2 response as these cells are major source of IL-4 
production at early stage of Th2 cell response. Origin of mast cell is not clear but 
certain studies suggest that mast cells and basophils are derived from common 
progenitors (Arinobu et al.. 2005) and these cells have many similarities with the 
basophils including cell surface expression of the high affinity Fc receptors for IgE 
(FceRI), IL-18R and Toll-like receptors (TLRs) and IL-4/IL-13 secretion (Yoshimoto 
and Nakanishi, 2006). However, in contrast to the basophils, mast cells reside in the 
periphery and well situated to the immediate response to the invading antigen while 
basophils circulate into the blood. During helminth infection the number of mast cells 
is increased in mucosal lining and infected tissue which is dependent upon Th2 type 
cytokines. 
Intestinal epithelial cells 
Intestinal epithelial cells are involved in intestinal immune homeostatis 
(Zeuthen et al., 2008). IEC produce a cytokine called thymic stromal lymphopoietic 
(TSLP). NFk B are the transcriptional regulator of TSLP which can be induced by 
viral, bacterial, parasitic pathogens and IL 1 beta and TNF alpha, the inflammatory 
cytokines (Allakhverdi et al., 2007; Lee et al., 2007). TSLP bind to high affinity 
receptors present on T cells, B cells, and dendritic cells (Soumelis et al., 2002; 
Allakhverdi et al., 2007; Chappaz et al., 2007; Liu et al., 2007) and promote Th2 cell 
response. TSLP also induce naive CD4+ cells to secrete IL4 and promote Th2 cell 
differentiation even in the absence of exogenous 1L4 and antigen presenting cells 
(Omori and Ziegler et al., 2007). TSI.P is both necessary and sufficient for initiation 
of Th2 derive cytokine production (Ziegler and Liu, 2006; Liu et al., 2007). Deletion 
of TSI.PR or the monoclonal antibody mediated neutralization of TSLP in normal 
resistant mice produces defective Th2 response and persistent infection (Taylor et al., 
121 
P2C2: R view of Literature 
2009). However, in case of helminthes. Heligosomoides polyk 'rus and N. brusiliensis, 
TSLP and TSLPR interaction have no significance in development of Th2 derived 
protective immunity (Massacand et al., 2009). 
IL-33 
IL-33 induce IL-13 production from mast cell by IgE dependent pathway from 
both human and mouse mast cells (Florian et al., 2006). Post transcriptionally IL-33 
bind with the receptor complex composed of ILIR family member ST2 and the IL-1R 
accessory protein (Acosta-Rodriguez et al., 2007). ST2 expressed in both mast cell 
and Th2 cells (Nakanishi et al.. 2001) and thus play important role in Th2 response 
(Yashimoto and Nakanishi, 2006). IL-33 has shown to be a chemoattractant for 'l'h2 
cells (Oshikawa et al., 2001). IL-33 along with TSLP on mast cells work in 
coordinated way for Th2 associated cytokine and chemokine production 
(Brunner et al., 2004) and enhance the TSLP induced response from mature mast cells 
(Loc. cit.). It is possible that the IL-33 promote Th2 driven immunity via TSLP in 
Trichuris mans infection (Fukumota et al., 2009). IL-25 also known as IL-17E which 
is related to the IL-7 can promote Th2 cell differentiation and nematode parasite 
expulsion (Fallon et al., 2006; Ovyang et al., 2006). 
Role of dendritic cell in Th2 response: 
DC play central role in Th2 mediated immune response. In vitro induced DCs 
with helminth extract develop Th2 biased helminth specific response 
(MacDonal el ul., 2001; Balic et al., 2004; Leech cat al., 2006). During Th2 response 
DCs respond via TLRs along with other pattern recognition receptor lectins 
(Medzhitov, 2007; van Vliet et al., 2008). The major difference between Th2 response 
and Thi response is that former develop normally in absence of My88 (Heimby et al., 
2003; Layland et al., 2005). NFkB and mitogen activated protein kinase (MAPK) 
show significant difference between DCs exposed to helminth products as compared 
to those exposed to the microbial products like LPS (Loc. cit.). For example, c junk 
terminal kinase, extracellular signal regulated kinase (ERK) and p38 are heavily 
phosphorylated after LPS exposure to DCs but in response to Schistosoma egg antigen 
ERK and lesser extent p38 are phosphorylated but not JNK (Kane et al., 2004). 
Exposure of DCs to helminth products has been reported to stimulate NFk13 activation 
(Loc. cit.). For example, LNFPIII stimulate rapid transient NFkB nuclear 
translocation and activation (Thomas et al., 2005). It is also shown that NFk BI"'- DCs 
are not able to mount Th2 response neither by Soluble Egg Antigen (SEA) nor with 
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LNFPIII (Thomas et al., 2003; Artis et al., 2005). ES-62 secreted by 
Acanthocheilonena viteae induced DCs to mount Th2 response through TLR4 
(Loc.cit, 2003; (ioodridge et al., 2005) while Lysophosphatidyl- serine from 
Schistosoma stimulate DCs vial TLR2 (van der Kleij et al., 2002). 
Alternatively activated macrophages and helminth infection 
Macrophages involved in IFN-y mediated Th 1 cell response to many bacteria 
and viruses but these cells play an important role in Th2 response too. These cells are 
different from classically activated macrophages (CAM(Ds) which are associated with 
the microbial infection and alternatively designated as AAM(Dsm (Stein et al., 1992) 
The alternatively activated macrophages are differentiated over the concept that they 
are activated in the presence of IL-4 and are deactivated in presence of IL-10 cytokine 
(Loc. cit.). Later it has also been established that IL-13 also exerts the similar effect 
on macrophages as IL-4 because IL-13 share common receptor chain with IL-4 
(Gordon, 2003). It has been found that when recombinant peroxiredoxin injected in 
wild type and IL-4"'- and IL-13-x- mice it induced the production of IL4 and AAM(Ds 
independent of IL4/IL13 signalling (Donnelly et al., 2008). 
Various helminth infections promote the AAM(Ds cell differentiation, along with Th2 
type of immune response. For example S. mansoni (Herbert et al., 2004), 
Tueniu crus.siseps (Rodriguez-Sosa et al., 2002), Trichinella spiralis (Dzik et al., 
2004), F. hepatica (Donnelly et al., 2005) and filarial parasites (Nair et al., 2003). 
Different marker are being used to identify AAM(Ds, including cell surface marker, 
IL-4R alpha and mannose receptor (CD206) by flow cytometry (Herbert et al., 2004), 
immunohistological technique (Anthony et al., 2006) and analysis of some metabolic 
products like urea, proline (Loke et al., 2002). It is well established that the 
Arginase-1 is upregulated in AAM(Ds and due to its higher affinity for arginine, 
competes with inducible nitric oxide synthase (iNOS) which metabolize arginine in 
CAM(Ds. Then AAM(Ds fail to generate the NO from arginine and arginase- I and its 
metabolic products, including urea and proline, are also the indicative of AAM(Ds 
differentiation (Loc.cit, 2002). 
Human AAM(Ds express some specific chemokine which is involved in Th2 cell 
recruitment through interaction with chemokine recptor 4 (CCR4). These chemokines 
include alternative macrophage activation-associated CC chemokine-1 (AMAC-1 
CCL 18) (Goerdt and Orfanos, 1999), macrophage derived chemokine (MDC; CCL22) 
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(Bonecchi et al, 1998) and thymus activation regulated chemokine (TARC; CCLl7) 
(Imai et al., 1999). 
AAM(Ds express FIZZ (found in inflammatory zone) family membrane protein, 
including FIZZ11RELM alpha, Yml and chitinase including acidic mammalian 
chitinase (AMCase) (Nair eat al., 2005). During nematode infection YmI is the highest 
upregulated among all the genes (Raes et al., 2002). 
Bacteria 
Parasite Chitin Proteases Lipid slvcan ES 	Virus 
Putativc 	Unknown 	TLRs FcrRl 	TLRs C-:ype lectins 	TLRs 
receptors  
IECs 	Eo MC (Baso 	DC 	DC 
IL-33 TSLP 	Th2-type IL-12 / 	'. cytoklnes 
.. ~. DC` 
MC ! Th2) 	(Th2)  
IL-13  IL-4, IL-13 etc.  
Parasite 	Y -.. - - .~-' ,r 
Thl .—' 	
Autoimmune 
2-Cys 	— — — — ~ AAM~~,S --------------►I 	disease 
peroxircdoxin 	 j 
Figur.17. The development of CD4 Th2 cell differentiation via innate cell recognition and 
response to parasite infection and the inhibiton of Thl-dependent autoimmune diseases. DC, 
dendritic cell; AAM , alternatively activated macrophage; IEC, intestinal epithelial cell; Eo, 
eosinophil; IL, interleukin; MC, mast cell; Th, T helper; TLR, Toll-like receptor; TSLP, 
thymic stromal lytnphopoietin.(Courtesy: Fukumoto, 2009 ) 
Besides many roles, AAM(Ds is involved in the immune regulation during 
helminth infection. Peritoneal administration of Brugia malayi L3 can elicit AAMOs 
with potent T cell suppressive properties (Nair et al., 2005). In addition, In vitro 
studies suggest that the T cell proliferation is independent of IL-10 and CTLA-4 but 
partially depends upon transforming growth factor (Taylor et al., 2006). Thus AAMO 
is more important in suppression of Thl type of immune response than its 
involvement in promotion of Th2 type of response, including Th2 cells. 
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Role of helminths infection in autoimmune prevention 
Helminthes or their derived products have been used as therapeutic agent 
against several autoimmune diseases such as 113D, diabetes, RA etc (Table.5). 
Increased type I diabetes in developed countries directly coincides with decrease in 
helminth infection (Gale, 2002). 
It has been studied that the infection with S. mansoni, T spirals and 
H polygyrus significantly protect from type I diabates in non obese diabetic mice 
(Cooke et al., 1999). The reason behind this protection might be due to the skewing of 
disease associated ThI type of immune response towards the anti-inflammatory 1h2 
type of immune response signature by IL-4, IL-5, IL-10 and IL-13 cytokine 
production (Zaccone et al., 2003). Uses of Schistosoma eggs against experimental 
auoimmune encepahalomylitis reduce the disease severity (Sewell et al., 2003) and 
also prevent experimentally induced colitis (Elliott et al, 2003b) and diabetes in 
nonobese diabetic mouse model (Cooke et al, 2004; David et al., 2004). 
Thl type pro-inflammatory response is predominant during autoimmune disease 
which can be strongly skewed towards anti-inflammatory Th2 type of immune 
response by helminth infection, in Crohn's disease. Crohn's disease and ulcerative 
colitis have high prevelance ranging from 10- 200 per 100,000 individual per year in 
North America and Europe (Bouma et al., 2003). IRD leads substantial morbidity and 
decrease the quality of life because it begins early and persist for long period 
(Blumberg et al., 2001). 
T spiralis ameliorates subsequent hapten-induced colitis in mice which is 
associated with a down regulation of the Thl response (Khan et al., 2002). It is also 
found that Trichuris ova therapy is effective against both Crohn's disease and 
ulcerative colitis without any adverse effect (Summer et al., 2005). Furthermore the 
increased expression may be suggestive marker for therapeutics against the Crohn's 
disease (Rimoldi et al., 2005) because it is found from the biopsies of patients with 
Crohn's disease that there was a decreased expression of TSLP. Thus TSLP-TSLPR 
pathway can be used as a potential therapeutic target for variety of immune mediated 
diseases. 
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Table.5. Helminth injections or products that prevent autoimmune diseases in animal 
models or humans 
Animal Model 	Helminths 	 Agents 
Animal model 
Type I diabates 	SchuYacoma 
S. mansoni 
ThickIn is spiralis 
encephalitis 
Collagen-induced 
arthritis 
Experimental colitis 
Human diseases 
[Bp: Crohn's disease 
f RIT. 
ulcerative colitis 
S. mansoni 
Acanthoeheilonema 
viteae 
S. mansoni 
S. mansoni 
Hcligmosomoides 
polygyrus 
Hymenolepis diminula 
7: spiralis 
Trichuris suis 
Inicction 
SWA, eggs or SEA 
Infection/Recombinant 
antigens 
Eggs 
ES-62 
Infection 
Eggs 
Infection or transfer of 
MLN from infected mice 
Infection 
Infection 
Infection 
Infection 
7: suis 	 Infection 
Necaror americanus 	Infection 
T. suis 	 Infection 
ES-62, excretory/secretory products of 62 kDa; M. inflammatory bowel disease; 
MLN, mesenteric lymph node; SEA, soluble egg antigen; SWA, soluble worm 
antigen (Fukumoto, 2009). 
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Helminth infection and arthritis: 
It has been shown in above sections that the severity and concominaM disdease 
in mice (WV, colitis, airway hyper-reactivity, experimental encephalomyelitis etc.) 
can be prevented by the administration of helminth derived products or infection 
with the helntinthes (McKay. 2009). The effect of these hclminthes in different 
diseases is species and model specific, responsible for the inhibition of Thl 
cytokine production (Khan WI et at., 2002), induction of regulatory cytokine 
(e.g. IL-10 and TGF beta) (Hunter, 2005; Setiawan et al.. 2007) production of 
Foxp34 regulatory T cells (Grainger, et al., 2010), and activity of alternatively 
activated macrophages (Espinoza-Jimcncz et al., 2010). 
In case of RA it was first reported that nematode Syphacia obvelate infecting rat 
reduces CFA induced arthritis (Pearson, 1975). Infection with Heligmaeomvides 
polygvrus or Nipposirougyh's brasilrenses inhibit the spontaneous arthritis 
development by reduced incidence of arthritis and synovial hyperplasia in Murphy 
Rothe Large (MRL)lpr mice (Matisz et al., 2011) along with other features 
including pannus formation, cartilage erosion, and bone destruction 
(Slings-Caxmona et al., 2009). Infection with Schistosoma mansoni attenuates CIA 
induced arthritis in mice (Osad et al., 2009). Osada et al. demonstrated that after 
immunization with parasite the level of IgG2a and Foxp3 mRNA. involved in 
pathology of CIA, significantly decreased in S. mansoni infected CIA+ mice. 
Recent studies show that the infection with rat tapeworm, Hymenolepsis dinlinuta 
significantly attenuates CIA with reduced joint inflammation (Shi et al., 2011). 
Therapeutic effect of unisexual (worm only) and bisexual (worm+egg) Schistosoma 
japonicum has been shown on CIA at the level of arthritis score joint histology and 
Thl/Th2 level (Song et al.. 2011). H. diminula infection can also attenuate the CIA 
by significantly inhibiting outcome of disease (Loc. cit.). Taken together the overall 
view, it can be concluded that generalization cannot be made with regard to the role 
of different helminth derived antigens in autoimmune disorders at this stage since 
knowledge about a number of helminth species including the liver flukes is either 
nonexistent or very limited. Therefore in this preliminary study an attempt has been 
made to fill in sonic gaps and lacunae to understand the role of liver fluke antigens 
in ameliorating the inflammatory condition in experimental autoimmune disorder 
i.e. Collagen Induced Arthritis (CIA) established in the lab with whatever limited 
facilities and resources available to accomplish this study. 
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CHAPTER 3 
2.3-MATERIALS & METHODS 
2.3.1. Preparation of Fasckila gigrrntica and Gigantocotyle explanatum cell free 
somatic extract for treatment 
The adult live worms were obtained from infected Indian water buffaloes, 
slaughtered at the local abattoir. Both the flukes were separately washed five times in 
Hanks' Balanced Salt Solution (HBSS) and then one more time with 100mM 
phosphate buffer saline (PBS), pH 7.4. containing 0.5% antibiotic/antimycotic 
solution (Hiniedia) to remove other microbes. After that worms were incubated in 
water bath at 37°C for l hour to allow regurgitation of gut contents. These worms 
were homogenized in 100mM PBS, pH 7.4.The homogenate was centrifuged at 
I0000xg for 30 minutes. The supernatant was aliquoted and stored at -80'C. The cell 
free supernatants were designated as'Fg for F, gigantica,'Ge' for G. explanatum and 
their combined preparation in the ratio of 1:1 was designated as '(IF' which were used 
as antigens !'or immunization. 	Before every use of these antigens, protein 
concentration was determined by the method of Spector (1978). 
2.3.2. Animal Model 
All the animal based studies were carried out on female Wistar rats, each 
weighing around 200g, were procured under the license of Department of 
Biochemistry, AMU, Aligarh and maintained as per the guidelines of CPCSEA. The 
Animals were maintained under standard conditions at 25+2 'C temperature and 
l I± I hours dark and light cycle, in the Animal House of the Department of Zoology, 
AMU, Aligarh fulfilling all the necessary criteria for animal maintenance. The 
animals were fed ad libitum on commercial pellet diet and clean water, recommended 
for rats. 
2.3.3. Induction of Collagen Induced arthritis (CIA) 
There are many models to study the progression and development of rheumatoid 
arthritis (RA) but collagen induced arthritis model is more important as it shares both 
immunological as well as pathophysiological feature with human RA. CIA model was 
developed according to the previously described protocols of Ilagqi et al. (1999). 
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Preparation of antigen emulsion (Timing 25 minutes) 
The chicken collagen type II (kind gill from Prof. Hagqi, USA) (2mg/ml in 
(L05M acetic acid) and CFA (Complete Freund's Adjuvant) were taken in a ratio of 
1:1 to prepare a water in oil emulsion, which was prepared in extra amount owing to 
both loss during preparation and the dead space in the syringe during injection, while 
100µl was used for injection. All the reagents were kept on ice to avoid the heat 
generation which could cause collagen denaturation. 
ImmunizaI tion 
Rat 9 were immunized with 100µI of emulsion intra dermalty (i.d.) at the base of 
the tail for 21 days, the time period required to produce prominent level of CIA. 
2.3.4. Treatment with Fasclota gigantiea (Fg), Gigantocotyle explanation (Ge) and 
combination of both (GP) somatic antigens (Ag). 
. The experimental rats were divided into five groups: Goroup I was given 
CIA+Facciola gigantica Ag (CIA+Fg-Ag) antigen, Group 11 was given 
CIA+Gigantocotyle explanatum antigen (CIA-4-Ge-Ag) and Group III was given 
CIA+Gigantocotyle-Fascinla (CIA+GF-Ag) combined antigen, Group IV contained 
CIA positive control (5 Rats), Group V also contained 5 Rats as a vehicle control 
where PBS was injected. The treatment groups- 1, 11 and 111 were divided into three 
subgroups according to three doses (50ug, 100µg and ISOpg) of each of the 
respective antigens i.e. Fg-Ag (Fg50, Fg100 and Fg150), Ge-Ag (0e50, Ge100 and 
Ge150), GP-Ag (GF50, GF100 and (F150) used for treatment. In treatment groups 
the rats were primed subcutaneously (Sc) one day (designated as -ID) before the day 
(designated as OD) of CIA induction and the treatment was continued subcutaneously 
daily with respective antigens up to 21 days. The schematic diagram of CIA 
induction and antigenic treatment is shown in Fig. I. 
2.3.5. Measurement of Paw thickness 
The measurement of paws was carried out with the help of digital vernier 
caliper by independent observer with no knowledge of the treatment protocol. The 
measurements were taken in mm and started from 7` day of CIA induction upto 21 
days. 
2.3.6. Collection of serum from Wistar Rats 
Serum was collected from vehicle control, CIA control and all the three groups 
in exactly similar manner. Briefly, blood was collected from all the groups by cardiac 
puncture with 5 ml syringe fitted with 22 gauge needle. The blood was stored, for 
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5-10 minutes at room temperature (RI) and then at 4°C for 2-3 hours, in 3.0 ml clot 
activator scrum collection vials. The vials were centrifuged at 3200xg for 10 minutes 
at 4°C and serum was aliquoted and stored at - 80°C until it was used for various 
studies. 
Experimental Design anti Schedule of treatment 
CIA 
Inimi,oa 	 Disease Severity 
lftq9ier. nL (Srmptmns begin 
1999 	 from 11 to 12 days) 
Anngru 
vrnulut KneelS4 t ring 
-IDOD 	 ID 	11D 14D 	 21D 22D 
T 
Antigen treatment with the dirferent concentratloas(SOpg, 	 Serum& 
	
IOOpg, 150µg)o fFg-Ag, Ge-.&g& GF-Ag 	 Joints 
Collection 
Groups (Fg-;lg Immunized) 	Groupli (Ge-Ag Inrmunixged) 	GruupILl(GF-Ag ImWmmmad) 
Three Sub Groups (SGs) 	Three Sub Groups(SGs) 	Three Sub Groups (SGs) 
SGI:5 Rars(CIA+5Opg Fg-Ag) 	SG I:5 Rats(CIA+<.Opg:Ge-Ag) SGI:5Rats(CIA+50pg:GF-Ag) 
SG Il: 5 Rats (CIA+l 00pgTS-Ag) SG II: t  Rats (CIA+100pg:Ge-Ag) SG D: 5 puts (CIA+100pg:GF-Ag) 
SG 111: 5 Rats(CIA+150pg.Fg-AS) SG11I: 5 Rats (CIA+150pg. Gc-Ag) SG II1: 5 Rts(CLtl 5Opg, OF-Ag) 
Figure.t. The schematic diagram of experimental design showing CIA progression and schedule of 
Treatment with liver fluke antigens. D: Day of treatment, CIA: Collagen induced arthritis. 
2.3.8. Serum Cytokine Assay 
The cytokines of interest were analyzed as per the instructions provided for 
using CBA kit (BD bioscience). Briefly, to detect the analytes of interest i.e. 
cytokines, the Rat Soluble Protein Flex Set Standard was prepared by pooling all the 
standard i.e. of IL-4, IL-l0, IFN-y, '1NF-u, in a 15 ml polypropylene tube and 
reconstituted with Assay Diluent provided with kit. It was labeled as a `Top 
Standard'. From this top standard we diluted the Rat Soluble Protein Flex Set 
Standard upto 1: 256 by serial dilution. The approximate dose (pp/ml) at each dilution 
was provided in kit instruction guide. After standard preparation we mixed the Rat 
Soluble Protein Flex Set capture beads of known cytokines according to the 
experimental requirement as each tube of known and unknown sample required 50 µl 
of diluted beads. These CBA beads were ready to transfer into the assay tube. The Rat 
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Soluble Protein Flex Set Detection Reagents was also prepared in the same way as the 
capture beads. For performing the assay 50pl of standards from each standard as well 
as rat serum sample at the dilution of 1:4 was mixed gently with 5Oµ1 of Capture 
Beads in separate tubes. The tubes were incubated for 1 hour at room temperature. 
Now 50µ1 of detection reagent was added and mixed again gently and incubated at 
room temperature for 2 hours.  After that Indof wash buffer provided in the kit was 
added to each tube and centrifuged at 200xg for 5 minutes. The supernatant was 
aspirated very carefully and discarded from each tube. At last 300µI of wash buffer 
was added to each tube and vortcxcd to resuspend the beads and then samples were 
analysed on LSR 11 Flow Cytometer at BD FACS Academy, Jamia Hamdard Central 
University, New Delhi. The data was analyzed using FCAP ARRAY software version 
3.0. 
2.3.9. Immuno Blotting (Dot Blot, Western Blot) of NF kappa B, MMP13 and 
MMPS of joints extract 
2.3.9.1 Preparation of Nuclear extract of the joint for NF kappaB p65 analysis 
The paws from Wistar Rats were incised outjust above and below the ankle and 
the skin was removed. The joints were snap frozen in liquid nitrogen and pulverized. 
Nuclear extract was prepared according to the method as described by Schreber et al. 
(1989) with some modifications. Homogenization of tissue was performed using 3m! 
buffer A(lOmM HEPES.pH7.9 ,1.5nnM MgCl2, IOmM KCI, 1mM DTT, I mM PMSF 
and 0.1% Nonidet P-40). The supernatant was discarded after incubation on ice for 15 
minute and centrifugation was carried out at 850xg at 4° C. The pellet was then 
resuspended in 4 ml buffer A without NP-40. The samples were centrifuged and 
supernatant was discarded again. After that I00u1 Buffer C (25%v/v glyccrol,20mM 
HEPES,ph7.9,.42ruM NaCI, 1.5mM MgCl,, 2mM EDTA, pH 8.0, 1mM EDIT and 
1mM PMSF), was added to the pellet and samples were placed on a rocker for 30 
minute at 4°C. The supernatant was aliquoted and stored at -80°C. The protein 
concentration was determined by the method of Spector (1978). 
2.3.9.2. Joint's tissue homogenate preparation for MMPs analysis 
Joints were macerated with mortar and pestle, in 50mM tris- HCI buffer, pH-7.6 
and 0.1% Triton X-100 and then homogenized in Teflon tissue homogenizer. 'fhe 
crude extract was sonicated with 3 pulses of 10 seconds keeping the samples on ice. 
Homogenate was either centrifuged at 10,000xg for 10 minutes at 4°C or at 5000xg 
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for 5 minutes at 4°C depending upon requirement. Supernatant was aliquoted and 
strored at — 80°C until use. 
2.3.9.3. Dot Blot analysis of NFkappB p65, MMP-13and MMP-8 in joint's extract 
Dot blot technique was used to detect the protein of interest on a PVDF 
(Polyvinylidene fluoride) membrane. In the present study we performed the dot blot 
of three protein markers namely- NP kappa p65. MMP-8 and MMP-13. A 341 sample 
containing 10.5µg protein was spotted on to PVDF membrane strip charged with 50% 
methenol for 2-3 minutes. The membrane was left to air dry. The membrane was kept 
in blocking buffer (5% BSA in 50mM PBS-T) for I hour at room temperature. After 
that membrane was washed 2-3 times (2 minutes) with PBS-T. Furthermore 
membrane was incubated with anti rat primary antibody produced in rabbit 
[NFkB p65 or MMP-13 or MMP-8 (Abeam) according to the need] at the dilution of 
1:8,000 for 2 hours followed by 2-3 washing steps and incubation with alkaline 
phosphatase conjugated anti rabbit secondary antibody (sigma) at the dilution of 
1:10,000 for 2 hours, Membrane was washed again with PBS-£ and incubated with 
BCIP/NBT detection reagents and monitored until strong color developed and then 
reaction was slopped with tap water. The spots showing different colour intensity on 
the membrane were scanned on a scanner (Samsumg) and percent pixel density was 
calculated by freely available ImageJ software, National Institute of Health. USA. 
2.3.9.4. Western Blot Analysis of NFkappaB p65, MMP-13 and MMP-S of joint 
extract 
The western blot was done by following the protocol of Towbin (1979) with 
certain modifications. Briefly. SUS-PAGE was performed by the method of Lacmmli, 
(1970) on a mini-Protean system (Bio Rad) using 11% resolving gel. TEMED and 
10% ammonium persulphate were always used fresh during gel polymerization. The 
resolving gel was allowed to set for 35-40 minutes. After polymerization of resolving 
gel a 5% stacking gel was poured and comb was inserted. The gel was allowed to 
polymerize f'or 25-30 minutes. The combs were removed from the gels, which were 
then transferred from the casting rig to the electrophoresis chamber containing 
lx electrophoresis buffer. Protein samples from joint's cell free suspension for 
MMP 13 (20 µg) and MMPR (20 µg) and for NFk B p65 from joints (55 tg of protein) 
were loaded into the wells alongside prestained protein markers in separate wells. 
Electrophoresis was performed at I00 V for 3-4 hours or until tracking dye began to 
run off from the end of the gel. Gels were carefully removed from electrophoresis 
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chamber and washed in distilled H2O and the 5% stacking gel was cut away and 
discarded. This SDS PAGE separated proteins were blotted on to activated PVDF 
blotting membrane using a semi drying assembly (Bio-Rad). Membranes were 
blocked for 2 h at room temperature with 5% BSA prepared in PBS-T. After that the 
membranes were washed in PBS-T (PBS-T) and incubated overnight at 4°C with the 
respective primary antibody at a dilution of 1:6000 [i.e. rabbit anti rat polyclonal to 
NFkB p65 or rabbit anti rat polyclonal to MMP-13 or MMP-8 (Abeam)]. The 
membranes were again washed with PBS-T buffer 3 times and incubated with goat 
anti rabbit IgG I-IRP conjugated secondary antibody (1:8000) prepared in PBST. The 
immunoreactive bands were detected by enhanced chemiluminance detection (ECL) 
kit (sigma). The blots were reprobed with an antibody for [3-actin as a control for 
equal protein loading and transfer. The image of protein bands were taken on Image 
Gel Documentation System (Bio-Rad) and percent pixel density was calculated using 
freely available software Image J. National Institute of Health, USA. 
2.3.10. Enzyme Linked Immunosorbent Assay (ELISA) NFkappaB p65, MMP-13 
and MMP-8 of joints extract 
ELISA was done to detect NFkB p65, MMP13 and MMP-8 level in joints. 
Briefly, the 1 75n protein (whole joint homogenate in case of MMPs and nuclear 
extract in case of NFkB p65) was poured in each well in duplicate taking every care to 
avoid any handling or experimental anomaly, and incubated over night at 4°C. The 
wells were washed three times with washing buffer, lx PBS containing 0.05% 
Tween-20 and incubated with 1001.11 of blocking buffer, 5% dry skimmed milk, for 
overnight and after that washed again 3-4 times. After blocking the nonspecific 
binding sites, 501.11 of anti rat primary antibody (1:6000) was poured and incubated 
over night. Thereafter washed again three times with washing buffer and incubated 
with 501.11 alkaline phosphatase conjugated anti rabbit secondary antibody for 75 
minutes. Reaction was stopped with 1M NaOH solution and absorbance was recorded 
at 415nm on iMark Micro Plate Reader (Bio Rad). The activity of NFkB p65, 
MMP-13 and MMP-8 was calculated by the following formula: 
Activih'/ minute = A,- Ah / Incubation times in detection reagent 
Where A, is the sample absorbance, while An is absorbance of blank 
2.3.11. Substrate Gel Zymography of Matrix Metalloproteinases of joint's extract 
SDS polyacrylamide gels containing gelatin (I mg/ml) were used to identify 
proteins with gelatinolytic activity of the joint tissues. This method detects both 
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activated and zymogen forms of MMPs. The presence of SDS in the gels induces 
conformational changes. After electrophoresis, gels were incubated in 2.5% 
TritonX-100 (2 x 15 min) of a shaker to remove SOS. Afer that gels were incubated 
overnight at 37°C in 50 mM Tris-HCI, pH 7.4. containing 10 mM Calcium chloride 
and 0.05% Brij 35 (Sigma). Gels were then fixed and stained with Commassie 
Brilliant Blue R 250 (Sigma Chemical). Gels were scanned on Gel Documentation 
system (Bio-Rad) and pixel percent density was calculated with the help of lmageJ 
software, National Institute of Health (NIH), IISA. 
2.3.12. Nitric oxide assay (Griess Reaction) of joint extract 
Nitric oxide (NO) level was determined by the method of Sajad or al. (1999) 
using the Griess Reagent System (Sigma). NO is an important physiological 
messenger and effector molecule in immunological systems (Bredt and Snyder, 1994). 
NO assay of joint extract was determined to know the change in its level in the 
inflamed joints following treatment. The stock solution for nitrite standard was 
prepared at the concentration of 0.IM in PBS and 100 p.M nitrite solution was 
prepared by diluting stock solution in 1:1.000 in matrix (buffer which was used for 
sample preparation) used for experimental samples. Standard was prepared in 
triplicate in 96 well ELISA plate by serial dilution with dilution factor of 0.5. 
Absorbance value was recorded at 540 nm. Standard curve was plotted against known 
dose of nitrite and change in OD was measured. 
The cell free suspension ofjoint extract was prepared for NO detection and 50µI 
of experimental sample was poured in 96 well ELISA plate in triplicate. After that 
100µ1 of Griess reagent (0.04g/ml) was layered by multi channel pipette quickly. 
Sample was incubated at room temperature for 5- 10 minutes in dark. The reading 
was taken at 540nm on iMark Elisa Plate Reader (BioRad). The level of NO QrM/ mg 
protein) in unknown sample was measured by comparing with standard curve. 
2.3.3.12. Superoxide disnrntase assay of Joint extract 
SOD level in CIA rats alter treatment with different doses of different antigens 
was measured according to the method of Marklund & Marklund (1974). Briefly, 
50µl sample solution (Joint homogenate) was added to 2.85 ml of 50mM 
Tris-Cacodylate buffer, pH 8.5. containing 1mM diethylenetriaminepentaaceticacid 
(DTPA) and ImM EDTA. The resulting solution was thoroughly mixed and kept at 
25°C for 10 minutes. After incubation the reaction was initiated by addition of 0.01 ml 
of freshly prepared 2.6mM pyrogallol in 10mM HCI to attain a final concentration of 
134 
P2C3: C7ttatenarciMetfiod1 
0.13mM in assay mixture. The mixture was transferred to a 3.5 ml cuvette and the rate 
of increase in the absorbance was recorded for 30 minutes after an initial lag of 30s, at 
420 ran on UV- 1100 spectrophotometer (Taurus Scientific). SOD activity was 
calculated by the following formula: 
SOD activity=(A-B/Ax50) x 100 
Where; A= OD of control, B= OD of sample 
Specific activity of SOD was determined as unit/mg protein. 
2.3.14. Glutathione-S-Transferase (GST) activity in Joint's extract 
The conjugation of GST with reduced glutathione was measured by the method 
of Habig (1974) with slight modifications. Briefly, 2.55ml of 0.IM sodium phosphate 
buffer, 0.3m1 of 1mM reduced glutathione and 0.lml of 1mM CDNB was taken in a 
test tube, then 50µI of sample (Joint homogenate) was mixed and the change in 
absorbance was recorded at 280nm for 3 minutes with an initial lag of 30 seconds, on 
UV-1100 Spectrophotometer (Taurus Sciuentific). Specific activity of GST was 
calculated in terms of Unitimg protein by using molar extinction co-efficient of 
0.0096 µM' tcm"'. 
2.3.15. Catatase Assays 
The catalse activity was assayed by the method of Aebi (1983). Briefly, reaction 
mixture contained 2.65m1 sodium phosphate buffer (50mM) 0.3m1 of 30mM 01 11202 
and 50µI of sample (Joint homogenate) was subjected to spectrophotometric analysis 
and the change in OD was recorded at 240mn wave length on UV-1100 
Spectrophotometer (Taurus Sciuentific). The specific activity of Catalase was 
calculated as UniUmg protein using 43.1 M'cm' as a molar extinction coefficient. 
2.3.16. Lipid Peroxidtion in Joint (measurement of MDA) 
MDA estimation is one of the most reliable products to assess the extent of lipid 
peroxidation. Its level was determined by the procedure of Buege and Aust (1978). 
The reaction mixture was made upto 0.5 ml homogenate with equal volume of TBA 
(0.67%) and TCA (30%) in centrifuge tubes that were incubated in a boiling water 
bath for 20 minutes. fhe tubes were later centrifuged (5000xg) for 15 minutes at 4°C. 
The absorbance of the pink supernatant was taken at 530 nm. The level was expressed 
in nmoles of MDA formed per mg of protein by using molar extinction co-efficient of 
1.56x10-5M-' cm' for MDA-TBA colored complex. 
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2.3.17. Protein Carbonylation in Joints 
The measurement of protein oxidation was carried out by the estimation of total 
carbonyl content in the sample by the method of Levine et al., (1994). A total of 1 ml 
of sample was mixed with 0.4 ml of ice cold 40% TCA followed by centrifugation at 
4°C for 10 minutes at 12000xg. The pellet was further dissolved in 0.2 ml of PBS 
(100 mM, pH 7.4) in which 0.4 ml of DNPH (20mM prepared in 4 N 1-ICI) was added. 
This reaction mixture was incubated for 1 hour at 37 °C on a shaking water bath 
followed by centrifugation at 12000xg and then the pellet was further mixed with 
0.35 ml of 40% TCA and again centrifuged at f2000xg. Then, the pellet formed was 
washed thrice with 1 ml of mixture of ethanol and ethyl acetate (1:1; v/v). Finally, it 
was dissolved in I ml of guanidine-HCl (6M) and its absorbance was taken at 360 and 
280 ma against guanidine MCI as blank. The carbonyl content was expressed in 
nmoles per mg of protein using molar extinction co-efficient of DNPH as 
1100 M-1  cm-1. 
2.3.18, Scanning Electron Microscopy (SENI) of Patella 
Joints of interest were dissected out and patellae were removed in such a way 
that no damage should occur to the articular cartilage and synovial lining. Patellae 
were fixed in 2.5% gultaraldehyde / paraformaldehyde (Sigma) for 24 hours at 4°C. 
Further sample preparation was performed at the national EM facility at All India 
Institute of Medical Sciences (AIIMS), New Delhi, India. The gold coated samples 
were safely brought to Aligarh and visualized on Jeol Scanning Electron Microscope, 
Model-6510 at the I Jniversity Sophisticated Instrumentation Facility, Aligarh Muslim 
University, India, and the digital images were saved. 
2.3.19. Histological Examination of rat joints 
CIA creates severe pathological conditions with excessive damage of synoviunt 
and cartilage. Therefore, the histopathological examination of joints is very important 
to see the extent of damage as well as protective effect of parasitic products, if any, at 
the termination of experiments. Rat knee joints were dissected, skin and muscles were 
carefully removed. Joints were dissected taking all the necessary care to avoid the 
damage to the synovial membrane and cartilage and were fixed separately in 10% 
neutral buffered formalin for 24 hours. After fixation tissues were washed 3 time with 
I xPBS, pH-7.4. Now the bones were decalcified with S% nitric acid for 20 days. 
After decalcification the specimens were rinsed with tap water and transferred into 
ammonia solution for 30 minutes to neutralize the acid left in specinmens. Now tissues 
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were washed in running tap water for 24 hours. Decalcified bones were processed for 
routine paraffin embedding (Durie et at., 1993). Tissue sections (5µ) were stained 
with haematoxylin and eosin for light microscopic examination. 
2.3.20. Statistics and data analysis 
The data was subjected to One Way ANOVA, using Tukie's Comparision Test 
by using GraphPad Prism 5 software. The values were presented in McanfSE. The 
level of significance with the p value less than 0.05 was considered as statistically 
significant. 
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CHAPTER 4 
2.4-RESULTS 
The results of this study are summarized in tables 2.4.1 to 2.4.7 and figures 
2.4.1.1 to 2.4.8. The apparent symptoms and clinical score of the arthritic paw 
(Fig. 2.4.1.1 to 2.4.1.3) of experimental rats clearly showed the successful 
development of collagen induced arthritis, thereby successful establishment of 
laboratory model of inflammatory disease. 
The serum level of pro-inflammatory and anti-inllatnmatory cytokines is used to 
assess the disease status in human as well as in animal models of different diseases 
including collagen induced arthritis (CIA). The two types of cytokines, Thl and Th2 
type, have antagonistic effect on each other. The anti-inflammatory cytokine IL-10 
has immunosuppressive potential for Thl cytokines. But is has been also investigated 
that IL-10 has immunoregulatory role and thus exert a balance between Th1/Th2 
paradigms. Besides this matrix metalloproteinases also play a very important role in 
disease progression. TNF-u pro-inflammatory cytokine also plays an important role in 
disease exacerbation by upregulation of MMPs which are involved in degradation of 
extracellular matrix in cartilage of affected joints and by many other ways. The 
intlammatory condition also produces the oxidative stress that disbalance the 
protective antioxidant mechanism and results into the excessive accumulation of nitric 
oxide and reactive oxygen species such as super oxide ions, hydroxyl ions etc. The 
expression of different mediators is achieved by a chain of signal transduction 
pathways and transcription factors including NFkB, API in rheumatoid arthritis. In 
the present study we assessed two anti-inflammatory cytokines (IL-l0 and IL-4) and 
two pro-inflammatory cytokine (IFN-y and TNF- a) to establish host serum 
environment along with the immunoblot analysis of transcription factor (NFkB-p65), 
immunoblot and zymographic analysis of some MMPs along with pathological 
markers like SOD (Super oxide dismutase), GST (Glutathione-S-tranasferase), 
catalase, NO (Nitric Oxide), MUA (Malondialdehyde) and PC (Protein 
carbonylation), SEM (Scanning Election Microscopy) of patellae, histology of 
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synovial membranes were done for the understanding of experimental disease (CIA) 
progression and then evaluation of the therapeutic or preventive potential of different 
doses of Fasciola gigantica somatic antigen (Fg-Ag), Gigantocotyle explanaluna 
somatic antigen (Ge-Ag) and combination of both the somatic antigens i.e. 
Gigantocotyle-Fasciola antigens (OF-Ag) in collagen induced arthritis (CIA) in 
Wistar rats. The overall results of the present study appeared to be very promising 
towards therapeutic efficacy of the liver fluke antigens in Wistar rats suffering from 
the collagen induced arthritis, which shares many similarities with rheumatoid 
arthritis in humans. 
2.4.1. Assessment of disease (CIA) severity by measurement of paw thickness 
with the help of digital vernier caliper. 
The,results of the present study clearly revealed successful induction of arthritis 
in Wistar rats by inoculation of purified typell collagen as evident from classical 
symptoms like difficulty in movements, redness of paws, joints and enormous 
swelling due to edema, giving significantly high clinical scoring (Fig. 2.4.1.1 to 
2.4.1.3). 
2.4.1.1. Changes in paw thickness after the treatment with Fasciola gigantica 
antigen 	(Fg-Ag). 
There was a significant disease remission in F. gigantica antigen treated rats in 
terms of paw thickness. The maximum protection was achieved at 150µg of Fg-Ag 
compared with CIA rats where sever swelling was recorded. There was decrease in 
swelling in paw after treatment with different doses (50µg, 100pg and 150µg) of 
tropical liver fluke derived antigens (Fig.2,4.1.1). 
2.4.1.2. Changes in paw thickness after the treatment with Gigantocotyle 
explanatum antigen (Ge-Ag). 
There was a significant disease remission in G. explaoatum antigen treated rats 
as well in terms of paw thickness. The protection level was near to the vehicle control 
at different doses of Ge-Ag compared to CIA rats where sever swelling and redness 
was recorded. The swelling and redness in paw was significantly reduced alter 
treatment with different doses (50pg, 100µg and 150µg) of this amphistome derived 
antigens (Fig.2.4,1.2). 
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2.4.1.3. Changes in paw thickness after the treatment with Gigantocotyle-Fasciola 
combined antigens (GF-Ag). 
There was a significant disease remission in Fasciola-Giguntica combined 
antigen treated rats in terms of paw thickness. The protection level was significantly 
high at different doses and it was close to the healthy control compared to CLA rats 
which showed significant swelling reflecting severity of the disease, was recorded. 
The swelling and redness in paw was almost nil after treatment with different doses 
(50µg, 100µg and 150pg) of the combination antigens (Fig.2.4.1.3). 
2.4.2. Serum cytokines analysis following collagen induced arthritis (CIA) in 
Wistar rats treated with different doses of F. gigantica antigen (Fg-Ag), 
G. explanaturn antigen (Ge-Ag) and the combined antigens (GF-Ag) of the two 
worms. 
The level of IL-10 control rats was 1081± 153.6 and in CIA rats it was slightly 
increased to 1271+ 35.4lpg/ml, whereas it increased significantly at all the treatments 
of Fg-Ag, Ge-Ag and GF-Ag. The level was increased almost three fold to 
3678 ± 189.0, 2687± 100.4 and 4010± 290.1 pg/ml when exposed to three different 
doses, 50µg, 100pg and 150µg, of Fg-Ag respectively, showing non dose dependent 
response (Table 2.4.1and 	Fig. 2.4.2.I.a), whereas in Ge-Ag exposed rats the level 
was 1901± 188.7, 2705± 1.335 and 2050± 154.3 against the three doses respectively 
(Table. 2.4.1 and Fig.2.4.2.2.a). The level of IL-10 was also increased significantly in 
rats exposed to all the three doses of OF-Ag (Table. 2.4.1 and Fig.2.4.2.3.a). 
The scrum IL-4 level in vehicle control rats was 1170+ 0.6100 41pg/ml and in 
CIA rats it was increased to 26.76± 1.480 41pg/ml, which further increased to 
128.1+ 3.525, 327.1± 27.32 and 229.5± 27.44 pg/mI when exposed to 50ug, 100µg 
and 150pg of Fg-Ag respectively, showing a non dose dependent trend (Table 2.4.1 
and Fig. 2.4.2.1.b), whereas in Ge-Ag exposed rats the level was 50.30± 0.325, 
220.6± 21.67 and 232.1 1- 13.64 pg/ml at three different doses showing dose dependent 
increase (Fable.2.4.1 and Fig. 2.4.2.2.b). the IL-4 level in response to OF-Ag 
significantly increased but not in a dose dependent manner (Table. 2.4.1 and 
Fig.2.4.2,3.b). 
The level of pro-inflammatory cytokine IFN-y in vehicle control rats was 
40.11± 0.4500 pg/ml, while in CIA rats it almost increased more than three folds to 
150.1' 9.745 pg/ml but its level remained at 71.91± 16.29, 61.75± 10.16 and 
64.88± 15.97 pg/m] when exposed to 50µg, 100µg and 150µg of Fg-Ag respectively, 
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showing non dose dependent response (Table.2.4.1 and Fig.2.4.2.1.c), whereas in 
Ge-Ag exposed rats the level was 59.08± 10.03, 42.77± 3.025 and 45.97= 16.06 pg/ml 
at three different doses showing non dose dependent effect of the amphistome 
antigens and the level of this cytokine remained significantly low in control as well as 
treated rats (Tahle.2.4.1 and Fig.2.4.2.2.c). The level in response to OF-Ag was also 
low as compared to CIA rats but the response to antigens was independent of dose 
level (Tahle.2.4.1 and Fig.2.4.2.3.c). 
The TNF-a level in control rats was 132.8 ± 2.310 pg/ml but in CIA rats it 
increased to 342.8± 8.440 pg/ml ,which then decreased to 274.9± 38.31, 133.8± 1.425 
and 118.1] 49.91 pg/ml, when exposed to 50ug, 100µg and 150µg of Fg-Ag 
respectively, showing somewhat dose dependent decrease (Table.2.4.1 and 
Fig.2.4.2.1.d), whereas in response to Ge-Ag the level was 95.60±54.17, 169.0±28.55 
and 159.8±24.50 pg/ml at three different doses showing non dose dependent decrease 
(Table2.4.1 and Fig.2.4.2.2.d). The level in response to combined antigens GF-Ag 
was also retained close to the vehicle control but in a dose independent manner 
(Table2.4.1 and Fig.2.4.2.3.d). 
2.4.3. Imntunoblot (Dot Blot and Western Blot) analysis of transcription 
regulatory factor, NFkB p65 (Nuclear Factor kappaB p65), Matrix 
Metalloproteinases (MMP-13 and 8) in joint's extract of Collagen Induced 
Arthritis in Wistar rats treated with different doses of Faciola gigantic antigen 
(Fg-Ag), Gigantocotyle explanatum antigen (Ge-Ag) and their combined 
(Gigs iocatyle-Fasciola) antigens (CF-Ag). 
The pixel percent density (PPD) of Dot blot and Western blot of NFkB p65, 
MMP13 and MMP-8 was measured using ImageJ software available online. 
2.4.3.1. Dot Blot analysis of NFkappaB p65 in joint's nuclear extracts of Wistar 
rats after treatment with different doses of Faesciola giganlica antigen (Fg-Ag), 
Gigantocolyle explanatum antigen (Ge-Ag) and the combined antigens (GF-Ag).. 
The pixel percent density (PPD) of dot blots of NFkB p65 of control rats was 
8.332± 0.7405 and in CIA rats was 15.66+ 0.8375. In Fg-Ag treated rats the minimum 
pixel density (7.396+0.2635) was observed at 150µg dose and showing dose 
independwnt decrease in pixel density whereas in Ge-Ag exposed rats the pixel density 
(8.035±0.597) was minimum at 50µg dose and there was insignificant dose dependent 
difference between 50µg to 150µg of antigen dose. The combined antigens (OF-Ag) 
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also showed dose independent effect in pixel density. Overall results show a 
significantly low NFkB p65 level in all the treated rats without any significant trend 
when compared to the CIA rats (Table.2.4.2 and Fig.2.4.3.1), thus all the antigens 
used in the present study kept the nuclear factor level close to the level of healthy 
controls. 
2.4.3.2. Dot Blot analysis of MMP-13 in joint's extract of Wistar rats after 
treatment with different doses of Facsciola gigantica antigen (Fg-Ag), 
Giganfocotrle expianatem antigen (Ge-Ag) and the combined antigens (GF-Ag). 
The PPD of dot blots of MMP- 1 3 of control rats was 8.721± 1.153, whereas in 
CIA rats it increased more than three folds to 26.00± 2.898. In Pg-Ag and Ge-Ag 
treated rats, there was dose independent decrease in pixel density of MMP-13. In 
GF-Ag treated rats there was again non dose dependent decrease in pixel density 
(Table.2.4.3 and Fig.2.4.3.2), clearly showing that this protease activity remained 
under control by the immunization of rats with liver fluke antigens. 
2.4.3.3, Dot Blot analysis of MMP-8 in joints extract of Wistar rats after 
treatment with different doses of Facsciola gigautica antigen (Fg-Ag), 
Gigantocoryle gzplo:otam antigen (Ge-Ag) and the combined antigens (CF-Ag). 
The PI'D of dot blots of MMP-8 of control rats was 10.27 t 2.405 and in CIA 
rats, while it was 26.58± 2.080. In Fg-Ag and Ge-Ag treated rats there was dose 
independent decrease in pixel density of MMP-8 which showed a similar trend as 
MMP-13. Likewise in GF-Ag treated rats there was again non dose dependent 
decrease in pixel density as compared to the CIA rats (Table.2.4.4 and Fig.2.4.3.3). 
Like WIMP-13, the level of MMP-8 also slightly fluctuated at different antigenic doses 
but largely remained close to the vehicle control. 
2.4.3.4. Western Blot analysis of NFkB p65 in joint's nuclear extract of Wistar 
rats after treatment with different doses of Facsciola gigantica antigen (Fg-Ag), 
Gigantocotyle explar:a!oer antigen (Ge-Ag) and the combined antigens (GF-Ag).. 
The PI'D of NFkB p65 in control rats was 5.775± 0.5450 and in CIA rats it was 
increased more than four-fold to 2358-2.850, which decreased in dose independent 
manner in Fg-Ag, Ge-Ag and GF-Ag treated rats with minimum level near the vehicle 
(Table.2.4.2 and Fig.2.4.3.4). Though the nuclear factor level at some the treatments 
were slightly higher than the controls but still much lower as compared to the diseased 
rats. 
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2.4.3.5. Western Blot analysis of MMP-13 and MMP-8 in joint's extract of 
Wistar rats after treatment with different doses of Facsciola gigantica antigen 
(Fg-Ag), Gigantocotyle erplanarsm antigen (Ge-Ag) and the combined antigens 
(CF-Ag). 
The pixel density of MMP-13 in control rats was 8.883± 0.7630, but it was 
23.7912.549 in CIA rats. In Fg-Ag treated rats there was non dose dependent 
inhibition in MMP level while there was dose dependent decrease in MMP level in 
Ge-Ag treated rats with minimum level at 150µg of Ge-Ag, while in GF-Ag treated 
rats almost a plateau was maintained in response to all the three doses of combined 
antigens, thus retaining the protease level close to the control level (Table.2.4.3 and 
Fig.2.4.3.5)• 
The pixel percent density of MMP-8 in control rats was 2.046± 0.2945 and 
21.86± 1.881 in CIA control. The pixel density decreased in dose dependent manner 
in both Pg-Ag and Ge-Ag treated rats, while there was no dose effect in GF-Ag 
treated rats. Over all minimum pixel density was evident in Ge-Ag and GF-Ag treated 
rats (Tabl'c.2.4.4 and Fig.2.4.3.5). 
2.4.4. Enzyme Linked Immunosorbant Assay (EL1SA) of transcription factor 
NF kappaB p65 and matrix mctalloproteinases (MMPs); MMP-13 and MMP-8 
in joint's extract of Wistar rats after treatment with Facsciola gigantica antigen 
(Fg-Ag), Gigantocolyle explanatanr antigen (Ge-Ag) and the combined antigens 
(GF-Ag). 
Quantitation of various biomarkers was also determined by ELISA in terms of 
activity/minute. The results revealed that the different disease biomarkers used in the 
present study were depleted at different doses of antigen treatments. 
2.4.4.1. Enzyme Linked Immunosorbanl (ELISA) Assay of NFkB p65 in joint's 
nuclear extract of Wistar rats after treatment with different doses of Fg-Ag, Ge-Ag 
and GP-Ag. 
the NFkB p65 activity per minute was calculated in vehicle control, CIA rats 
and in treated rat's joints. The NFkB p65 activity in control rats was 0.0047k 0.0001 
and CIA rats was 0.0072= 0.0002 which was significantly dropped in Fg-Ag treated 
rats in dose independent manner at three different doses (50µg, 100µg and 150µg), 
whereas in Ge-Ag treated rats the activity was also insignificantly different at three 
different doses. The activity in GF-Ag treated rats was again dropped in dose 
independent manner with some inhibition at 150ug antigen, however, overall results 
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suggest significant decrease in activity of NFkB p65 at all the doses as compared to 
untreated rats with CIA alone (fable.2.4.2 and Fig.2.4.4.1). 
2.4.4.2. Enzyme Linked Immunosorbant (ELISA) Assay of MMP-13 in joints extract 
of Wistar rats after treatment with different doses of Facsciola gigantica antigen 
(Fg-Ag), Gigantocoryte explanation antigen (Ge-Ag) and the combined antigens 
(GF-Ag). 
The MMP-13 activity per minute was determined in vehicle control, CIA 
positive only and in treated rats. The activity in vehicle control and CIA joints was 
0.0015 f 0.0003 and 0.0060 i 0.00045, respectively. The activity in Fg-Ag treated 
rats was dropped in dose independent matmer with maximum inhibition at 150µg of 
antigen, whereas in Ge-Ag treated rats the activity was dropped again in dose 
independent manner with maximum inhibition at 100µg of antigens. Similarly, the 
activity under combined treatment (GF-Ag) was also significantly lower than the CIA 
rats. The overall results suggest a significant decrease in MMP-13 activity 
('rable.2.4.3 and Fig.2.4.4.2) as compared to non treated CIA rats, reflecting a 
protective potential of the liver Iluke antigens. 
2.4.4.3. Enzyme Linked Immunosorbant (ELISA) Assay of MMP-8 in joints extract 
of Wistar rats after treatment with different doses of Facsciola gigantica antigen 
(Pg-Ag), Gigontocotyle explunatum antigen (Ge-Ag) and the combined antigens 
(GF-Ag). 
The MMP-8 activity per minute was determined in CIA, vehicle control and in 
treated rat joints. The activity in vehicle control and CIA was 0.00I0f 0.0002 and 
0.00235+ 0.00025 activity per minute, respectively, while the activity in Fg-Ag 
treated rats as compared to CIA rats was dropped in non dose dependent manner with 
maximum inhibition at 150µg dose, and the level still remained close to the control 
level. A similar trend was observed in Ge-Ag and GF-Ag treated rats with an 
inconsistent trend. The overall results suggest a very significant inhibition of MMP-8 
at all the doses of different antigens used as compared to the rats suffering from CIA 
(Table.2.4.4 and Fig.2.4.4.3). 
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2.4.5. In gel zymography of different Matrix Metalloproteases (MMPs) (MMP-9,  
MMP-2 and MMP-13) in joint's extract of Wistar rats after treatment with 
Facsciola giguntica antigen (Fg-Ag). Gigantocolyle explunatam antigen (Ge-Ag) 
and the combined Gigantocotyle-Fasciola antigens (GF-Ag). 
Ryiuogram of matrix metalloproteinases (MMPs) in soluble joint's extract of 
Wistar rats following induction of CIA and treatment with different doses of Fg-Ag 
and GF-Ag have shown in (Fig. 2.4.5.1) and Ge-Ag in (2.4.5.2). In gel enzyme 
activity revealed the predominant presence of proMMP-9, activcMMP-9, proMMP-2, 
activeMMP-2 and MMP-l1 
2.4.5.3. Pixel percent density of pro MMP-9 in joints extract after treatment with 
F. gigantdca antigens (Pg-Ag), G. explanalum (Ge-Ag) and Gigantocotvle-Fasciola 
antigens (OF-Ag). 
The MMP-9 expression was determined in terms of percent pixel density (PPD)  
for comparison and it was calculated by using ImageJ Software. The both pro MMP-9 
and active MMP-9 were expressed in CIA. Pro-MMP-9 was not detected in vehicle 
control and also at most of the treatments. '[he pixel percent density in control as well 
as Ge-Ag and GF-Ag was almost zero, whereas in CIA rats it was 40.76 ± 4.952. The 
pixel percent density of pro MMP-9 in Fg-Ag treated rats was dropped in dose 
dependent manner with maximum inhibition at 150µg, which was considerably higher 
than the vehicle control. The overall results suggest a significant inhibition of 
pro MMPI -9 at various doses fluke antigens used in this study (Table.2.4.5 and 
Fig.2.4.5.6). 
2.4.5.4. The expression level in terms of pixel percent density of active MMP-9 in  
vehicle control and CIA rats was 6.110+0.3095 and 19.68 ±3.222, respectively, almost 
more than three folds higher in diseased rats. The level in Fg-Ag treated rats 
decreased in dose dependent manner with maximum inhibition at 150µg of antigen 
whereas in Ge-Ag and GF-Ag treated rats the level was dropped in dose independent 
manner. The overall results suggest the significant under expression of active MMP-9 
under the influence of different antigenic treatments (Table.2.4.5 and Fig.2.4.5.4). 
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2.4.5.5. Pixel percent density of pro-MMP-2 in joints extract after treatment with 
F. gigan1ica antigen (Fg-Ag). Cl. explanaium antigen (Ge-Ag) and Gigantocoryle-
Fasciola antigens (GF-Ag) (Fig.2.4.5.1-2.4.S.2). 
The pro MMP-2 was expressed in CIA, control and lower concentration of 
Fg-Ag and Ge-Ag treatment white in rest of the treatments pro MMP-2 did not show 
any expression. The pixel percent density in vehicle control was nil for pro MMP-2, 
while it increased to 26.15±1.950 in CIA rats (Fig.2.4.5.5). The pixel percent density 
in Fg-Ag treated rats was decreased in dose independent manner with maximum 
inhibition at 150µg of antigen whereas in Ge-Ag treated rats there was a dose 
dependent inhibition of pro MMP-2 expression with maximum under expression at 
150µg of antigen. In OF-Ag treated rats the expression of pro MMP-2 was not 
observed. The overall results suggest a very significant under expression of 
pro MMP-2 at dillerent antigenic treatments (Table.2.4.5 and Fig.2.4.5.5). 
2.4.5.6. The pixel percent density of active MMP-2 in vehicle control and CIA rats 
was 3.838±0.2380 and 22.02I.917, respectively. As compared to the CIA rats the 
band density significantly declined at three different doses of Fg-Ag in a dose 
independent manner, whereas the enzyme expression level in Ge-Ag treated rats 
decreased in a dose dependent manner. In OF-Ag treated rats the level was decreased 
in dose independent manner. The GF-Ag acted as a significant inhibitor of active 
MMP-2 at all the doses. The overall results suggest a very significant under 
expression of active MMP-2 at different antigenic treatments, particularly the 
combined antigens, which produced more pronounced inhibitory effects (Table. 2.4.6 
and Fig.2.4.5.6). 
4.4.5.7. Pixel percent density of active MMP-13 in joints extract after treatment with 
F. gigantica antigen (Fg-Ag), G. explanatum antigen (Ge-Ag) and Gigunlucoryle-
Fasciola antigens (GF-Ag). 
The percent pixel density of active MMP-13 in vehicle control and CIA rats was 
0.538510.1285 and 31.58±1.475 respectively, while the level was decreased in dose 
independent manner in Fg-Ag treated rats with maximum inhibition at 150µg. Again, 
the dose dependent inhibition of MMP-13 level was not observed in Ge-Ag treated 
rats. In GF-Ag treated rats the expression of MMP-13 was not evident. The overall 
results suggest a significant under expression of -MMP-13 at different antigenic 
treatments (Table. 2.4.5 and Fig. 2.4.5.7) when compared with the CIA affected rats. 
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2.4.6. The biochemical changes in joints extract of Wistar rats after treatment 
with Facsciola gigantica (Fg-Ag), Gigantocotyle explanotam (Ge-Ag) and the 
combined Gigantocotyle-Fasciola antigens (CF-Ag). 
2.4.6.1. The specific activity of Superoxide dismutase (SOD) in joint's extract after 
treatment with F. gigantica (Fg-Ag). G. explanalum (Ge-Ag) and combined 
Gigantocoiyle-Fasciola antigens (GF-Ag). 
Expression of superoxide dismutase is used as a marker for disease pathology. 
Under diseased condition the level of SOD depleted dramatically from normal 
condition. In the present study the SOD level was significantly dropped in CIA rats as 
compared to vehicle control. The level of SOt) in control and CIA rats was 
5.667 ±0.5783 and 1.800 +0.3464 unit/mg protein, respectively. The level of SOD in 
Fg-Ag treated rats was dramatically increased at three different doses (50µg, 100µg 
and 1501g) in somewhat dose independent manner, whereas the SOD specific activity 
in Ge-Ag treated rats was increased in dose dependent manner at three different doses 
used. The SOD specific activity in combined antigens ((IF-Ag) treated rats did not 
increase in dose dependent manner. The overall results suggest a very significant 
increase in SOD specific activity under different antigenic treatments (Table.2.4.6 
and Fig.2.4,6.1) indicating that the trematcdes antigens understudy might be 
promoting the anti CIA environment within the diseased rats. 
2.4.6.2. The specific activity of Glutatliione-S- transferase (GST) in joint's extract 
after treatment with F. gigantica 	(Fg-Ag), G. explanatum (Ge-Ag) and 
Gigantocotyle-Fasciola antigens (GF-A). 
The GST is another antioxidant biornarker which is used to assess the disease 
status in joints. The level of GST in vehicle control and CIA positive control was 
2.197± 0.2221 and 0.0690± 0.01801 respectively. the specific activity of GST in 
Fg-Ag, Ge-Ag and GF-Ag treated rats was increased in dose independent manner. 
The overall results suggest a significant increase in specific activity at different 
antigenic treatments (Table.2.4.6 and Fig. 2.4.6.2) 
2.4.6.3. The specific activity of Catalase in joints extract after treatment with 
F. giganlica (Fg-Ag), G. explanalum (Ge-Ag) and Gigantocoty(e-Fasciola antigens 
(GF-Ag). 
The antioxidant enzyme Catalase also plays a very important role in disease 
exacerbation or remission. The level of catalase in joints of vehicle control and CIA 
was 3.440 ± 0.2468 and 1.403 = 0.1189 unitmg protein, respectively, while it 
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increased after rats were treated with Fg-Ag in dose independent matmer, while in 
Ge-Ag and GF-Ag treated rats the level was also increased in dose independent 
manner. The overall results suggest a significant increase in catalase specific activity 
at different antigenic treatmcuts (Table, 2.4,6 and Fig.2,4,6.3) almost maintaining the 
enzyme level almost near to the normal level at most of the doses. 
2.4.6.4. Nitric Oxide (NO) level in joint's extract after treatment with F. giguntica 
(Fg-Ag), G. explanatum (Ge-Ag) and Gigantocotyle-Farciola antigens (GE-Ag). 
Nitric oxide (NO) serves as an important pathological marker during 
rheumatoid arthritis and collagen induced arthritic. The NO level in vehicle control 
and CIA rats was 29.30±2.000 and 78.05=3.150 µmol/mg protein, respectively. The 
NO level in Fg-Ag treated rats however decreased in dose independent manner with 
maximum inhibition at 150µg of antigen. Similarly, in Ge-Ag treated rats also the 
level was decreased in dose independent manner which was also true for the GE-Ag 
treated rats at three different doses (50µg, 100µg, 150µg) where the level was almost 
close to the healthy controls (Table.2.4.7 and Fig.2.4.6.4). 
2.4.6.5. Malondialdehyde (MDA) in joint's extract after treatment with F. gigantica 
(Fg-Ag), G. explanatum (Ge-Ag) and Gigantocotyle-Fasciola antigens (GF-Ag). 
Lipid peroxidation in joints was measured in terms of malondialdehyde (MDA) 
production. Under diseased condition the MDA level tend to increase from normal. 
The MDA level in vehicle control and CIA positive rats was 0.72871 0.09356 and 
2.873± 0.2709, respectively. The MDA level in Fg-Ag treated rats was decreased in 
dose independent manner with maximum inhibition at 150µg of antigen (Fig. 2.4.6.6). 
Similarly in Ge-Ag treated rats the level was decreased in dose independent manner, 
rather maintained at the control level. The level of MDA in GF-Ag treated rats was 
close to the untreated control. The overall results suggest that the MDA level can be 
maintained close to the normal level by treatment of diseased rats with different liver 
fluke antigens (Table.2.4.7 and Fig.2.4.6.5). 
2.4.6.6. Protein Carbonylation (PC) in joint's extract after treatment with 
F gigantica (Fg-Ag), G. explanahrrn (Ge-Ag) and Gigantocofyle-Fasciola antigens 
(GF-AR). 
The level of protein carbonylation is also used as an indirect parameter of 
oxidative stress. The PC level in vehicle control and CIA positive rats was 
8.400= 0.8505 and 15.08- 0.9792, respectively. The PC level arthritic rats was 
significantly brought down by all the three antigens used in the present study, almost 
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maintaining the level close to the controls. The overall results suggest the significant 
inhibition in PC level at different antigenic doses almost maintaining the normal level 
(Table.2.4.7 and Fig.2.4.6.6). 
2.4.7. Pateller morphology of Wistar rats after treatment with different doses of 
Fasciola gigaulica (Fg-Ag), Gigmitocotyle exptauatum (Ge-AE) and Gigantacotyle-
Fasciola combined antigens (GF-Ag) by Scanning Electron Microscopy (SEM). 
The patellar surface morphology can be used an important parameter for the 
disease remission or exacerbation as it is one of the most affected tissue in CIA. The 
patellae of CIA rats showed a sever pathology with synovial hypertrophy which leads 
to the significant protrusion of synovial membrane, recruitment of inflarmnatory cells 
at synovium-cartilage junction, high blood vascularization and a prominent fissuring 
of articular cartilage. The overall disruption and shrinkage of patellae was observed in 
CIA rats (Fig.2.4.7.2) while patella of vehicle control rat was healthy with smooth 
cartilage surface and normal synovial membrane and did not show any pathological 
evidence (Fig.2.4.7.1). 
In Fg-Ag treated rats though patella was not as healthy as control but showed 
some level of protection with slight synovial hypertrophy and presence of PMNCs at 
synovium-cartilage junction that suggest some level of disease remission since no 
prominent cartilage damage was evident. In Fg-Ag treated rats the precise description 
of dose dependent morphological changes is possible at this stage and certain level of 
apparent difference could be observed (Fig. 2.4.7.3 to 2.4.7.5). 
The patellae of Ge-Ag treated rats also showed a marked difference compared 
to CIA rats. The level of disease remission was more than Fg-Ag treated rat since the 
synovial hypertrophy was neither as much evident as in CIA rats nor Fg-Ag treated 
rats but the presence of PNINCs could be observed at lower doses while no PNI C 
could he seen at highest dose (150µg) of Ge-Ag (Fig.2.4.7.6 to Fig.2.4.7.8). 
The patellae of GF-Ag treated rats showed maximum protection level with no 
synovial hypertrophy, articular cartilage damage or presence of PNINCs. The fibrous 
meshwork was intact and very close to the healthy control. The dose dependent 
interpretation of changes in morphoplogy of patella could not draw differential 
conclusions (Fig.2.4.7.9 to 2.4.7.11). 
149 
p2C4: rkestdts 
2.4.8.1 Change in synuviaI pathology of Wistar rats after treatment with 
different doses of Fasciola gigantica (Fg-Ag), Gigrnetocotgle explanacum (Ge-Ag) 
and Gigantocotyte-Fascioka combined antigens (GF-Ag). 
The histological examination further suggests the protective role of liver fluke 
antigens in collagen induced arthritis (CIA) in Wistar rats. The severe pathological 
changes of synovium with high influx of immune cells were observed in CIA rats 
while in healthy controls comparatively fewer immune cells were observed. In 
Fasciola gigantica treated rats the protective effect was less with enough numbers of 
immune cells in synovium but low compared to CIA rats and high compared to 
healthy rats. In Gigantocoryfe explanatum treated rats protection level was high 
compared to F. gigantica treated rats. The maximum protection was observed in 
combined. Gigantocotyle-Fascio(a, antigenic treatment. The dose dependent precise 
level of protection in terms of immune cell recruitment was not easy to interpret at 
this stage but the highest doses seems to be more therapeutically efficient 
(Fig.2.4.8.1). 
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FIGURES 
2.4.1.1. Change in paw thickness of Wistar rats after induction of Collagen 
Induced Arthritis (CIA) and treatment with different doses of Fasciola gigantica 
(Fg) somatic antigens (Ag). 
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Figure.2.4.1.1. Induction of Collagen Induced Arthritis in Wistar rats showing 
disease severity in terms of paw thickness as evident in the representative 
photographs, without treatment (CIA) and after treatment with three different 
doses viz. 50µg, 100µg and 150µg of F. gigantica (Fg) antigen (Ag). There 
was a significant remission of disease in treated rats at 150 µg of antigenic dose. 
The values are represented as Mean-SE. The p value<0.05 was considered as 
significant. 
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2.4.1.2. Change in paw thickness of Wistar rats after induction of Collagen 
Induced Arthritis (CIA) and treatment with different doses of Gigantocotyle 
explanalum (Ge) somatic antigen (Ag). 
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Figure.2.4.1.2. Induction of Collagen Induced Arthritis in Wistar rats showing 
disease severity in terms of paw thickness as evident in the representative 
photographs, without treatment (CIA) and after treatment with three different 
doses viz. 50µg, IOOpg and 150µg of G. explanalum antigen (Ge-Ag). There 
was a significant remission of disease in treated rats with all the three doses. 
The values are represented as Mean±SE. The p value<0.05 was considered as 
significant. 
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2.4.1.3. Change in paw thickness of Wistar rats after induction of Collagen 
Induced Arthritis (CIA) and treatment with different doses of 
Gigantocotyle-Fasciola combined (CF) antigens (Ag). 
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Figure.2.4.1.3. Induction of Collagen Induced Arthritis in Wistar rats showing 
disease severity in terms of paw thickness as evident in the representative 
photographs, without treatment (CIA) and after treatment with three different 
doses viz. 50µg. 100µg and 150µg of with Giganlocotyle-Fusciola combine 
antigens (Fg-Ag). There was a significant remission of disease in treated rats at 
150 pg of antigenic dose. The values are represented as Mean.tSE. The 
p value<0.05 was considered as significant. 
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2.4.2.1. Serum cytokines analysis in collagen induced arthritis (CIA) in Wistar 
rats without treatment (CIA) and after treatment with different doses of 
F. gigantica (Fg) antigen (Ag). 
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Figure.2.4.2.1. 'l'h2 dominated immune response in collagen induced arthritis (CIA) 
in Wistar rats was observed after treatment with different doses (50µg, 100µg 
and 150pg) of Fasciola gigantica (Fg) antigen (Ag). The IL-10 and IL-4 level 
was significantly elevated at all the treatments in comparison to diseased (CIA) 
control and healthy (vehicle) control but the increase in IL-l0 and I[-4 level 
was independent of the dose dependent effect of antigen (a & b). The level of 
IFN-y significantly decreased as compared to the diseased rats (CIA) by the 
treatment with liver fluke antigens in a dose independent manner (c). The level 
of TNF-a significantly under expressed at the higher doses (100µg and 150 µg) 
(d). The values are represented as Mean3SE. The p value <0.05 is considered 
significant and (•): < 0.05 and (s.): <001-0.0001. 
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2.4.2.2. Serum Cytokines analysis in collagen induced arthritis (CIA) in Wistar 
rats without treatment (CIA) and after treatment with different doses of 
G. explanatum ((;e) antigen (Ag). 
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Figure.2.4.2.2. 'I'h2 dominated immune response in collagen induced arthritis (CIA) 
in Wistar rats without treatment (CIA) and after treatment with different doses 
(50µg. 100µg and 150µg) of G. explanatum antigen (Ge-Ag). The IL-10 was 
elevated at all the doses of the treatment in dose independent manner with 
significant elevation at 100µg and 150 pg of Ge-Ag (a). while IL-4 level was 
also elevated significantly at higher doses (100µg and 150µg) in treated rats 
when compared with CIA rats as well as with vehicle controls (b). In case of 
IFN-y and T F-u level was significantly decreased when compared with CIA 
rats in dose independent manner (c & d). The values are represented as 
Mean. SE. The p value <0.05 is considered as significant and (•): < 0.05 and 
(..): < 0.01-0.0001. 
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2.4.2.3. Serum cvtokines analysis in collagen induced arthritis (CIA) in Wistar 
rats without treatment (CIA) and after treatment with different doses of 
combined antigens i.e. Gigantocotyle-Fasciola (GF) antigens (Ag) 
Figure.2.4.2.3.112 dominated immune response in collagen induced arthritis (CIA) in 
Wistar rats without treatment and after treatment with different doses (50µg, 
100µg and 150µg) of Giganlocoiyle—Fasciola combined antigens (GF-Ag). 
The level of IL-10 was significantly higher in all the treated rats (a). The level 
of IL-4 was also significantly higher in treated rats but in a dose independent 
manner when compared with CIA rats as well as with vehicle controls (b). In 
case of IFN-v, and TNF-a, their level remained significantly low under all the 
treatments (c & d). The values are represented as Mean±SE. The p value <0.05 
is considered as significant and (-): < 0.05 and (.-): <0.01-0.0001. 
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2.4.3.1. Dot Blot analysis of NFkappaB p65 in joint's extract of Wistar rats after 
treatment with different doses of Fasciola giganticu (Fg), Gigantocottyle 
explanation (Ge) and Gigantocoh,le-Fusciolu (CF) antigens (Ag). 
20 
R 
0 
oo~~` 
C 
~.~~o ~~p ~~ G~o ~~~ c~~oG~~o~~oo~o 
G 	F 4 	Cs c 	C~ C~ 
Treatments 
Figurc.2.4.3.1. Dot Blot analysis o1' transcription factor NFkBphS in .joints of Wistar 
rats. 1 he expression level was determined in the form of pixel percent density. 
The level of NFkBphS decreased tollowing treatment of diseased rats with the 
different doses (50µg. 100 pg and 1 S0 pg) of 1''ci.sciolcr gigoinlicu (Fg). 
Giguniocoirle expicinatnn (Ge) and (iiguruoco>vle-Fu.ticiolu (GF) antigens 
(Ag). The NFkB p65 level was observed close to the control rats after treatment 
with different anticens. In case of Fucciolu antitiens (Fg-Ag) and combine 
antigens ((IF-Ag) the level of NFkl3p6S 	as down regulated in dose 
independent manner while in (igamocoIyIc antigens (Ge-Ag) there was 
insignificant dose dependent effect. The values are represented as Mean±SE. 
The p value <0.05 is considered as significant and (•): < 0.05 and (•. ): < 0.01-
0.0001. The tipper panel of the figure is showing the representative spots of the 
dot blot. 
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2.4.3.2. Dot Blot analysis of M1;1MP-13 in joint's extract of Wistar rats after 
treatment with different doses of Fasciola gigantica (Fg), Gigantocotrle 
erplanatnm ((;e) and Gigantocottvle-Fasciola (G F) antigens (Ag). 
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Figure.2.4.3.2. Dot Blot analysis of' MMP-1 i in joint's extract of Wistar rats. The 
level was expressed in the forni of pixel percent density. The level of MMM11'-13 
was decreased significantly after treatment with the different doses (0µg, 
10Oµi, and 150 pg) of' Fusciolu gigantica (Fg-Ag). Giguntocolyle exphznutunr 
(Ge-Ag) and (ii antocnrt lc'-f asciolu (GF-Ag). a reflection of disease remission. 
There was dose independent effect on h- MP-1 3 level under all the treatments. 
The values are represented as Mean-ESL. the p value <0.05 is considered as 
significant and (•): < 0.05 and (.•): < 0.01-0.0001. The upper panel of the figure 
is showing the spots of the dot blot. 
158 
2'2C4: figures 
2.4.3.3. Dot Blot analysis of MMP-8 in joint's extract of Wistar rats after 
treatment with different doses of Fasciola gigantica (Fg), Gigantocotyle 
explanatum (Cc) and Gigantocotyle-Fasciola (GF) antigens (Ag). 
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Figure.2.4.3.3: Dot Blot analysis of MMP-8 in joints of Wistar rats. The level was 
expressed in the form of pixel percent density. The level of MMP-8 decreased 
significantly after treatment of diseased rats with different doses (50pg, 100 µg 
and 150 µg) of F. gigantica (Fg), G. explanalum (Ge) and Giganticotyle-
/ asciola (GF) antigens (Ag). The level of MMP-8 largely remained close to the 
control level, which was highly significant when compared with the diseased 
ones. The values are represented as Mcan=Sl:. The p value <0.05 is considered 
as significant and (-): < 0.05 and (•_): < 0.01-0.0001. The upper panel of the 
figure is showing the spots of the dot blot. 
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2.4.3.4. Western Blot analysis of NFkB p65 in joint's nuclear extract of Wistar 
rats after treatment with different doses of Fasciola gigantica (Fg), Gigantocotyle 
explanalum (Ge) and Gigantocotyle-Fasciola (GF) antigens (Ag). 
NflcBP 1l 
PA4P11 :m 
f fc p C~ C~ 
Treatments 
Figure.2.4.3.4. Western blot analysis of transcription factor NFkB p65 in joints of 
Wistar rats. The expression level was determined in the form of pixel percent 
density. The NFkB p65 level decreased in diseased rats (CIA) after treatment 
with the different doses (50µg. 100µg and 150µg) of Fasciola gigantica (Fg). 
Gigantocotyle explanatum (Ge) and Giganiocotyle-Fasciola (GF) antigens. The 
NFkB p65 level was observed close to the control rats after treatment with most 
of the antigenic treatments. The overall level remained significantly lower 
under all the treatments than the untreated arthritic rats (CIA). The values are 
represented as Mean±SE. The p value <0.05 is considered as significant and 
(••) :< 0.01-0.0001. R- actin was used as a marker to show equal loading in all 
the wells of SDS-PAGE. 
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2.4.3.5. Western Blot analysis of MMP-13 and MMP-8 in joint's extract of 
Wistar rats after treatment with different doses of Fasciola gigantica (Fg), 
Gigantocotyle explanalum (Ge) and Gigantocotyle-Fasciola (GF) antigens (Ag). 
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Figure.2.4.3.5: Western blot analysis of h1MP-13 and Mh1P8 in joint's extract of Wistar 
rats. [he level as expressed in the form of pixel percent densith. The lerels of both 
`IMP-13 and MMP-8 significantly decreased in all the diseased rats after treatment 
with different doses (SOµg. l OOµg and ISO µg) of Fasciola ,giganlic•u antigen (Fg). 
(Jigu»tocnty/c' e.\/)lcmutu,~, antigen (Ge) and (;igcniir,cle /izsciulu (GF) antigens 
(A,_), here GF-Ag as more eflecti\e in bringing the ti1ti1P-8 level down. The values 
are represented as Ivlean±SE. The p value <(1.05 is considered as significant and (.): < 0.05 
and (..) :<0.01-0.0001. (3- actin was used as a marker to sho\\ equal loading in all the wells 
of SDS-PAGF. 
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2.4.4.1. Enzyme Linked Immunosorbant Assay (ELISA) of NFkB p65 in joint's 
extract of Wistar rats after treatment with different doses of Fasciola gigantica 
(Fg), Gigantocotyle explanalum (Ge) and Gigantocotyle-Fasciola (CF) antigens 
(Ag). 
Treatments 
Figure.2.4.4.1. Enz\me Linked Immunosorbant Assa> of NVkB p65 in Joint's extract of 
Wistar Rats. The NFkBp65 results have been expressed as activity/minute at 
\%avelength of 425nm. (here was a significant decrease in NFkB p65 activity in 
diseased rats after the treatment \\ ith different doses (50µg. 100µg and 150µg) of 
F. gigwztica (Fu). G. e.iplanarum (Ge) and Giganncon-le-Fusciolu ((iF) antigens (Au). 
The NFkB p65 level following treatment of rats \%ith all the antigenic doses remained 
close to the control rats that too were significantly lower than the arthritic (CIA) rats. 
he \aloes are represented as MeaniSi:. l'he p value <0.05 is considered as significant 
and (• ): < 0.05 and (.. ): < 0.01-0.0001. 
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2.4.4.2. Enzyme Linked Immunosorbant Assay (ELISA) of MMP-13 in joint's 
extract of Wistar rats after treatment with different doses of Fasciola gigantica 
(Fg), Gigantocotlyle e_vplanatum (Cc) and Gigantocothyle-Fasciola (GF) antigens 
(Ag). 
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Figure.2.4.4.2. Enzyme Linked immunosorbant Assay of MMP-l3 in joint's extract of 
Wistar rats. The level of MMP-13 was expressed as activity/minute at 425nm 
wavelength. There was significant decrease in MMP-13 activity after the 
treatment with different doses (50µg. 100µi, and 150µg) of P giganlica antigen 
(Fg). G. explanatum (Ge) and Giganiicoivle-I asciola antigens (GF). The 
significantly low MMP-13 level in treated rats as compared to the diseased 
untreated rats (CIA) clearly reflects the protective potential of the liver fluke 
antigens though the level was still higher than the controls. The values are 
represented as Mean=SF.. The p value <0.05 is considered as significant and 
(•): < 0.05 and (..): < 0.01-0.0001 
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2.4.4.3. Enzyme Linked Immunosorbant Assay (ELISA) of MN1P-8 in joint's 
extract of Wistar rats after treatment with different doses of Fasciola gigantica 
(Fg), Gigantocottrle e.rplanatuni (Ge) and Gigantocotvle-Fasciola (GF) antigens 
(Ag). 
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Figurc.2.4.4.3. Enzyme Linked Immunosorbant Assay of MM.P-8 in joint extract of 
Wistar Rats. The level of MMP-8 was expressed as activity/minute at 
wavelength of 425nm. A significant decrease in MMP-8 activity was observed 
in arthritic rats after their treatment with different doses (50µg. 100µg and 
150µg) of F. giganhica (Fg). G. explanatum (Ge) and Giganticotvle-Fasciola 
(GF) antigens (Ag) that resulted in bringing the MMP-8 level close to control 
which was significantly lower than the diseased rats (CIA). The values are 
represented as Mean--SE. The p value <0.05 was considered as significant and 
.. 
 
<0.01-0.0001 and - <0.05. 
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2.4.5.1. A representative zymograph of the joint's extract of Wistar rats after 
treatment with Fasciola gigantica (Fg), and Gigantocoryle-Fasciola (GF) antigens 
Figure.2.4.5.1. Zymogram of matrix metalloproteinases (MMPs) in joint's extract of 
Wistar rats treated with F. gigantica (Fg) and Gigantocotyle - Fasciola 
combined (GF) antigen (Ag) at different doses (50µg, 100µg and 150(.ig) 
respectively. Broad range (10-250 kD) molecular weight markers (Bio-Rad) 
were used. CIA: Collagen Induced Arthritis Sample. The level of matrix 
metalIoproteinases (MMPs) is increased following induction of collagen 
induced arthritis. When such rats were treated with different doses of parasite 
antigens the enzyme activity was significantly low. 
•P2C4: -Figures 
2.4.5.2. A representative zymograph of the joint's extract of Wistar Rats after 
treatment with Gigantocotyle explanatum (Ge) antigens (Ag). 
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Figure.2.4.5.2. Zymograph of matrix metalloproteinases (MMPs) in joint's extract of 
Wistar rats treated with G. explanalum antigens. CIA: Collagen Induced 
Arthritis Sample. Broad range (10-250 kD) molecular weight markers 
(Bio-Rad) were used. The level of matrix metalloproteinases (MMPs) increased 
following induction of collagen induced arthritis. When such rats were treated 
with different doses of parasite antigens, the enzyme activity was reduced. 
,P2('4: I:gures 
2.4.5.3. Pixel percent density of pro MMP-9 in joint's extract after treatment 
with Fasciola gigantica (Fg), Gigantocotyle e.vplanatum (Ge) and Gigantocotti•le- 
Fasciola (GF) antigens (Ag). 
0 *r . , 	.* *1, 	* ** ** 
~o ~~ 1~O G~~o ds
4 4 vC~' C~  
Treatments 
Figure.2.4.5.3. Pixel percent density of' pro MMP-9 in joints of Wistar rats in CIA, 
vehicle control and after treatment with different doses of F. giganhica (FFg). 
G. explanatum (Ge) and Giganlocolyle-Fasciola combined (GI:) antigens (Ag). 
The level of' pro MMP-9 was very high in CIA rats. In vehicle controls the 
enzyme activity was not observed. The Fg-Ag treatment suppressed the enzyme 
level significantly in a antigenic dose dependent manner but the level was still 
much higher than the control at Fg-150, while Ge-Ag and GF-Ag found to be 
more promising as these antigens completely suppressed the enzyme up to the 
control level. The values are represented as Mean1_SI... The p value <0.05 was 
considered as significant. • : <0.05 and .- : < 0.01-0.0001. l'he upper panel of' 
the figure is the gel strip showing bands of pro MMP-9, which were cropped 
from main zymograph. 
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P2('4: Figures 
2.4.5.4. Pixel percent density of active MMP-9 in joint's extract after treatment 
with Fasciola gigantica (Fg), Gigantocotyle erplanatum (Ge) and Gigantocotyle-
Fasciola (GF) antigens (Ag). 
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Figure.2.4.5.4. Pixel percent density of active MMP-9 in joints of Wistar rats in CIA, 
vehicle control and alter treatment with different doses of F. giganlica (Fg). 
G. explanalum (Ge) and Gigantocotyle-Fasciola combined (GF) antigens (Ag). 
The active MMP level was very high in CIA rats but the MMP-9 level was 
significantly suppressed at all the treatments. 'l'he decrease in enzyme level was 
somewhat in a dose dependent manner in case of Fg-Ag and Ge-Ag but not in 
GF-Ag. The values are represented as Mean=SE. The p value <0.05 was 
considered as significant. - : < 005 and #t ; < 0.01-0.0001. The upper panel of 
the figure is the gel strip showing bands of active MMP-9, which were cropped 
from main zymograph. 
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2.4.5.5. Pixel percent density of pro-MMP-2 in joint's extract after treatment 
with Fasciola gigantica (Fg), Giganlocotyle explanatum (Ge) and Gigantocoh'le-
Fasciola (CF) antigens (Ag). 
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Figure.2.4.5.5. Pixel percent density of pro MMP-2 in joint's of Wistar rats with CIA 
and alter treatment with different doses of F gigantica (Fg). G. explanatum 
(Ge) and Gig>unmocotyle-Fasciola (GF) antigens (Ag). The pro MMP level was 
very high in CIA rats as compared to the controls which were almost 
undetectable. However, a significant decrease in the expression of this enzyme 
was observed in diseased rats following treatment with the different antigens 
used in the present study. The Fg-Ag produced non dose dependent, while the 
highest dose of Ge-Ag (Ge 150) suppressed maximally. But the enzyme activity 
was completely wiped out by GF-Ag. The values are represented as Mean-SE. 
The p value <0.05 was considered as significant. •:< 005 and .-:< 0.01-0.0001. 
The upper panel of the figure is the gel strip showing bands of pro MMP-2. 
which were indi\ idually scanned. 
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2.4.5.6. Pixel percent density of active MMP-2 in joint's extract after treatment 
with Fasciola gigantica (Fg), Gigantocotyle explanatum (Ge) and Gigantocotvle- 
Fasciola (GF) antigens (Ag). 
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Figure.2.4.5.6. Pixel percent density of active MMP-2 in joint's of control. CIA and 
the antigen treated Wistar rats. The arthritic rats were treated with different 
doses (50µg. 100µg and 150µg) of F. giganlica (Fg). G. explanulum (Ge) and 
Giganiocotyle-Fasciola combined (GF) antigens (Ag). The active MMP-2 level 
was very high in CIA rats. The decrease in the enzyme level of Fg-Ag treated 
rats as compared to the CIA rats was highly significant, while Ge-Ag produced 
maximum effect at 150 µg dose. The maximum suppression was observed in 
GF-Ag treated rats with pixel density value close to the control. The values are 
represented as Mean±Sl:. The p value <0.05 was considered as significant. 
* :< 005 and iT : < 0.01-0.0001. The upper panel of the figure is the gel strip 
showing bands of active MMP-2. which were individually scanned. 
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4.4.5.7. Pixel percent density of active \'IMP-13 in joint's extract after treatment 
with Fasciola gigantica (Fg), Gigantocotyle explanatum (Ge) and Giganlocoryle-
Fasciola ((;F) antigens (Ag). 
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Figure.2.4.5.7. Pixel percent density of active MMP-13 in joints of control. CIA, and 
antigen treated Wistar rats. The F. giganhica (Fg), G. explanalum (Ge) and 
Giganiocoivle-I asciola combined (GF) antigens produced differential effect on 
MMP-13 of diseased rats.. The level of active MMP-9 was significantly 
suppressed at all the treatments but maximum protection was found in GF-Ag 
treatments in which the level was below the detection limit of our protocol for 
zymography. The values are represented as Mcan~SE. The p value <0.05 was 
considered as significant. • :< 005 and 	: <0.01-0.0001. The upper panel of 
the figure is the gel strip showing bands of MMP-13, which were individually 
scanned. 
, 2C4: 'Figures 
2.4.6.1. The specific activity of Superoxide dismutase (SOD) in joint's extract 
after treatment with Fasciola gigantica (Fg), Gigantocotrle explanatum (Ge) and 
Gigantocotyle-Fasciola (GF) antigens (Ag). 
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Figure.2.4.6.1. Super oxide dismutase (SOD) specific activity in joints of control, 
arthritic (CIA) and antigen treated rats. Different doses of Fl gigantica (Fg), 
G. explanalum (Ge) and Gigantocotyle-Fasciola combined (GF) antigens 
produced differential stimulatory effect on the SOD activity as compared to the 
CIA rats. The decrease in level of SOD in CIA joints was highly significant as 
compared to the controls. Upon treatment of diseased rats with different doses 
of the parasite antigens the SOD level was increased significantly, even higher 
than the controls in some treatments reflecting a recovery of the animal from 
the disease and suggesting the therapeutic potential of parasite derived 
products. The values are represented as Mean1SE. The p value <0.05 was 
considered as significant. - :< 005. and *:<0.0l-0.0001. 
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2.4.6.2. The specific activity of Glutathione-S- transferase (GST) in joint's 
extract after treatment with Fasciola gigantica (Fg), Gigantocotyle explanatum 
(Ge) and Gigantocotyle-Fasciola (GF) antigens (Ag). 
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Figure.2.4.6.2. Glutathione-S-transfcrase (GST) specific activity in joints of Wistar rats 
subjected to CIA and treatment with different doses of F. giganlica antigen (Fg). 
G. explanatum (Ge) and Giganiocoiv ie-1 asciola combined (GF) antigens (Ag). 
The specific activity in diseased rats (i.e. CIA) the GST level decreased in a 
highly significant manner. While the specific enzyme activity following 
treatment of rats was completely recovered, showing a highly significant increase 
at all the treatments in comparison to the CIA alone. On comparing the healthy 
control rats with the antigen treated ones, there was an insignificant difference. 
The values are represented as Mean~-SE. The p value <0.05 was considered as 
significant :< 005 and A : <0.01-0.0001. 
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2.4.6.3. Catalase specific activity in joint's extract after treatment with Fasciola 
gigantica (Fg), Gigantocon-le erplanatum (Ge) and Gigantocon'le-Fasciola (GF) 
antigens (Ag). 
Treatments 
Figure.2.4.6.3. Catalase specific activity in joints of control, arthritic (CIA) and 
antigen treated Wistar rats. The CIA induction significantly inhibited Catalase 
activity but the enzyme level was almost recovered completely in rats treated 
with different doses (50µg, 100µg and 150µg) of F gigantica antigen (Fg), 
G. explanalum (Ge) and Gigamocotyle-Fasciola (GF) antigens, maintain the 
enzyme level close to the untreated control. The values are represented as 
Mean+SF,. The p value <0.05 was considered as significant. • :< 005 and 
-•: <0.01-0.0001. 
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2.4.6.4. Nitric Oxide (NO) level in joint's extract after treatment with Fasciola 
gigantica (Fg), Gigantocotvle explanatum (Ge) and Gigantocottile-Fasciola (GF) 
antigens (Ag) 
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Figure.2.4.6.4. Nitric oxide (NO) level in joints of Wistar rats after treatment with 
different doses of Fasciola g>igantica (Fg). Gigantocotyle explanatum (Ge) and 
Gigantocotyle-htuciola combined antigens (GF). The level in diseased rats i.e. 
CIA was increased in highly significant manner. The NO level in Fg-Ag. Ge-Ag 
and GF-Ag treated rats was decreased significantly in non dose dependent 
manner in comparison to CIA rats. The values are represented as Mean=Sl.. The 
p value <0.05 was considered as significant. • :< 005 and •• :<0.0l-0.000l. 
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2.4.6.5. Malondialdehyde (MDA) in joint's extract after treatment with Fasciola 
gigantica (Fg), Giganlocotyle explanalum (Ge) and Gigantocotyle-Faseiola (GF) 
antigens (Ag). 
Treatments 
Figure.2.4.6.5. Malondiaidehyde (MDA) level in joints extract of Wistar rats in CIA. 
control and after treatment with different doses (50µg, 100µg and 150µg) of 
F gigantica antigen (Fg), G. expianatum (Ge) and Giganrocntyle-Fasciola 
(GF) antigens. The MDA level was increase in highly significant manner in 
diseased rats i.e. CIA in compare to healthy controls. 	There was dose 
independent decrease in MDA level in all the Fg-Ag, Ge-Ag and GRAB treated 
rats when compared to CIA rats. The GF-Ag alone maintained the MDA level 
close to controls in treated rats. The values are represented as Mean t SE. The p 
value <0.05 was considered as significant...; <0.01-0.0001. 
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2.4.6.6. Protein Carbonylation (PC) in joint's 	extract 	after treatment with 
Fasciola gigantica (Fg), Gigantocotyle explanatum (Ge) and Gigantocotyle- 
Fasciola ((iF) antigens (Ag). 
Treatments 
Figurc.2.4.6.6. Protein Carbonylation (PC) level in joints of control, diseased (CIA) 
and antigen treated Wistar rats. The PC level was increased significantly in 
diseased rats (i.e. CIA) in comparison to healthy control. When the diseased 
rats were subjected to treatment with different doses of F gigantica antigen 
(Fg). G. explanatum (Ge) and Giganlocolyle-Fasciola combined (CF-Ag) 
antigens, there was a dose independent significant decrease in the PC level 
which was almost close to the control. The values are represented as 
Mean=SE. The p value <0.05 was considered as significant. :< 0.05 and 
.. <0.0]-0.0001. 
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2.4.7.1. The representative Scanning Electron Micrograph of patella of healthy 
Wistar rat. 
Figure.2.4.7.1. Patellar morphology of healthy Wistar rats. The surface of articular 
cartilage was found smooth (arrow) with normal synovial membrane (a). There 
were no fissures on the cartilage surface with no synovial protrusion or 
hypertrophy (arrow) (b). Near the synovial and cartilage junction a layer of 
mucilaginous material was also present (arrow head) (c). 
2.4.7.2. The representative Scanning Electron Micrograph of patella of Collagen 
Induced Arthritic (CIA) Wistar rat. 
Figure.2.4.7.2. Patellar morphology of Wistar rats after CIA (Collagen Induced 
Arthritis) Induction. A severe damage was observed in patellae with significant 
protrusion of synovial membrane which might be the outcome of synovial 
hypertrophy (arrow) and the surface of articular cartilage was shrunk (star) (a). 
A very prominent fissuring (arrow head) of cartilage surface and probably outer 
ligament layer was observed (arrow) (b). Disrupted cell remnants as part of 
irregular meshwork of fibrous material were also observed in CIA patella with 
increased blood vascularization as well as high level of recruitment of PMNCs 
at synovium-cartilage junction where some RBCs can also be seen (c). 
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2.4.7.3. The representative Scanning Electron Micrograph of patella of Collagen 
Induced Arthritic Wistar rat after treatment with 50µg of Fasciola gigantica 
antigen (Fg-Ag) at different magnifications. 
Figure.2.4.7.3. Patellar morphology of CIA (Collagen Induced Arthritis) in Wistar 
rats after treatment with 50µg of Fasciola gigantica antigens (Fg-Ag). Disease 
remission was found upto certain extent with no cartilage damage (star) (a). The 
synovial hypertrophy was prominent (shown by arrow) with loose fibrous 
meshwork (star) (h). The magnified view shows loose fibrous meshwork around 
the cartilage (arrow) (c). 
2.4.7.4. The representative Scanning Electron Micrograph of patella of Collagen 
Induced Arthritic Wistar rat after treatment with 100µg of Fasciola gigantica 
antigen (Fg-Ag) at different magnifications. 
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Figure.2.4.7.4. Patellar morphology of CIA (Collagen Induced Arthritis) in Wistar 
rats after treatment with 100µg of Fasciola gigantica antigens (Fg-Ag). There 
was a significant disease remission with no cartilage damage and without 
shrinkage of articular cartilage (star) however, enough tissue out growth could 
be seen (arrow) (a). The severe svnovial hypertrophy was not evident showing 
disease remission upto certain extent (b). Fibrous meshwork was somewhat 
intact but the presence of PMNCs was observed at synovium-cartilage junction 
(arrow) (c). 
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2.4.7.5. The representative Scanning Electron Micrograph of patella of Collagen 
Induced Arthritic Wistar rat after treatment with 150µg of Fasciola gigantica 
antigen 	(Fg-Ag) at different magnifications. 
Figure.2.4.7.5. Patellar morphology of CIA (Collagen Induced Arthritis) in Wistar 
rats after treatment with 150µg of Fasciola gigantica antigens (Fg-Ag). There 
was a significant disease remission with no cartilage damage and no synovial 
hypertrophy (a). The synovial membrane was flanked on cartilaginous surface 
more as compared to control (arrow) (b). Synovial lining (arrow) and fibrous 
meshwork appeared to be completely intact (star) (c). 
2.4.7.6. The representative Scanning Electron Micrograph of patella of Collagen 
Induced Arthritic Wistar rat after treatment with 50µg of Gigantocotyle 
explanatum antigen (Ge-Ag) at different magnifications. 
F'igure.2.4.7.6. Patellar morphology of CIA (Collagen Induced Arthritis) in Wistar rat 
after treatment with 50µg of Gigantocotyle explanalum antigen (Ge-Ag). There was a 
significant disease remission with no cartilage damage (shown by star), no synovial 
hypertrophy (arrow) (a). The severe synovial hypertrophy is not seen while rough 
surface was observed at synovium-cartilage junction (arrow) (b). The synovial linings 
were intact but the accumulation of PMNCs was observed at synovium-cartilage 
junction (arrow) (c). 
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2.4.7.7. The representative Scanning Electron Micrograph of patella of Collagen 
Induced Arthritic Wistar rat at different magnifications after treatment 
with 100µg of Gigantocotple explanatum antigens (Cc-Ag). 
Figurc.2.4.7.7. Patellar mcrrpholog-, of Uli\ (Lollagen Induced Arthritis) in Wistar 
rats after treatment with L00µg of (;iganrocotyle explanalum antigen (Ge-Ag). 
There was a significant disease remission with almost no cartilage damage (star) 
(a). The severe svnovial hypertrophy was not observed (b). Fibrous meshwork 
was intact but the accumulation of PMNCs was observed at synovium-cartilage 
junction (c). 
2.4.7.8. The representative Scanning Electron Micrograph of patella of Collagen 
Induced Arthritic Wistar rat after treatment with 1S0pg of Giganlocotyle 
explanatunt antigen ((c-Ag) at different magnifications. 
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1 igurc.2.4.7.8. f'at~if.. inurhholog: of C1.•\ t( ollagcii Induced Arthritis) in 
rats after treatment with 1 5O.g of Giganiocot_vlc explunutum antigen. There was 
a significant disease remission with no cartilage damage (star) while synovial 
linings appeared normal (a) The synovial hypertrophy was not shown (b) 
Fibrous meshwork was intact but some scattered PMNCs were observed at 
synovium-cartilage junction (c). 
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2.4.7.9. The representative Scanning Electron Micrograph of patella of Collagen 
Induced Arthritic Wistar rat after treatment with 50µg of Gigantocolvle-
Fasciola combined somatic antigens (GF-Ag) at different magnifications. 
Figure.2.4.7.9. Patellar morphology of CIA (Collagen Induced Arthritis) Wistar rats 
after treatment with 50µg of Gigantocozyle-Fasciola combined antigens 
(GF-Ag). There was a significant disease remission with no cartilage damage 
(star), synovial linings also appeared normal (arrow) (a) The synovial 
hypertrophy was not evident (arrow) (b) Fibrous meshwork was intact (arrow 
head) (c). 
2.4.7.10. The representative Scanning Electron Micrograph of patella of 
Collagen Induced Arthritic Wistar rat after treatment with 100µg of 
Giganfocohrle- Fasciola combined antigens (CF-Ag) at different magnifications. 
Figure.2.4.7.10. Patc1lar nio!t)li.ilug oC L i:A L o.lat;LII lnduceJ 1Ar1h:lli') ii: vl i>Lu 
rats after treatment with 1OO.ig of Giganlocotyle-Fasciola combined antigens 
(CF-Ag). There was a significant disease remission with no cartilage damage 
(star) and the synovial linings were normal (arrow) (a) The synovial 
hypertrophy was not observed (arrow) (b) The magnified view of synovial 
lining showing intact condition while there was some rupturing at the synovium 
cartilage junction (c) and some fibrous material appeared to be deposited on the 
surface. 
P2C4: Tigures 
2.4.7.11. The representative Scanning Electron Micrograph of patella of 
Collagen Induced Arthritic Wistar rat after treatment with 150µg of 
Gigantocotrle- Fasciola combined somatic antigens (GF-Ag) at different 
magnifications. 
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Figure.2.4.7.11. Patellar morphology of CIA (Collagen Induced Arthritis) in Wistar 
rats after treatment with 150µg of Gigantocotyle-Fasciola combined antigens 
(GV-Ag). There was a significant disease remission with no cartilage damage 
(star) with normal synovial linings (arrow) (a). The synovial hypertrophy was 
not evident (arrow) (b). The synovial linings are showing the intact tissue 
(arrow head) (c). 
Note: The excessive polymorphonuclear cells (PMNCs) with some red blood cells 
and the kind of fissures which were clearly evident in untreated CIA rats were 
not seen in any of the experimental rats which were treated with any of the 
parasite antigens used in the present study. 
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Change in synovial pathology of Wistar rats after treatment with 
!nt doses of Fasciola gigantica antigen (Fg-Ag), Gigantocotyle explanatum 
n ((;c-Ag) and Gigantocotyle-Fasciola combined antigens (CF-Ag). 
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Figure.2.4.8.1. the synovial pathology in CIA rats after treatment with different doses 
(50µg, 100µg and 150µg) of Fasciola gigantica antigen (Fg-Ag), Gigantocotyle 
explanalum antigen (Ge-Ag) and Gigantocotyle-Fasciola combined antigens; 
GF-Ag. In CIA rats there was a severe influx of immune cells (arrow) which 
were normal in healthy rats. In Fg-Ag treated rats there was enough recruitment 
but less compared to CIA. The maximum protection in terms of synovial 
pathology was achieved in GF-Ag followed by Ge-Ag treated rats. 
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Table,2,4,1, Serum cytokine level during CIA in N'istar rats after treatment nith different doses of I. NUIVlcaa antigen 	(I g-Ag), 
t;. expianalum antigens (Ge-Ag) and (iigdlllocoi►le-1 ircinla combined antigens (GF-Ag). 
Treatments 	Control 	CIA 	F. giganlica 	1 	(erplanatum 	°ganto~~  h'1 - Fasa'a  la 
Antigens (rig) Antigens (µ4) 	 Antigens (µg) 
Cytolanes 	---- 	--- 	50 	100 	ISO 	-50 	100 	ISO I SO 	100 P 150 
IL-10 	1081± 	127± 	36181 	2687± 	4010± 	1901± 	27051 r 2050± 1 2517± 	2866± 	29221 
	
153.6 	35.41 	189.0 	100.4 	290.1 	188.7 	1.335 	154.3 	315.6 	253.8 	87.73 
p= 0,0002; F= 58.27; r2= 0,9790; Df=9 	p= 0.0018; F= 24.05; 	r2= 	p= 0.0028; F= 20.08; 	r2= 0.9414; 
_ _ _ _ _ 0.9506; D1;- 9 	Df r 9  
114 	11.70± 	26.81218.1± 327.1± 	229.5± 	50.301 	220.61 	232.1± 	63.101 ' 63.401 	63.801 
L 0.610 	1.48 	3.525 - - 27.32 , 27.44 	0.3250 1 21.67 	13.64 	6.885 X4.495 	13.18 
p= 0.0002; F= 59.72; r2= 0.9795; Df= 9 	- p= < 0.0001; F= 89.81; 	r2= p= 0.0080; F=12.60; 	r2- 0097 
0.986; Df 9 Df 9 
1F '.y 	40.11± 	150.11 71.911 	61.75± 	64.88± 	59.08± 	42.111 	45.97± ! 81.95± 	95.271 ! 	68.191 
0.450 	9.745 	16.29 	10.16 ~ 15.97 	10.03 	3.025 	16.06 	15.25 1 8.965  	0.9150 
p= 0.0084; F=12,36; r2= 0.9082; Df= 9 	p= 0.0019; F= 23.56; 	r2= 	p= 0.0027; F= 20.26; 	r2= 0.9419; 
0.94961, Df-9 	__ 	Df - 9 
TNF-a 	132.8± 	342.8± 274.9± 	133.81 	118.0± 	95.60± 	169.0± 	159.8± I 156.8± T 159.8± 	156.51 
2.310 	8.440 38.31 1.425 149.91 	54.17 	28.55 	24.50 	40.47 1 29.40 	6.750 
p= 0.0076; F=12.89; r2= 0.9116; DF 9 	p= 0.0125; F=10.28: 	r2= 	r00062; F=14.18; 	r2= 0.9190; 
0.8915;Df=9 Df9 
The quantir}' of cylokines was calculated in pg ml of serum sample. Al! the values are represented as Mean±SE ►►ith p value (,0.05 was 
considered as significant). F value, r'►alue and 1)f value, 
Table,2.4,2, The Pixel Percent value (Pixel Percent Density) and activity"minute of NFkB p65 in joints nuclear extract Wistar rats obtained fror 
the Dot Blot. Western Blot analysis and ELISA, respectively. 
Treatmens 	Control 	CIA 	F. gigand'ca 
	
G. planatum 
	
GigantocoE1e•Fastiola 
Antigens (µg) 
	
Antigens (µg) 	 Antigens (µg) 
NFkB p65 	._. 	-... 	50 	100 	150 	50 	100 	lSO 	50 	100 	150 
Dot Blot 	8.332± ~15.66± 	9.379± 	105±7396± 	8.0351 	8.4941 	9,006± 	8.202± 	8.943± 	7.540± 
	
0.7405 	0.8375 	0.7525 	0.9525 	0.2635 	0.5970 	0.6940 	0.2640 	0.4980 ! 0.1575 	0.4395 
p= 0.0010: F= 7.913; r2= 0.8780 ; Df= 2l 
Western 	5.775±:23.58± ! 8.120± 	12.62± 	6.345± 	1105± 	1.539± 	10.65± 	5.190± 7.215± 	5.955± 
Blot 	0.5450 	2.850 	0.8900 	0.8350 	0.7850 	0.5450 	1.039 	0.9330 	0.8500 	0.7650 	0.8350 
p-< 0,0001-1 F=15.05: r2- (► 9319 ; DF 21 
ELISA 	00047±0.0072±0 0.004-  5± T0.00465±0. 0.0041± 0.00465± 0.00485± ~ 0.00515± 0.0045± 0.0047± 0.0039± 
0.0001 	.0002 1 0.0004 I 00025 	0.0002 	0.0004 	0.00025 	0.00035 0.00045 0.00035 0.0003 
iL 
p 0.0010; F= 7.856; r?= 0.8772 ; Df =? 1 
The Pixel Percent value of Dot Blot and Western Blot of NFkB p65 was calculated by using lmageJ software by importing gel in tiff format. The 
values obtained by ELISA experiment represented as activity minute. All the values are represented as Mean=SE with p value (<0.05 was 
considered as significant), F value, rvalue and Df value. 
Table,2.4,3, The Pixel Percent value i.Pixel Percent Densitk I and actin itv minute of MMP• 13 in joints extract of Wisiar rats obtained from the 
Dot Blot. Western Riot analysis and HiSA, respectively. 
sTreatments Control 	CR 	F.giga►►tica 
	
G. ~tpla►►alum 
	
Gigan1ocohvle-Fasciola 
Antigens (µg) 	 Antigens (pg) 	 Antigens (µg) 
	
111P• 13 	..... TJ 	5p 	100 	1 SO 	SO 	100 	150 	50 	1 p0 	15U 
Dot Blot 	8.721± 	26.001 	8.4351 	13.741 	8.868E 	5.7541 	5.5131 	5.5361 	6.9991 	3.686± 	7.485± 
1.153 	2.898 	0.4360 	1.972 	0.7475 	0.5335 	1.135 	1.181 	1.909 	1.263 	3.115 
 F1l28; r?= 0.917 Df 21 
Western 	8.883±2379± T.28245111.26± 	9.6931 	6.850± 	6 850± 	4.465± 	7.5751 6.6021 5 9 3± 
0.7630 	2.549 	1.575 	2.139 	2.463 	0.5500 	0.2500 	0.6845 '0.8750 	1.152 	1.893 Blot 
_r 0.0006 F 9.003; r2- 0.8911: Df- 21 	__ 
ELISA 0.0415± 0.006± 0.0031± 0.0048±0.0035± 0.0035± 0.0019± 0.0027± 0.0029± 0.003± 0.0021± 
0.0003 ; 0.0005 	0.0005 	0.00035 	0.0006 	0.00055 	0 0004 ! 0.00025 	0.0003 	0.0002 	0.00025 
0 0002: F- 11.13 : r?= 0.9100, Df= 21 
The Pixel Percent value of Dot Blot and Western Blot of MMP•13 was calculated b~' using lmageJ software b' imlx~rting gel in tiff format. 
'l'he values obtained by ELISA experiment represented as activity; minute. All the values are represented as Mean:SE. with p value t405 was 
considered as significant). F value. r'value and Df value. 
Tahle.2.4.4. The Pixel Percent value (Pixel Percent Densir<) and activiminute of MMP-8 in joint's extract of Wistar rats obtained from 
the Dot Blot, Western Blot analysis and ELISA, respectively 
Treatments Control 	CIA 	F. gigattliea 
	
G e planatum 	Gigantoco '!e-Fasciola 
Antigens (pg) Antigens (µg) Antigens (µg) 
50 	100 150 50 	100 	150 50 	100 	150 
7.281±11.551 7.234± 	5.868± 6.402± 	5.931±  6.7141 	6.192± 	7.614± 
1.348 	2.650 1.337 0.6790 1.563 	0.9590 0.2485 	3.429 	, 	1.850 
P= 8.524: r2- 0,8857 ; Df 	21  0,0007: F= 
MP-8 
Dot Blot 	10.27±~ 26.58± 
1.405 	2.080 
	
\%esters 	2.0461 	21.861 T 14.39± 	13.66± 	10.57±10.60± 	7.157±4.350± 	5.262± 	4.869± 	5.530± 
Blot 	0.2945 	1.881 	1.193 	0.6800 	1.550 	1.626 	1.487 	1.150 	1.518 	1.251 	0.5500 
_- -- - P= <0.0001; F- 25.07: r?- 0.9580 ; Df = 21
ELISA 	O00110.0002± 0.0013. 0.0015±J 0.0011± ! 0.00091 10.0008± 	0.00105± 0.000725± 0.00105± 0.000725± 
0.0002 0.00025 0.00005 0.0001 	0.0001 ! 0.0001 	0.0002 	0.00015 	0.0002 	0.00015 	0.00013 
P= 0.0004; F= 9.469; r2= 0.8959: Df 21 
The Pixel Percent value of Dot Blot and Western Blot of MMP.13 was calculated by using Image) soft%%are by importing gel in tiff format 
followed by the invert command to the gel image. The values obtained by ELISA experiment represented as activitv minute. All the values 
are represented as Mean±SE with p value (<0.05 was considered as significant). F value, (value and Df value. 
T^hl14* The Pixel Percent value /~~J0m~n D"~i\ ,f~A^\~i"W^w 	(WMVU.1 13 obtained from the ' 	 ' 	 . ` 	. 
8m,^,mk| analysis joint's 	of 	rats. nnm/'.
-------' --------'---- ! -----  	--- ---~~~ 	---- 
	
Control ~~~ 	F. 	 G. ~  ~vum ^xwm~u~um 	CIA x,~~wm~o 	| 	x~u~xoouum 	w~owmmV~n~u~~ 
. | 	.  
~ 	 | Antigens /o ) Antigens (rig) 	Antigens (rig) 
~ 	~ 1 1 %A 	 ~~ ~~ ~v .~ 	150 
-_  __'_ 	~ __  ___ _ 	. --. 
Pro 	0.0± 	8076f|284f 2456 ± 6.5~f 	AMf 	00f 	00f 	00+ 	00f 	DAf | 	 ~ ~ MM0 9 	! 	0.0 	80A 	~~~ | ~70~ 	~ 	| 07295 | 00 
| ^ 	 ---_-__-- 	
0.0 	0.0 	0.0 ' _--__---- ---'-__-__^-__----_---__^  
P< -'.,. -9.2~7~. ~. 
/  Active 	~ 6 11f 	19.68f 	yQ 	10.62f 	5028f 	0800f 8.230 ± 	7048f 	6.406 ± 	3.331 ± 	7 800f 
MMO9 0 3095 3.222 0 6950 3.840 08100 1.100 0 7000 0 2880 0.3055 ) 069 0 3000 --__
--_-- -_-_ iIIIIiiE 
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-_'
-
l 
 
— 
8m 	0Af 	)~~~ 	11 tA 	~D4 ~ 0806f ~ ~7~0| 11 ~f 	~~f ~ 00f 	00f ... ~.- ^.~~ ^°~~ ^~"^^ "",-^  ^'^°^ ^^~^^ =°^~ ~ ,°~ ~,~ 
MMPJ 	0 0 	1 950 	1.376 	2.024 	1 '097 	1 422 	0.7500 	0.0 	00 	0.0 --------'--------'----- - -----~-----~--'--' -_ 	 _ ____ 	| ~______ 
D=<0AA0| C~~00O,1~00~V| UL1\ 
(-------- ------- -----'---------|-~--'--------------~-- 
8rho* 3838+ 21 02± 8038f 11.66± 5.155± 15.95± 1186± 0055f 28221 1611 2.3504 
MMVJ 	0.238 	1.917 	0.938 	2065 ~ 2.426 	1 0 	1.364 	0.7550 	0.6785 31811 ~ 07~W _---__.-_-0.93 1.251.36 .6785'_-  
0,000..' ' '_ ` - ,9--.-. 21 __-____-----_-_--__-  
Active 	0~~K~f 	~1 ~~ 	11$Cf 	17~~ ~~0kf 	~71f 11 ~H 	DU~c~ 	0Af ~ 00f 	00f ",°`° ~'^'~^~ '^''"^ ^^''"` ~ ^''^~~  ^^""^ ^"''^~ ^^'^"~ ^"'"'~ °'°^ 	"'"~ 
~ ~~~1~ 	0Mk5 	1475 	1~4 	1 081 09125 1~0 	)~N 	2.550 	0.0 	00 | 0 0 --'~' -~^~---^^ --~~~~'--~~~' ^'~~~ ^~~^ ~~~~__~ ~~__ 
0=(00AA| ~=)U~1,1~086~|:k~?| ~ 	-'`~ _~".~ .~_ _ _-__- 
The Pixel Percent value was calculated 	using lmage software hi' |opmm
'
Mggel in t iff  fm,m^u followed by the inve command to 
the gel image. All the values are represented as 	"|thp value ( <0.05 was considered 	~mm\^ value, r 
^
value and D/ value.  
Table,2,4,6. The status of antioxidant enzymes: SOD. GST and catalase in joints extract of CIA Wistar rats after treatment vith different 
doses of Fg-Ag, Ge•Ag and GF-Ag. 
Treatments Control 	CL4 	F. gigantica 	F 	G. erplanatum 
_ 	 Anti ens (_ 	Antigens (g 
Anti 
Oxidants 	-" 	50 	100 	150 	50 	100 	154 
Gigantocoty 1e-Fa cciola 
Anti ens L 
150 
50 	100 
SOD 	5.667± 	1.800± 4.633± 4.133± 	5,500± 6567±6600± 	7.433± i 5.767± 	6.8331 	5.933± 
C.5783 	0.3464 	0.3844 L_0.9528 	0.3215 
	
0.6227 	0.4726 	0.4372 	0.3156 	0.2333 	0.8413 
P-<0.0001: F=8.103x=0.7865:Df=32 
GST 	2197± 0.0690± 2.7371 	2.120± 	2.960± ' 2.4671 	2.8001 ! 2.433± 	2.783± 	3.203± 	2.847± 
0.2221 0.01801 0.08373 0.4104 	0.0851  10.1302 	0.1365 	0.1794 _ 0.1017 	0.1277 	0.0726 
P= < 0.0001; F= 23.63; r`= 0.9148; Df = 32 
(atalase 	3.440± T 1.403± 	2953±1913± ' 2947±1 2.917+ 	3.467± 	2.920+ 	2.633± 	2780i7 2820± 
0.247 0.1189 0.1146 0.155 0.191 0.159 0.225 0.238 0.121 0.140 H.l95  
P= < 0.0001, F=11.49: r`= 0.8393; Df = 32 
The quantity of antioxidant enzymes was calculated and it is expressed as unitmg protein. All the values are represented as Mean±SE with p 
value (<0.05 was considered as significant). F value, r` value and Df value, SOD: Superoxide dismutase, GST: glutathione-S-transferase. 
Table,2.4,7, The status of oxidative stress markers (Pathological markers - NO, MD1\ and PC in joints of CIA Wisiar rats after treatment with 
different doses of Fe-AR. Ge-At, and (IF-AR. 
Treatments 	Control 	CIA 	F. gigantica 	I 	G. e.tplantunl 	Gigantocolyle-hscioia 
Antigens (µg) 	Antigens (µg) 	 Antigens() 
Path, !Harker 	...... 	_.... 	sp 	100 	1511 	 '0 	fl) 	19 	SO 	100 	150 
	
NO 	29.30 	78.05 	49.33 	50.45 	38.55 	36.00 	29.30 	43.25 	28.45 	35.60 	29.40 
±2.000 	±3.150 	±6.325 	±8.450 	±1.650 	±3.600 	±2.000 	±5.950 	±1.250 	±1.200 	±1.000 
P=; F=: r2= .- Df= 2 
MDA 0.7287_ 2.873± 1.347± 1.687± 1.034± 0.9487± 0.928± 1.2901 0.7670± 0.7200± 0,7833± 
0.0936 	0.271 	0.3778 	0.4116 	0.1753 	0.0993 	0.135 	0.1852 	0.120 	0.163 	0.1298 
P- < 0.0001, F 8.160; r20.7877 ; Df 32 
PC 	8.40± 	15.08± 	9.087± 	10.67± 	6.300± 	8.607± 	7.843± 18.133± 	7.267±T 7.000± 	7.5001 
0.8505 	0.979 	0.718 	0.953 	1.914 	0.6996 	0.4315 	0.4667 	0.4667 	0.5132 	1,210 
P-0.000I ; F= 6.638; r?= 0.1511: Df-32 
The quantity of Nitric Oxide (NO), Malondialdehvde (MI).A i and Protein Carbon lation (PC) was calculated in limol,'mg protein, nmol nig 
protein and nmol mg protein. All the values are represented as Mean±SF with p value (<:0.05 was considered as significant). F value, r value 
and Df value, 
P2C5: Discussion 
CHAPTER 5 
2.5-DISCUSSION 
Collagen induced arthritis is an experimentally manipulated autoimmune 
disorder having many similarities with the rheumatoid arthritis in human. As evident 
from the present results that the experimental disease induction resulted in 
considerable inflammation in joints of the experimental rats and their subsequent 
treatment with Fasciola and the amphistome derived antigens resulted in the 
remission of disease. The present study provides a suggestive statement of the concept 
that molecular characterization and understanding of the host-parasite relationship can 
offers therapeutic potential in the context of autoimmune disorders. It has been shown 
for the first time here that Fasciola gigw[eica and Grganlocotyle explanation derived 
somatic products individually and in combination can significantly suppress 
experimentally induced inflammatory condition i.e. CIA. This study suggests that the 
antigen printing before disease induction and daily immunization with parasitic 
products was effective in reducing disease severity, characterized by many patho-
immunological markers including cytokines, transcription regulatory factor, matrix 
metal loproteinases, oxidative stress markers etc. This effect was associated with 
Ag-dependent immune suppression, whereas mitogen-induced responses remained 
intact. Currently available therapeutics in rheumatoid arthritis (RA) are characterized 
often by favorable benefits with certain toxic effects. Recent cytokinc-targeting 
therapies have proven encouraging but as yet to provide a significant level of effect 
(American College of Rheumatology: 50% response or more) in only 40-50% of 
patients (Bathon ci al., 2000 and Lipsky et al., 2000). Therefore, there remains a 
clinical need for novel and robust therapies. The therapeutic strategy explored herein 
capitalizes on co-evolution of parasites with their hosts over millennia to safely and 
specifically modulate host immune responses which could facilitate long-lasting 
parasite establishment in vivo. 
Helminth specific immune response is characterized by the Th2 type of 
immunity, capable of skewing the cell mediated, ThI type immunity responsible for 
autoimmunity. It has been found that the humans infected with filarial nematodes 
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show reduced production of IFN-y and increased production of IL-4/IL- 10 together 
with elevated 1gG4 levels, that indicates a predominant Th2/anti inflammatory 
phenotype, which is instrumental to both parasite survival and host health (Lawrence, 
and Devaney,2001; Hoerauf and Brattig , 2002). It has been well documented that 
such polarisation can facilitate host hyporesponsiveness to coinfeetions by 
suppressing 'lhl/'fh17 responses or by inducing anti-inflammatory responses 
(van Riet et al., 2007). This Thl/Th17 response is characterized by high level of 
IFN-y, TNF-a, IL-2, ILI-13 and 11-17 etc. The Schistosoma adult worms lay eggs in 
the portal veins and the eggs deposited in the liver robustly modulate host immune 
responses from '[hi to Th2 (Grzych et al., 1991; Pearce et al., 1991). Schistosome 
eggs are known to have various immunological effects on immune cells: e.g., 
activation of Treg cells (Mo et al., 2007; Yang et at., 2007) or expansion of B-1 cell 
numbers (Velupillai et al., 1997). Several in vivo studies showed that schistosome 
infections or schistosome antigen (Ag) injections prevent autoiuunune/allergic or 
inflammatory disorders, including Grave's. hyperthyroidism (Nagayarna et al., 2004), 
experimental colitis (Elliott et al., 2003; Mo et al., 2007; Smith ct al., 2007), type-1 
diabetes (Cooke et al., 1999; Zaccone et al., 2003), experimental allergic 
encephalomyelitis (La Flamme and Ruddenklau K Backstrom, 2003; Sewell et al., 
2003) and airway hypersensitivity (Mangan et al., 2006; Yang et al., 2007). These 
observation support the present findings regarding the polarization of immune 
response by the F. gigantica and G. explanatvm derived somatic antigens at the 
cytokine level where the level of anti-inflammatory cytokines; IL-10 and IL-4 
(characteristic of Th2 response) were elevated in antigen treated rats suffering with 
CIA, while the level of pro-inflammatory c) tokines; IFN-y and TNF-a (characteristic 
of Thl response) largely remained under control. It has been found that the filarial 
nematode infection has also been shown in some cases to modulate the human 
immune response to heterologous antigens including vaccines. Of particular interest, 
the Th2-polarizing effect of infection can convert a response that would normally be 
ThI (e.g., to mycobacterial Ag) to Th2 dominance (Stewart et al., 1999). The recently 
defined "Hygiene Hypothesis" proposes that increased incidence of disease associated 
with exacerbated immune responses in the Western world reflects an absence of 
appropriate priming of the immune response with anti-inflammatory nature by 
infectious agents such as parasitic helminthes during childhood (Sewell et al., 2002). 
Consistent with this, it has been suggested that many autoimmune disorders exhibit 
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reduced incidence and severity in geographic regions with high parasitic burden 
(Loc.cit)_ For example, in filarial endemic areas the reduced incidence of RA has been 
recorded, that suggests that environmental factors may subtly alter disease 
progression (Beighton, 1975). ES62 a PC (phosphorylcholine) containing molecule 
has immunosuppressive effect in Thl associated collagen induced arthritis by 
suppressing pro-inflammatory cytokine TNF-a and IFN-y (McInnes et a., 2003). 
During the disease progression. Thl and 1117 cells enter the joint tissues, releasing 
pro-inflammatory cytokines and chemokines which promote macrophage and 
neutrophil infiltration and activation (Firestein, 2003). Different therapeutic 
approaches to prevent the activation of inflammation have been developed for the 
treatment of RA. However, conventional treatments for autoimmune diseases are 
mainly immuno suppressants, which have a variety of adverse effects and do not 
inhibit the inflammatory process in a specific manner (Breedveld and Combe, 2011). 
Among various products from helminth parasites, after being recognized by innate 
immune cells, are capable of inducing several changes. such as the down-regulation of 
pro-inflammatory cytokines in maturated Dendritic Cells via TLR dependent 
pathway, thereby inducing alternative activation of macropltagcs the IL-10 
production by Tregs and B cells, and the production of IL-4 by Basophils (van Riet 
et al., 2007; Maizels, 2007). It has been demonstrated in several experimental models 
that helminth infections can suppress the inflammation through downregulation of 
inflammatory T helper subsets (Thl, Th17, and allergic Th2) (van Riet et al., 2007; 
Segura et al., 2007; Hamilton et al., 2009). In a previous study it as observed that the 
Fasciola hepatica infection induces the suppression of immune responses to 
autoantigens and thus attenuates the clinical symptoms of experimental autoimmune 
encephalomyelitis (Walsh et al., 2009). Furthermore, there are many studies which 
suggest that the IL-10 inhibits the MMPs expression by upregulating TIMPs 
expression (Mark et al., 1999, Kumada et al. 2005; Roth and Fisher, 1999; Mtairag 
et al., 2000). Cytokines such as IL 1-a,(3. T-NF-a are the potent inducer of the MMPs in 
rheumatoid synovial fibroblasts and are directly involved in joint destruction 
(Firestein and Paine, 1992; Dayer et al., 1985). The available cytokine based therapies 
are proven promising upto certain extent in RA and other inflammatory arthritis as 
this therapeutic strategy is aimed to neutralizing pro-inflammatory effector cytokines 
such as TNF-a, IL-I, and IL-6 (Bresnihan et al., 1998; Bathoact al., 2000; Lipsky 
et al., 2000; Nishimoto et al., 1997) and therefore, help in disease remission through 
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many pathways. In terms of disease initiation, it is often considered that the 
autoreactive T cell response in RA is biased toward 4 Thl-type response (Miossec, 
1997), and exploration of therapeutic strategies that necessitates blockade of the 
Thl-associated cytokine (IFN-y) has begun (Sigidin et al., 2001). In the present study 
the level of IL-10 as well as [[:4 was elevated while level of IFN-y and'[NF-n was 
depleted showing that these antigenic therapies promoted secretion of 
anti-inflammatory cytokines and blocking the expression of pro-inflammatory 
cytokines leading to disease remission. 
The inflammatory response produced by the Thl immunity in CIA is also 
accomplished by the excessive secretion of matrix metalloproteases (MMPs) as also 
evident in this study that are involved in extracellular matrix degradation, migration 
of immune cells at infected sites. Functional disability of the joints as a consequence 
of progressive cartilage and hone degradation is a hallmark of RA. MMPs and 
cathepsins are the known effector molecules in the distmetion of articular cartilage 
and hone. These enzymes have been implicated in several pathological processes such 
as tumor, invasion, augiogenesis, atherosclerosis and RA. In RA, angiogenesis is 
considered as a key event in the expansion of the synovial lining of the joints as well 
as immuge cell migration. In synovium, angiogenesis requires proteolysis of the 
extracellular matrix, proliferation and migration of ECs (Endothelial Cells), as well as 
synthesis of new matrix components. RA synovial fibroblasts are the major source of 
MMPs within the synovial lining layer and these cells drive joint destruction as well 
as angiogenesis in RA. MMPs have the ability to degrade ECM components including 
gelatin, collagens, tibronectin, and laminin. Among MMPs. MMP2 plays a crucial 
role in angtogenesis. Although the function of MMP2 in RA has not yet been fully 
elucidated, several studies showed an important role of this MMP in RA. The 
secretion of different MMPs is regulated by cytokines and growth factors usually 
found in arthritic joints. In RA, the activated macrophages of synovium produce 
inflammatory eytokines such as IL-] and tumor necrosis factor-a (TNF-a) that 
stimulate connective tissue cells such as synovial fibroblasts and articular 
chondrocytes to produce MMP-1 and MMP-13 (Mitchell et al, 1996; Firestcin et al., 
1991; Clark ct al, 1993; . Westhoff et al., 1999). The collagenases (MMP-1, MMP-8 
and MMP-13) have the unique ability to cleave the triple helix of collagen, that 
become susceptible to further degradation by other MMPs. Recently, MMP-8 
(traditionally termed as neutrophil collagenase) has been found in arthritic lesions, 
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even in the absence of neutrophils, indicating that ehondrocytes, and perhaps synovial 
cells, can also produce this enzyme (Tetlow et al., 2001 and Shlopov et al., 1997). Dot 
blot and Western blot and ELISA analysis clearly indicate the suppression of 
MMP-13 and MMP8 in joints at different antigenic treatments and their role in 
disease alleviation and thereby protecting the disease severity. The maximum 
inhibition in level of these MMPs was achieved in the order: combined antigen 
(Gigantocoryle-Fasciola)% G. explanatum antigen> F. gi£anlica antigen. 'the gelatin 
zymography also indicated the therapeutic role of these antigens in CIA. The level of 
pro-MMP-9 and active MMP-9, proMMP-2 and active MMP-2 and active MMP-1 3 
significantly decreased at different antigenic treatments but maximum therapeutic 
potential was shown again by the G. explanatvm antigens and also the combined form 
of antigens used. The exact reason behind the suppression is not clear at this stage and 
hence needs to be explored further. Strong polarization of pro-inflammatory inunune 
response induced by type 11 collagen towards the anti-inflammatory immune response 
(a prominent feature of helminth infection) appeared to be induced by the helminth 
antigens understudy, and therefore it would suppress the macrophages and neutrophil 
influx at the site of inflammation through the inhibition of MMPs secretion or 
induction of over expression of TIMP; a natural inhibitor, and by interrupting signal 
transduction pathways. In RA expression of the MMPs is under the control of signal 
transduction pathways, which are stimulated by the cytokines like IL-1(i, TNF-a 
which bring a sequence of reaction that ultimately facilitate transcriptional induction 
of MMPs (Vincenti et al., 2001). This regulatory pathway is also stimulated by 
oxidative stress. NFkB pathway is a major cytokine induced signaling pathway which 
stimulate the translocation of NFkB family members from cytoplasm to the nucleus 
and trigger specific gene or set of genes for the production of different MMPs. NFkB 
pathway is coordinately activated by IL -I (1 and TNF-a and form a central pathway in 
RA and OA (Osteo-Arlhritis). These kinase cascade leads to the transcription of an 
array of inflammatory genes. NFkB pathway is a potential therapeutic target in PL'A. 
This has been supported by the work of Bondeson ct al. (1999) in which the reduced 
expression of inflammatory cytokines and MMPs without the reduction of 
anti-inflammatory cytokines or tissue inhibitor of matrix metalloproteinases was 
achieved. In the present study the NFkB p65 level was significantly down regulated in 
antigen treated rats in general and in G. explanatum and combined antigen therapy in 
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particulanl The reduced expression of NFkB p65 suppresses the pro-inflammatory 
cytokine without compromising anti-inflammatory cytokines. The activation of the 
NF-kB pathway, in the synovial cells of patients with rheumatoid arthritis (RA), leads 
to the transactivation of many responsive genes that contribute to the inflammatory 
phenotype, including TNF-a from macrophages, matrix metalloproteinases from 
synovial fibroblasts and chemokines that recruit immune cells to the inflamed pamtus. 
This is mainly a outcome of activation of the canonical NF-kB pathway which 
involves heterodirners of p5O/p65 subunits (Simmond and Foxwell, 2008). In RA, 
7:NF-a in particular is the prime inflammatory mediator that also induces apoptosis. 
Tmportant(y, the genes encoding "1NF-a and many of the other factors like 
chemokines (such as IL-8, IP-10. MCP-1, M[P-1, and RANTES), matrix 
metalloproteinases (MMPs, such as MMP-1, -3, -9 and -13) and metabolic proteins 
(such as Cox-1, Cox-2 and NNOS) are now known to be under the control of NF-kB 
transcription factors (May and Ghosh, 1998), suggesting that NF-kB could be one of 
the master regulators of inflammatory cytokine production in RA. The presence of 
activated NF-kB transcription factors have been demonstrated in cultured synovial 
fibroblasts (Fujisawa et al., 1996; Koshak ct al., Yamasaki et al. 2001), human 
arthritic joints (Muller-Ladner et al., 2005; Carlsen et al. 2002; Sioud ei al. 1998;  
Marok etal., 1996; Handel ct al., 1998; Benito et al., 2004; Darning et al, 2000) and 
in the joints of animals with experimentally induced RA (Tsao et al, 1997; Han et al., 
1998,). The presence of both p50 and p65 in the nuclei cells lining the synovial 
membrane and macrophages has been demonstrated by Immunohistochemistry 
technique (Loc cit.). Furthermore, it has been demonstrated that the nuclear extracts 
of synovial cells have an ability to bind to the NF-kB consensus sequence (Loc cif). 
Another face of pathology in arthritis is heavy oxidative stress. The reactive 
oxygen species in the form of nitric oxide, superoxide ion, hydroxyl ions, 
peroxinitrile, are the major source of oxidative stress. It is well known that ROS 
(reactive oxygen species) has an important role in the pathogenesis of RA (Kamanli 
et al., 2004; Ilitchori ct al., 2004) and oxygen-free radicals have been implicated in 
joint and cartilage damage (Loc cit.; Karatas et al., 2003). Proteins, lipids, nucleic 
acids, and matrix components are the major target for reactive oxygen species (ROS) 
and its excessive production may cause malfunction in these biornolecules (Loc cit.). 
ROS also serves as important intracellular signaling molecules that amplifies the 
synovial inflammatory-proliferative response and also serve as a stimulus to the 
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transcription factory NFkB. One of the indices of oxidative damage is 
malondialdehyde formation as the end product of lipid peroxidation (Ozkan et al., 
2007). The induction of arthritis in mice significantly increased MDA level and 
oxidized proteins such as protein carbonyl (PC) etc. in various organs (Choi, 2007). In 
the present study the level of antioxidant enzymes SOD, GST and catalase were 
significantly elevated in rats treated with liver fluke/amphistome antigens, thereby 
saving the animal from the oxidative damage produced due to collagen injections. The 
effective antioxidant system appeared to be further supported by the minimal level of 
MDA formation and oxidized protein in the form of protein carbonylation in joints. 
Nitric Oxide (NO) is a free radical that serves as an important signaling molecule in 
inflammatory conditions (Kerwin and Ileller et al., 1994). In arthritis NO induces the 
production of pro-inflammatory cytokines such as TNF-u. IL-113 and IFN-y as well as 
collagenases (I-Ieirholzer et al., 1998; McInnes. 1998). In the present study the level of 
NO was very high in CIA rats which coincides with the high level of MMPs. 
pro-inflammatory cytokines, transcription factor and high oxidative stress in the form 
of depleted antioxidant enzymes, high lipid peroxidation and protein carbonylation 
which were significantly dropped at most of treatments using the parasite antigens 
selected in the present study suggesting, the anti-inflammatory environment and thus 
suppression of pro-inflammatory environment. 
Scanning electron microscopic results further provide a strong clue for the 
therapeutic efficacy of the antigens used in our study. Results revealed a distinctly 
disrupted patellae in ('IA rats with synovial and ligament growth, shrinkage in the 
area of articular cartilage. While no such destruction was observed in treated rats, but 
there was folding in synovial membrane suggesting the synovial hypertrophy and 
loosening of the membrane. The results showed the maximum protection by treatment 
with combined antigens followed by treatment with G. rxplanaWan antigens and then 
by F. gigunticu antigens. The reason behind this differential therapeutic effect of these 
antigens certainly requires further extensive studies. 
An anti-arthritic effect of F. gigantica antigens. G. explancitum antigens and the 
combined forum was also evident in histo-pathological examination of the inflamed 
paws, indicating that antigenic treatments could suppress not only inflammation but 
also restricted the progression of arthritis. "I'he histological examination showed a 
differential recruitment of immune cells in synovial membrane. Taken together, it can 
be concluded here that the present study is the first preliminary successful attempt to 
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explore the therapeutic potential of the flukes of great economic importance and it 
could not only form an important contribution to the existing knowledge but it would 
also open up new vistas for the future investigations. 
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CONCLUSION 
mmune response against helminth parasites is dominated by Th2 type 
which is humoral in nature and the Thl arm of immune mechanism does not operate 
effectively reflecting an ineffective role of the innate immune cells as the large bodied 
worms cannot be engulfed by these cells. The main characteristic of the Th2 response 
is the production of anti-inflammatory cytokines including IL-10 and IL-4. Thus these 
parasites skewed the host body protective mechanism for the well being of both the 
host and parasite and thus lead to the establishment of long lasting host-parasite 
relationship. This concept of the helminth behavior can be effectively capitalized for 
the therapeutic strategy in autoimmune disorders. 
In the present study, the helminth parasites; Fusciola gigantica and 
Giguntocoty1c explanalum somatic antigens exerted sufficient Th2 immune response 
in Wistar rats. The level of anti-inflammatory cytokines; IL-4 and IL-10 and pro-
inflammatory cytokines; IFN-y and TNF-a was significantly changed after the 
different antigenic challenges for 24 hours as well as 21 days with somewhat 
dominated anti-inflammatory Th2 type of response. The level of nitric oxide (NO) 
which act as an important signaling molecule directing the immune response, was also 
changed but such change was not capable to exert enough oxidative stress in serum 
while the high level of NO with the significant elevation in lipid peroxidation and 
protein carbonylation was observed in different tissues viz, liver, spleen, lungs and 
kidney at certain doses of different antigens showing the site specific oxidative stress. 
Among all the tissues used, liver was found to be more prone to the antigen induced 
oxidative stress while the exposure of rats to combination of both the antigens 
induced least oxidative stress. 
The immune response developed against F. gigantica and G. explanurtiH 
derived somatic antigens was enough to exploit them as a therapeutic agent in 
autoimmune arthritis i.e collagen induced arthritis (CIA) in Wistar rats. The 
subcutaneous treatment with these antigens gave enough protection at certain doses. 
The level of anti-inflammatory cytokines; IL-10 and IL-4 was significantly elevated, 
whereas the expression of pro-inflammatory cytokines; IFN-? and TNF-a was 
Conclusion 
depleted in a significant manner suggesting the therapeutic efficacy of these antigens. 
The matrix mctalloproteinases (MMPs) have key role during the pathogenesis of RA. 
The level different MMPs (MMP2, MMP-8, MMP-9 and MMP-13) was significantly 
down-regulated after the different antigenic treatments. The low level of MMPs again 
suggests the anti-inflammatory environment inside the host that can be correlated with 
the cytokines milieu. It is well known that the MMPs secretion is upregulated by high 
level of TNF-a (Dayer et al.. 1985), which was already under expressed after 
antigenic treatment leading to the suppression of MMPs. Furthermore, in 
pathophysiological perspectives oxidative stress play a major role in RA. The 
uncontrolled over production of ROS/ free radicals induces sever pathology, causing 
tissue damage (Mapp et al., 1995). In the present study, we used various oxidative 
stress markers namely: antioxidant enzymes; super oxide dismutase (SOD), 
glutathione-S-transferase (OST), catalase and oxidative damage markers; 
malondialdehyde (MDA) and protein carbonylation (PC). In CIA rats the level of 
antioxidant enzymes significantly depleted while oxidative damage markers' were 
highly expressed which shows the disease severity due to the collagen inoculation. In 
contrast, the treatment with liver fluke antigens significantly ameliorates the disease 
severity by excessive production of antioxidant enzymes to scavenge the ROSs and 
subsequently the inhibition of `oxidative damage markers' was achieved. The 
significant under expression of transcriptional factor NFkB p65 in treated rats is the 
outcome of the suppression of pro-inflammatory cytokines and low oxidative stress 
that are the main inducer of NFkB p65 mediated transcriptional initiation of myriad of 
the pro-inflammatory genes. 
Additionally, the patellar surface morphology and synovial histology also 
suggest the protective role of these antigens in CIA in Wistar rats. The low level of 
above discussed bio-markers further suggests the prevention of synovial membrane 
and articular cartilage damage by these antigens. The high pro-inflammatory 
environment, upregulation of MMPs, and high expression of oxidative stress result in 
to the destruction to the cartilage, bone tissue and cause severe synovial pathology 
that ultimately leads to the disability, which could certainly be protected by 
inoculating the antigens used in the present study. However, further studies are 
necessary to identify and characterize the active components out of the whole may of 
somatic antigens used since limited resources did not allow us to carry out this aspect 
at this stage. 
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